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ABSTRACT
A mixture of different mtDNA molecules in a single sample is a significant obstacle to
the successful use of standard methods of mtDNA analysis (i.e., dideoxy dye-terminator
sequencing). Forensic analysts often encounter either naturally occurring mixtures (e.g.,
heteroplasmy) or situational mixtures typically arising from a combination of body fluids
from separate individuals. The ability to accurately resolve and interpret these types of
samples in a timely and cost efficient manner would substantially increase the power of
mtDNA analysis and potentially provide valuable investigative information by allowing
its use in cases where the current approach is limited or fails. Therefore, this research
was aimed at developing a strategy for the use of Denaturing High-Performance Liquid
Chromatography (DHPLC) as a developmentally-validated forensic application for
resolving mixtures of mtDNA. To facilitate the adoption of this technology by the
forensic community, a significant effort has been made to ensure that this technology
meets the Scientific Working Group on DNA Analysis Methods (SWGDAM)
developmental validation criteria and interfaces smoothly with previously validated
methods of forensic mtDNA analysis. To do this, the method developed using DHPLC
employs mtDNA amplicons, PCR conditions and DNA sequencing protocols validated for
ii

use in forensic laboratories. These factors are essential in implementing DHPLC analysis
in a forensic casework environment and for the admissibility of DHPLC and Linkage
Phase Analysis in court.
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Chapter 1: The Introduction
§1-1

General Background
When traditional genomic DNA analysis based on short tandem repeat

(STR) loci fail to yield results, forensic analysts have sought alternative means in
order to determine a genetic profile. Mitochondrial DNA (mtDNA) analysis has
often proved to be a powerful analytical approach to such forensic
investigations. Conventional DNA typing relies on high molecular weight nuclear
DNA, which can degrade quickly and thus fail to yield sufficient probative
information to investigators. In these cases, the abundance, small size and
circular nature of mtDNA make it an attractive target for forensic analysis. The
scientific basis for mtDNA analysis have been thoroughly tested and validated by
the forensic community and standard operating procedures are in place for
sample handling, amplification and data analysis. The high copy number per cell
(hundreds to thousands of copies/cell), subcellular sequestration and
exonuclease-resistant circular nature aid in the successful analysis of severely
degraded or otherwise challenging samples (Budowle et al., 1999; Holland and
Parsons, 1999). The small size of the amplification product obtained from
mitochondrial hypervariable regions 1 and 2 (HV1 and HV2) also facilitates the
analysis of challenging evidentiary material. This has been helpful in solving cases
such as the identification of skeletal remains from the Vietnam War (Holland et
1

al., 1993); identification of bone material from a grave in Yekaterinburg, Russia,
thought to belong to Tsar Nicholas II (Ivanov et al., 1996); and the identification
of shed hairs from robbery caps (Allen et al., 1998).
Developments based on these and other studies have resulted in an
accepted approach to mtDNA analysis that has withstood several court
challenges (e.g., State v. Council, 335 S.C. 1, 515 S.E.2d 508 (S.C., Apr 05 (The
State v. Donney S. Council, 1999)) (NO. 24932), People v. Klinger, 713 N.Y.S.2d
823, 2000 N.Y. Slip Op. 20450 (N.Y.Co.Ct., Sep 05 (People v. Micheal Klinger and
Raymond Klinger, 2000)) (NO. 0849/00), State v. Ware, 1999 WL 233592
(Tenn.Crim.App., Apr 20 (State of Tennessee v. Paul William Ware, 1999)) (NO.
03C01-9705CR00164)).
§ 1 - 1.1

Mitochondrial DNA Genetics

The two strands of the ≈16Kb human mtDNA genome differ considerably
in their base composition. The heavy strand is rich in guanine and the light
strand, rich in cytosine. A duplicated stretch of the heavy strand exists as an
independent fragment (7S DNA). This fragment binds to the D-loop where it
participates in the formation of a triple helical DNA structure. The sequence of
the mitochondrial genome encodes a total of 28 genes on the heavy strand and 9
genes on the light strand. Of these, 22 encode mitochondrial tRNAs, two encode
rRNA components (16S and 23S) of mitochondrial ribosomes, and the remaining
2

thirteen are templates for mRNAs that direct the synthesis of polypeptide
subunits that contribute to the structure of mitochondrial respiratory complexes.
The mitochondrial genome contains very little non-coding sequence (7%),
in contrast to the nuclear genome where approximately 97% of the sequence is
thought not to be expressed. The 37 genes of the mitochondrial genome lack
introns, are nearly contiguous with each other, and even overlap in some cases.
With the exception of one or two non-coding bases that often exist between
neighboring genes; the only significant non-coding region of the mitochondrial is
the displacement loop also known as the D-Loop. This region of triplex DNA, also
known as the “control region”, contains the origin of replication for the heavy
strand and the predominant transcriptional promoters for the generation of
large multigenic transcripts. Portions of this region, designated hypervariable
region 1 (HV1) and 2 (HV2), are of particular forensic utility because of the high
degree of sequence polymorphism they exhibit within human populations. A
third region, hypervariable region 3 (HV3), has also been described and is used
only by a handful of laboratories and then only to try and differentiate
indistinguishable HV1/HV2 samples (Lutz et al., 2000; Bini et al., 2003).
The mitochondrial sequence database MITOMAP (www.mitomap.org)
which maintains a list of published mtDNA polymorphisms currently lists 845
polymorphisms (as of January 28th, 2011) that occur throughout the 674 bases of

3

the forensically informative HV1 and HV2 regions. Single base substitutions (56%
transitions and 33% transversions) account for the overwhelming majority of
these polymorphisms, although insertions and deletions are also seen. Even
though many of these polymorphisms are seen only infrequently or are limited to
specific ethnic populations, pair-wise comparisons of mtDNA sequences for both
hypervariable regions between maternally unrelated individuals usually reveal
multiple sequence differences. Based on studies of 4839 unrelated individuals
the highest amounts of sequence diversity recorded are observed in populations
of African extraction with an average of 14.5 sequence differences between
individuals (Monson et al., 2002). The lowest diversity was seen in Caucasians
where an average of only 7.9 differences has been reported between individuals.
Even so, the most common HV1/HV2 haplotype found in Caucasians account for
approximately 7% of the population. Only 12 additional haplotypes are found at
frequencies greater than approximately 0.5% (ignoring C-stretch polymorphism
in HV2).
By some estimates, mutations arise and are fixed in the mitochondrial
genome at a rate approaching twenty times that of equivalent sequences in
nuclear genomes (Parsons et al., 1997). A number of factors have been proposed
to account for this degree of sequence instability including an inefficient system
for DNA repair, oxidative damage, and the greater number of replicate cycles

4

that mtDNA undergoes relative to nuclear DNA during cell growth and
development (Pinz et al., 1995; Shadel and Clayton, 1997; Dianov et al., 2001).
§ 1 - 1.2

Inheritance Issues

The mitochondrial genome is maternally inherited thus an individual’s
haplotype is a direct reflection of the up to 100,000 copies of the mitochondrial
genome present in the oocyte at fertilization. The preponderance of evidence
examined to date suggest that in most individuals, in spite of an accelerated
mutation rate, the majority of mtDNA molecules within any single individual at
maturity will still be represented by a single sequence (homoplasmy).
Occasionally, a de novo mutation may arise and proliferate within the mtDNA
population resulting in the existence of two distinct haplotypes within a single
individual (heteroplasmy). This should theoretically, increase the discriminatory
power of forensic mtDNA analysis by providing an additional character state for
inclusion in the haplotype. This was the case for forensic analyses of mtDNA that
were used to help identify the putative remains of Czar Nicholas II exhumed in
1991 from Yekaterinburg, Russia (Ivanov et al., 1996). Haplotyping of bone
fragments suspected of being those of Czar Nicholas revealed a rare
heteroplasmic mixture of mtDNA at position 16169 in HV1 where C and T
appeared to account for about 70% and 30% of the mixture, respectively.
Haplotyping of mtDNA from the exhumed remains of the Czar’s brother Grand
Duke Georgij's revealed a similarly rare heteroplasmic mixture of C and T at
5

position 16169. When combined with sequence identity throughout the
remainder of the D-loop, the inclusion of a shared heteroplasmy significantly
strengthens the weight of the mtDNA match. In practice, however, the
overlapping peaks seen in direct sequencing data from the PCR-amplified mtDNA
of

heteroplasmic

individuals

often

complicates

interpretation

of

the

electropherogram. In cases of near equal mixtures of mtDNA, such positions are
often discarded by the analysis software or the analyst as ambiguous bases. In
other cases, the position may be subjectively called by an experienced DNA
analyst. The exclusion of a base from consideration results in a decrease in
discriminatory power.
§ 1 - 1.3

Mutation Rates

Due to the lack of recombination and the lack of highly effective DNA
repair mechanisms, mtDNA provides an excellent opportunity to investigate
human evolution and migration. Mitochondrial genetics, due to strict maternal
inheritance, enables researchers to gain a higher resolution perspective on
modern human population structures and divergence times (Cann et al., 1987;
Ingman et al., 2000) than would be possible based on nuclear markers. More
significantly, this makes it possible to divide humans into a collection of mtDNA
haplogroups which can be used as biogeographic indicators of genetic
populations.

6

The high rate of nucleotide substitutions in mtDNA has been of interest in
the scientific community for some time. Various contributing factors have been
proposed to explain this. These include the oxidative environment of the
mitochondria, and insufficient repair mechanisms (Shadel and Clayton, 1997).
Poor DNA replication activity could also be raised as a contributing factor, since
only one DNA polymerase is dedicated to mtDNA replication. While polymerase
gamma (γ), a high fidelity polymerase, with 3’-5’ exonuclease activity (Copeland
and Longley, 2003), would not be predicted to result in high mutation rates,
oxidative damage can cause misincorporation during DNA replication (Pinz et al.,
1995). Additional DNA repair mechanisms include nucleotide excision and base
excision repair. Nucleotide excision repairs (NER) restores the majority of UVinduced DNA damage (e.g. thymine dimers) by removing a short section of single
stranded DNA surrounding the lesion. This is subsequently filled in by DNA
polymerase using the opposite strand as a template. Base excision repair (BER)
restores the integrity of DNA bases that have been modified by deamination or
alkylation, causing incorrect base pairing. This is achieved by removing the
modified base to yield an abasic site. This is subsequently filled in by DNA
polymerase much as is the case for NER (Friedberg et al., 1995). While BER
appears to be efficient in the mitochondria, NER is not as well developed
(Clayton et al., 1974; Dianov et al., 2001).

7

Human mtDNA recombination and the possibility of paternal inheritance
have been topics of discussion in recent years. There is a lack of evidence
supporting recombination of human mtDNA and periodic reports in the literature
claiming recombination of human mtDNA have been strongly criticized as being
due to sequencing errors, incorrect phylogenetic construction due to
assumptions of hypothetical ancestral haplotype extinction and rejection of
mutational hot spots (i.e., sites within the mitochondrial D-loop which mutate
even more rapidly than others in the same region) (Budowle et al., 2003). The
inability to even detect recombination of mtDNA has been largely unsuccessful,
even in experiments where hybrid cells are formed from two donors (Shadel and
Clayton, 1997). If, in fact, recombination does occur, it would appear to be
extremely rare. The same can be said for paternal inheritance of mtDNA. Initial
claims were reported by Hagelberg et al., where a rare mutation was detected in
three unrelated populations within one geographic origin. This could only be
explained by paternal leakage and recombination. The paper was later retracted
due to sequencing alignment errors, but the argument continues as reports of
paternal mitochondria entering the egg have periodically appeared in the
professional literature (Cummins, 2000). Even in cases where this might occur,
however, the paternal mtDNA sequence would be rapidly and enormously
diluted since unfertilized eggs have been reported to have as many as 100,000
mtDNA genomes (Chen et al., 1995). Furthermore, selective destruction of sperm
8

mitochondria by the developing zygote due to ubiquitin tagging which takes
place during spermatogenesis would appear to effectively eliminate the potential
for paternal leakage (Sutovsky et al., 1999).
A single case of paternal leakage has, however, been reported in the
literature (Schwartz and Vissing, 2002). In this case, the subject suffered from
mitochondrial myopathy as a result of a novel 2bp deletion in the gene encoding
for a subunit of the enzyme complex I of the mitochondrial respiratory chain. It
could be that the pathogenic mutation conferred a selective advantage allowing
it to escape destruction. Additional studies of individuals suffering from the same
muscle disease have, however, failed to identify any evidence of paternal
transmission of mtDNA (Filosto et al., 2003; Johns, 2003; Taylor et al., 2003).

§1-2

Forensic Assessment and Validation Standards
Ever since scientific evidence became an integral part of the criminal

justice system a question of whether the evidence is trustworthy and based on
accurate and consistent scientific methods has been asked. In order to be
admissible to a court of law, any item of evidence must be obtained, presented
and analyzed in a manner that is generally accepted in the scientific community.
Ever since 1923, following a decision by the District of Columbia Court of
Appeals, and subsequently referred to as the Frye standard (Frye v. United
States, 293 F. 1013, 1014 (D.C. Cir. (Frye vs. United States, 1923)), a technology
9

or methodology cannot be considered admissible until it has been widely
accepted by the relevant scientific community. The Frye standard, however, was
and still is criticized for being overly restrictive, as it can dismiss testimony based
on novel but credible scientific approaches which have yet to gain wide
acceptance as measured by the professional literature. As the speed of scientific
development increases, this imposes a significant obstacle for newer
technologies.
As a result of Daubert vs. Merrell Dow Pharmaceuticals, Inc. (509 U.S. 579
(Daubert vs. Merrell Dow Pharmaceuticals, Inc., 1993)) the rules of general
acceptance have been broadened such as to allow for admission of scientific
technologies and resulting evidence that are lacking in broad acceptance in the
scientific literature. Known as the Daubert standard, admissibility requires that
the technology rest on sound scientific footing; that it has been thoroughly
tested and validated; that it has representation in the peer review literature and
that it has an established error rate. The change to the Federal Rules of Evidence
in 2000 cemented the evolving Daubert standard, bringing into practice rules
that not only outlined the standards associated with the evidence, but also the
testimony of expert witnesses based around that evidence.
Testability of the scientific methods must be obtained through extensive
validation studies performed within the laboratory as well as between
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laboratories. In terms of DNA validation studies, several agencies have published
explicit guidelines on factors to be taken into consideration when performing
them and the specific experiments to be conducted. Results of the validation
studies are used to determine the error rates necessary for the method to be
considered scientifically sound. Data from validation studies are then published
in peer review journals.
The Scientific Working Group on DNA Analysis Methods (SWGDAM) has
published revised developmental validation guidelines for the implementation of
new forensic DNA analysis technologies (SWGDAM, 2004). For the purpose of
mtDNA mixture analysis, previously validated procedures for mtDNA analysis on
genetic markers, species specificity and amplification conditions were not
repeated as they were not germane to the application being developed.
However, reproducibility, sensitivity and accuracy of the mixture separation
method in question were determined in accordance with the established
guidelines and the previously validated amplification procedures and conditions.
§ 1 - 2.1

Current Approaches to Forensic Analysis of mtDNA

In contrast to the majority of forensic DNA profiling methods that rely on
the identification of length polymorphisms in nuclear DNA, mtDNA profiling
relies on direct examination of DNA sequence from an extra-nuclear molecule of
DNA. With rare exception (Iwabe and Miyata, 2001), mtDNA is present in the
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cytoplasm of virtually all eukaryotes. In humans, the mitochondrial genome is a
single circular molecule of DNA typically consisting of 16,569 base pairs
(Anderson et al., 1981). The majority of human cells contain several hundred to
thousands of copies of the mitochondrial genome such that the total compliment
of mtDNA accounts for as much as 0.5% of the DNA in a nucleated cell. The
abundance of mitochondrial molecules makes mtDNA an especially robust target
for forensic analysis since it can often be amplified from tissues where sufficient
amounts of chromosomal DNA may be absent (e.g., hair shafts and
environmentally degraded tissues).
The profiling of human mtDNA is achieved by comparison of DNA
sequence data to the revised Cambridge Reference Sequence (rCRS) (Anderson
et al., 1981; Andrews et al., 1999) (Figure 1.1). Differences are noted and
reported by indicating the nucleotide position and the identity of the altered
base. Automated DNA sequencing of PCR-amplified hypervariable regions of
mtDNA is the current method of choice for forensic analysis. Amplification of the
HV1/HV2 regions of the D-loop is achieved by use of up to four pairs of PCR
primers (Wilson et al., 1995). For hairs without follicle tissue or for degraded
tissues where severely fragmented or low levels of mtDNA are likely to be
present, all four primer pairs are employed. Two primer pairs amplify HV1 to
yield overlapping products of 278 and 271 base pairs, respectively. These primers
pairs are designated L15997/H16236 (defining HV1A) and L16159/H16391
12

Figure 1.1: Schematic representation of the circular human mitochondrial DNA
genome showing the locations of the D-loop and genes encoded by the circular
genome. The D-loop region is divided into two large fragments, HV1 and HV2
(433 and 401bp, respectively) which for forensic purposes are further divided
into two amplicons each (HV1A, HV1B, HV2A and HV2B). These smaller
fragments are amplified using the primers listed in table 2.1.
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(defining HV1B) where “H” and “L” refer to the heavy and light strand and the
number indicates the base position of the primer relative to the Anderson
sequence (Anderson et al., 1981; Budowle et al., 2000). Two other primer pairs
(L048/H285 defining HV2A and L172/H408 defining HV2B) amplify the HV2
region to yield overlapping products of 278 and 277 base pairs, respectively
(Figure 1.1).
Additional primer pairs have been developed and are currently in use in
the forensic community. The Armed Forces DNA Identification Laboratory
(Rockville, MD) has developed primer sets which include “mini-primers”. These
are sets of amplification primers optimized for amplification of severely degraded
remains. These further divide the mtDNA hypervariable regions into eight
overlapping regions maximizing the potential to amplify target sites from highly
fragmented mtDNA molecules (Gabriel et al., 2001).
The PCR amplified fragments serve as templates for DNA sequencing by
the dideoxy chain termination method (Sanger et al., 1977). The DNA templates
are cyclically denatured and nascent strands of DNA are synthesized in the
presence of fluorescently labeled dideoxyribonucleotide terminators. The use of
PCR and laser-induced fluorescence for sequencing makes it possible to analyze
extremely minute quantities of evidentiary material.
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Alternative sequence detection/screening technologies for the analysis of
mtDNA have been investigated. In recent years, these include the use of
immobilized sequence-specific oligonucleotide (SSO) probes (Reynolds et al.,
2000; Gabriel et al., 2001), microarrays (Fukushima, 1999) and time-of-flight
mass spectrometry (Butler and Becker, 2001). These approaches are limited to
the detection of polymorphisms for which the researcher has a priori knowledge.
Thus, it is often necessary to design additional probes in order to detect novel or
population-specific polymorphisms.
§ 1 - 2.2

Mitochondrial DNA Validation for Forensic Casework

Validation studies have been performed for consistency in mtDNA
profiling. These span a variety of tissue types, varying degrees of degradation and
environmental contaminants as well as cross amplification testing between
species (Wilson et al., 1995). Sequencing results were obtained for known
samples of hair and blood as well as blood and semen stains on various
substrates. These substrates included fabrics, such as nylon and denim, carpet,
leather, wallboard and wood, all of which represent frequently encountered
types of evidentiary material. To test the detection capabilities of the
amplification process with degraded material, tissue samples were incubated at
room temperature for a number of weeks prior to DNA extraction. Sequences
were also obtained from blood subjected to environmental contaminants
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commonly encountered in a forensic context such as used motor oil, gasoline,
soil, detergent, NaOH and acetic acid.
Additional validation studies tested the cross-reactivity of the human
specific primers on non-human samples, such as rabbit, chicken, goat, horse
among others, as well as several species of primates (macaque, orangutan,
Celebes ape and gorilla). Macaque, orangutan and gorilla yielded amplifiable
products; however, sequencing results on 215 bases from gorilla yielded 37
polymorphisms and 5 insertions when compared to the human reference
sequence. For the same region, a database search of 1907 human sequences
revealed that the greatest number of polymorphisms observed was 13.
Haplotyping of hairs subjected to a variety of treatments was performed
as part of the validation study. DNA extracts were prepared from hair treated
with conditioners, dyes and microscopic mounting media, as well as hair
contaminated with dirt and body fluids. Hair samples were recovered from
deceased individuals as well as from various areas of the head and body. Due to
the rudimentary extraction procedures as well as insufficient knowledge of the
ease of mtDNA cross-contamination at the time of the validation study, reagent
blanks and negative controls frequently resulted in amplification at a level
greater than 10% of the amplified product from the known sample. This was
most likely due to reuse of grinding vessels employed during the extraction
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process. For samples that were not contaminated, the haplotypes obtained
matched the donor’s blood sample haplotype in all cases. Current interpretation
guidelines, however, still follow the 10% “contamination standard”, where the
presence of underlying peaks in the sequencing electropherogram are
considered dye-terminator artifacts as long as they account for <10% of the
major peak. Due to improvements in sample extraction protocols, cross
contamination between samples has been significantly decreased from that
reported in the original DNA extraction validation studies. For example, the
contamination rate was determined to be 2.4% based on an analysis of 1218
casework extractions. Furthermore, in no case was contamination seen for all 4
amplification reactions needed for complete mtDNA haplotyping (Melton and
Nelson, 2001).
Thus, the original mtDNA validation studies showed that PCR
amplification and subsequent sequencing of PCR products is a reliable method
for mtDNA typing from hair, blood and semen. Although significant
precautionary methods must be employed to minimize the potential for sample
contamination during processing, the approach yields reproducible and
dependable results.
Sequence analysis of mtDNA has since then been used to identify
weathered skeletal remains for which nuclear DNA analysis had failed (Holland et
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al., 1993). In these cases, bone samples were pulverized and the DNA was
subsequently isolated (Hochmeister et al., 1991) and sequenced for direct
comparison to known maternal reference samples. Identification of skeletal
remains, through mtDNA typing has since become a mainstay of the Armed
Forces DNA Identification Laboratory, giving closure to families of soldiers that
have gone missing in action.
§1-3

The Problem of Mitochondrial DNA Mixtures in Forensics
While mtDNA analysis is usually advantageous in a forensic context

(Wilson et al., 1993), mtDNA sequence data can also be compromised by
contaminating DNA (i.e., DNA from a minor source contributor) (Wilson et al.,
1995; Budowle et al., 2000). As pointed out previously, studies to date suggest
that as long as the contaminating DNA accounts for less than 10% of the
amplified product it will not compromise the accuracy of sequencing results
obtained for the major source amplicon. While this makes sequencing somewhat
“tolerant” of low-level DNA contamination, it also prevents the accurate
detection and characterization of many cases of sequence heteroplasmy (i.e.,
those where the heteroplasmic sequence is <10% of the major haplotypes).
Conversely, the presence of one or more DNA sequence variants (especially
length variants) at levels greater than 10% of the amplified major source product
makes interpretation of sequence data difficult if not impossible. The challenge
of analyzing mtDNA mixtures is one of the most significant obstacles to the
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broader use of mtDNA in forensics. Mixtures can be either “natural” (i.e.,
heteroplasmy within an individual) or “situational” (i.e., resulting from a mixture
of DNA from multiple unrelated individuals). In forensics, natural or situational
mixtures of mtDNA molecules that differ by sequence or length can prevent an
analyst from being able to determine the true level of discrimination between
sequences that are thought to “match” (Fourney, 1998). Variations in DNA
sequence result in ambiguous base calls while variations in DNA length result in
large stretches of unreadable sequence data (Figure 1.2). In these cases, an
analyst can try to employ additional sequencing primers in an effort to obtain
readable sequence from amplicons that flank rather than traverse the site of the
length variant. Even when this approach works, however, the total amount of
sequence data that can be used to characterize a given haplotype is reduced
(Holland and Parsons, 1999).
Extensive casework records indicate that a significant proportion of hairs (20.1%)
are either heteroplasmic or display a mixed profile (Melton et al., 2005).
Moreover, the occurrence of non-heteroplasmic mixed mtDNA profiles appears
to increase with the age of a sample and is usually not ameliorated even when
following extensive validated cleaning methods (Melton et al., 2005). This,
however, is likely to represent only the “tip of the iceberg” since samples which
are suspected to contain mixtures are usually not accepted for analysis.
Therefore, a reliable means of identifying the individual sequences within a
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Figure 1.2: DNA Sequencing electropherogram showing ambiguous base calls as
indicated by overlapping electrophoretic peaks (arrows in Figure 1.2A) and
unreadable sequence data resulting from a mixture of mtDNA length variants
(Figure 1.2B). Length variants cause the sequence to fall out of register beginning
at the site of the insertion/deletion that produces the variation in length.
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mixture could greatly aid investigators by increasing the range of casework
samples suitable for mtDNA testing.
§ 1 - 3.1

Current Strategies for mtDNA Mixture Separation

In forensics, medical diagnostics and basic research, the accurate
detection of DNA sequence variation is critical. Its excellent resolving power has
long made polyacrylamide gel electrophoresis through slab gels or capillaries the
technology of choice for DNA sequencing. The mobility and separation efficiency
of nucleic acid fragments in these systems, however, can be adversely influenced
by the conductivity difference between the analyte and the surrounding buffer
unless measures are taken to ensure efficient removal of salts from the sample.
Additionally, the denaturing gel systems that are the mainstay of mtDNA typing
are often incapable of producing useful data from mixed populations of
molecules that either differ in sequence but are identical in length or that are
nearly identical in sequence but which contain at least one length polymorphism,
(e.g., cases of mtDNA sequence and length heteroplasmy).
Several alternative strategies have, therefore, been proposed to separate
DNA mixtures. These include denaturing gradient gel electrophoresis (DGGE)
(Hanekamp et al., 1996), single-strand conformational polymorphism (SSCP)
(Barros et al., 1997) analysis and sub-cloning into bacterial vectors (Hatsch et al.,
2007). These approaches are generally time consuming, necessitate multiple
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handling steps, require laborious product purification and are not readily
adaptable to automation. These factors have all been obstacles to the
implementation of these technologies by forensic laboratories. Both DGGE and
SSCP require manual recovery of fractionated DNA from polyacrylamide gels and
a second round of PCR amplification to generate enough template for DNA
sequencing. This poses a significant problem in a forensic context as
reamplification of PCR products increases the risk of contamination and effects
of

polymerase-mediated

nucleotide

misincorporation

events.

Also,

in

comparative studies, SSCP is only able to detect mixtures in 50-97.5% of samples
depending upon the length and base sequence of the analyzed fragment (Gross
et al., 1999; Dobson-Stone et al., 2000). Similar results were found for other
methods including DGGE (Liu et al., 1998; O'Donovan et al., 1998; Jones et al.,
1999).
Subcloning is an even more time and labor-intensive approach. It would
require forensic scientists to screen and sequence DNA from multiple
transformed bacterial colonies to ensure that observed sequence differences
reflect genuine contributors to the starting template rather than artificial
variants that were introduced as a result of DNA nucleotide misincorporation by
the Taq polymerase used for PCR. While alternate methods (e.g., sub-cloning)
could readily separate the contributors to a mixture, such approaches are time
consuming; contamination prone due to increased sample manipulation and
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interpretation of the resulting data can be compromised by artificial sequence
variants that frequently arise.
§ 1 - 3.2

The Current State of DHPLC Technology

Denaturing HPLC, widely used in medical research, is an accurate method
for rapid, low-cost detection of DNA mixtures and fractionation into their
individual components in preparation for subsequent characterization by direct
DNA sequencing. While doing so, DHPLC addresses the limitations of the
alternative strategies described above. Forensic laboratory implementation of a
commercial DHPLC analysis system can be achieved with minimal training at a
very reasonable startup cost that is comparable to that of existing DNA
sequencing technologies. Seamless incorporation, integrated software and
minimal sample consumption also allow for a high degree of automation and
streamlining of sample processing and analysis. Finally, the reagent cost for
DHPLC analysis is significantly less than that for alternative approaches.
Denaturing HPLC is a method of comparative nucleic acid sequence
detection that employs crude PCR products and which is not compromised by the
presence of salts or sequence/length heteroplasmy. As originally developed, the
technique allows comparative sequence analysis based on the chromatographic
separation of denatured and renatured nucleic acids. DHPLC enables the
fractionation and subsequent recovery of a DNA mixture on the basis of either
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nucleotide sequence or length. Thus, it is possible to isolate and identify the
individual contributors to a mixture even in cases where two DNA molecules are
identical in length but differ in sequence. The fundamental principle that makes
this possible is Temperature Modulated Heteroduplex Analysis (TMHA). This
process separates DNA molecules into a series of discernable chromatographic
peaks (Huber et al., 1993) (Figure 1.3). The injected DNA binds to a hydrophobic
HPLC column in a buffer of triethylammonium acetate (TEAA), which acts as an
ion pairing reagent between the negatively-charged backbone of the DNA and
the alkylated poly(styrene-divinylbenzene) resin of the HPLC column (Huber et
al., 1993). The chemistry and nonporous structure of the column matrix ensure
high-resolution nucleic acid separation with rapid regeneration and equilibration
between runs.
The DNA is eluted from the column with an increasing gradient of
acetonitrile at an elevated temperature. Under these conditions, partial
denaturation of double-stranded DNA occurs such that even subtle sequence
differences (i.e., single nucleotide substitutions, insertions, deletions) between
DNA molecules are readily indicated by the appearance of one or more early
eluting peaks/shoulders in the resulting chromatographic profile. These early
eluting (i.e., shorter retention time) peaks are produced by heteroduplex
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Figure 1.3: DHPLC chromatographic trace of a mtDNA mixture illustrating heteroand homoduplices produced by cross-hybridization of two HV2A amplification
products. One amplicon has an A/T basepair while the other has a G/C basepair
at the same site. The earliest eluting peak contains the most destabilizing
basepair mismatch (i.e., A/C) while the latest eluting peak has the most
stabilizing basepair (i.e., G/C) at the same position.

25

molecules that denature and elute at lower concentrations of acetonitrile than
corresponding homoduplices (O'Donovan et al., 1998; Hou and Zhang, 2000). As
illustrated in figure 1.3, the retention times at which individual heteroduplex and
homoduplex peaks resolve is a function of the specific base composition,
nucleotide mismatch(es) and nearest neighbor interactions of the molecules
being separated. Accordingly, the presence of a single chromatographic peak is
consistent with sequence identity between the questioned and reference
samples. Conversely, the presence of more than one peak is consistent with
sequence non-identity between a questioned and reference sample.
A major challenge for DHPLC-based mtDNA mixture fractionation has
been the difficulty of completely eliminating the secondary component of a
mixture from all recovered fractions. While it is often possible to significantly
enrich for one component over another, some fractions still show secondary
peaks (i.e., mixed bases) on sequencing electropherograms. Though the
electrophoretic peaks for these minor-components are reduced relative to nonfractionated samples, their presence can complicate the interpretation of the
mixture. Initial efforts to minimize the presence of these secondary peaks
focused on improving the precision with which individual chromatographic peaks
are captured. Although this has improved the quality of separations that can be
achieved, discussions with Terry Melton (Mitotyping Inc., State College, PA) have
resulted in an innovative strategy that allows DHPLC to resolve most if not all
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mixtures. Several key experiments (detailed in chapters 5 and 6) have
demonstrated the accuracy and reliability of this approach, now coined “linkage
phase analysis.”
§ 1 - 3.3

Linkage Phase analysis

Although the term linkage analysis originates from the study aimed at
establishing linkage between genes on a chromosome, due to their close
proximity and tendency of being inherited together (Ott, 1999), linkage phase
analysis in a forensic mtDNA context applies the concept of coordinated
nucleotide linkage to the analysis of DNA sequence data from mixed samples.
The underlying principle of linkage phase analysis is that peak heights on
sequencing electropherograms reflect the relative efficiency with which DNA
molecules are terminated at a given position together with the efficiency of
laser-induced florescence of individual dideoxy dye-terminators. While sequence
context results in significant peak height differences among individual bases,
these relative differences in the height of any one peak relative to any other peak
are highly reproducible. When a DNA mixture is sequenced, overlapping
electrophoretic peaks occur wherever the amplicons differ in primary sequence.
Because peak height is sequence context dependent, measurements of peak
height alone cannot be used to determine the relative abundance of the
amplicons within the mixture. However, studies have shown that a change in the
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ratio of one component to another in a mixture produces a corresponding
change in the ratio of the fluorescence signals for the overlapping
electropherogram peaks (Danielson et al., 2007). In other words, the peak
heights for all bases associated with one amplicon will increase while the peak
heights for all bases associated with the other amplicon will decrease. By
analyzing this “linkage phase” of the bases at all mixed base positions, the
correct haplotype for each contributor to a mixture can be reliably determined.
§ 1 - 3.4

Impact on the Criminal Justice System

The practical significance of DHPLC-based mtDNA mixture fractionation is
that this technology may aide criminal investigations by making it possible to
obtain crucial probative information in cases where existing methods yield
ambiguous or uninterpretable results. The successful forensic validation of
DHPLC for mtDNA mixture analysis will provide the forensic community with
tools to efficiently fractionate and interpret mixtures of mtDNA in casework
samples. As an added benefit, DHPLC has the potential to streamline the overall
process of mtDNA analysis. This has the potential to provide the analyst with a
rapid and cost-effective means of assessing mtDNA sample integrity and
determining whether a sample is a mixture requiring fractionation. Once such a
determination has been made, DHPLC yields a product which is ready for
conventional sequencing analysis without reamplification or further purification.
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The equipment start up cost for DHPLC is comparable to other analytical
instruments used in forensic DNA laboratories such that implementation of
DHPLC-based analysis can be achieved with minimal training and at a reasonable
equipment startup cost ($135K). The cost of separating and recovering individual
components of a DNA mixture by DHPLC is significantly less than it would be for
the far more labor-intensive electrophoretic techniques or subcloning.
Separation and recovery of a two-contributor mixture of DNA by DHPLC can be
performed for less than $10 in reagent cost. The technology also offers analysts a
significant opportunity to streamline the standard workflow at nearly every step
in the process. On the front side, DHPLC makes it possible to determine with near
100% accuracy whether an amplified mtDNA sample consists of a single amplicon
or represents a mixed product (i.e., either a heteroplasmic or situational
mixture). If the product is mixed, it is often possible to determine by DHPLC the
approximate level of complexity (e.g., 2 contributors vs. >2 contributors). Also on
the front end of the mtDNA amplification process, DHPLC makes it possible to
very accurately determine the amount of template amplified in the PCR process
and to simultaneously purify the target template for optimal dye terminator
labeling. This not only eliminates the need for laborious yield gels and expensive
PCR product clean up columns but also ensures that the analyst is using an
optimal quantity and quality of mtDNA for the dye terminator labeling reaction.
In the case of mixed samples, fractionation allows the mtDNA sequence of
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individual contributors to be unambiguously determined without secondary
amplification or excessive manipulation. Finally, this technology is amenable to a
high degree of automation with minimal sample consumption. In toto, the ability
to accurately analyze evidentiary material that is not amenable to existing
methods of analysis while also enabling the forensic analyst to streamline the
overall analytical process would represent a significant contribution to enhanced
justice and public safety.
§1-4

Objectives and Soundness of the Dissertation Research
A mixture of different mtDNA molecules in a single sample is a significant

obstacle to the successful use of standard methods of mtDNA analysis (i.e.,
dideoxy dye-terminator sequencing). Forensic analysts often encounter either
naturally occurring mixtures (e.g., heteroplasmy) or situational mixtures typically
arising from a combination of body fluids from separate individuals. The ability to
accurately resolve and interpret these types of samples in a timely and cost
efficient manner would substantially increase the power of mtDNA analysis and
potentially provide valuable investigative information by allowing its use in cases
where the current approach is limited or fails. Therefore, the ultimate goal of this
research is to develop a strategy for the use of DHPLC as a developmentallyvalidated forensic application for resolving mixtures of mtDNA. To facilitate the
adoption of this technology by the forensic community, a significant effort has
been made to ensure that this technology meets SWGDAM developmental
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validation criteria and interfaces smoothly with previously validated methods of
forensic mtDNA analysis. To do this, the method developed using DHPLC employs
mtDNA amplicons, PCR conditions and DNA sequencing protocols validated for
use in forensic laboratories.
§ 1 - 4.1

Hypothesis

The central concept being tested is that DHPLC will provide a rapid,
accurate, and cost effective method of separating DNA mixtures. This will
increase the number of forensic samples for which definitive sequence analyses
will be possible. The specific experimental core hypotheses of this project are
that:
(1) DHPLC will be able to sufficiently detect and fractionate mtDNA
mixtures regardless of the location (i.e., base position) and number of
mixed sites being assayed.
(2) There will be a significant correlation between a change in DNA
mixture ratios (i.e., based on quantity) and DNA electrophoretic peak
height ratios at all mixed base positions and that this will allow for
high-confidence linkage phase analysis of mtDNA mixtures for the
subsequent determination of individual contributor haplotypes.
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(3) DHPLC fractionation and linkage phase analysis will have the
quantitative sensitivity, reproducibility and accuracy to meet forensic
/ SWGDAM validation standards.
§ 1 - 4.2 Summary of Research Goals
§ 1 - 4.2.1

Chapter 2

The focus of Chapter 2 are experiments to support the development of a
single specific DHPLC assay for each of the four forensically relevant fragments of
the D-loop of mtDNA for the purpose of detecting sequence identity/nonidentity. This will serve as a presumptive test for detection of mixed mtDNA
amplicons arising from a two (or more) contributor mixture.
§ 1 - 4.2.2 Chapter 3
The focus of Chapter 3 is a set of experiments to determine the
applicability of HPLC for the purification and accurate quantification of PCR
amplicons prior to dye-terminator labeling. The combination of the purification
and quantification process into a single step will minimize sample consumption,
decrease analysis time and provide an opportunity for automation.
§ 1 - 4.2.3 Chapter 4
The focus of Chapter 4 is a set of experiments to investigate the degree of
consistency in context-specific differences in relative peak heights across mtDNA
sequencing electropherograms. Additional tests evaluate the use of a DNA
32

sequence electropherogram pattern matching algorithm for the detection of
peak height anomalies, changes in peak height context specificity and mutation
analysis by comparison to a reference sequence pattern. This computational
approach will facilitate the automated analysis of sequence electropherograms
allowing the analyst to more readily focus on genuinely anomalous areas of
sequence and to, therefore, interpret results with greater confidence.
§ 1 - 4.2.4

Chapter 5

The focus of Chapter 5 is a set of experiments designed to determine the
extent to which mtDNA mixtures can be analyzed as a function of changes in
overlapping electrophoretic peak height fluorescence ratios at individual mixed
base positions. A strong correlation between a change in DNA quantity ratio and
a corresponding change in DNA peak height ratio will allow for the accurate
determination of relative DNA quantities and thus linkage phase for virtually all
two-contributor mixtures and the subsequent ability to correctly identify the
individual mtDNA haplotypes present in a mixture.
§ 1 - 4.2.5 Chapter 6
The focus of Chapter 6 is a set of experiments designed to determine the
efficacy of DHPLC for the fractionation of two-component mtDNA mixtures. The
efficacy with which sequence-ready DNA can be recovered without
reamplification represents a critical bench mark. The development of a statistical
33

approach for the accurate determination of linkage phase of the individual
contributors to a mtDNA mixture, will also be presented.
§ 1 - 4.2.6 Chapter 7
The focus of Chapter 7 is a series of studies designed to validate the
linkage phase approach, detailed in Chapter 6. Using simulated forensic samples,
DHPLC in combination with linkage phase analysis will be used to predict the
haplotypes of contributors to a series of two-component mixtures. The results of
these studies will establish the applicability and reliability of statistical
approaches to the analysis of sequence data from DHPLC-fractionated mixtures.
§ 1 - 4.2.7 Chapter 8
The focus of Chapter 8 is a series of studies designed to validate the use
of the DHPLC instrumentation for mtDNA analysis of forensic casework samples.
These include tests for column and injection reproducibility, column and fractionto-fraction cross-contamination, detection sensitivity, concentration accuracy
and determination and negative control screening. The results of these studies
will serve to validate DHPLC in accordance with SWGDAM and DNA Advisory
Board (DAB) standards.
§ 1 - 4.2.8 Chapter 9
The focus of Chapter 9 is a summarization of an optimized overall sample
process flow for mtDNA analysis by DHPLC, prior to dye-terminator sequencing.
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Additionally, data are presented to demonstrate and validate the mixture
detection and linkage phase analysis capabilities of a prototype expert
bioinformatic system, i.e., the Fractional Linkage Phase Analysis Resource
Software (FLiPARS).
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Chapter 2: Comparative Sequence Analysis of the HV1 and
HV2 Regions of Human Mitochondrial DNA by
Denaturing High-Performance Liquid
Chromatography
§2-1

Introduction
Analysis of mtDNA for forensic casework is relatively expensive, time

consuming and requires the expertise of skilled analysts currently employed by a
limited number of public and private laboratories. Many efforts to streamline the
processing of forensic mtDNA casework have sought to develop rapid, cost
effective and reliable methods of comparative mtDNA sequence analysis to
“assay” for sequence identity/non-identity between samples or for the presence
of mtDNA mixtures within a single sample prior to direct sequence
characterization.
A variety of approaches for mtDNA comparative sequence analysis have
been investigated in recent years. These include, hybridization to linear arrays of
sequence-specific oligonucleotides (SSO) (Reynolds et al., 2000; Gabriel et al.,
2001); denaturing gradient gel electrophoresis (DGGE) (Hanekamp et al., 1996;
Steighner et al., 1999); single-strand conformational polymorphism (SSCP)
analysis (Alonso et al., 1996; Barros et al., 1997); time-of-flight mass
spectrometry (Butler and Becker 2001); and microarray-based analysis
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(Fukushima 1999). These approaches, suffer from a number of limitations which
include: the interrogation of only a subset of variant sites; cross-hybridization to
non-target sequences; laborious manipulations of gels (Meyers et al., 1988;
Reynolds et al., 2000); and interference by primer impurities (Butler and Becker
2001). Most critically, however, all of these approaches suffer from the fact that
they consume often precious forensic evidence while not necessarily providing a
reliably comprehensive assessment of all possible sequence differences across
the entire amplicon.
Denaturing

high-performance

liquid

chromatography

(DHPLC)

circumvents these limitations while offering the potential to characterize
sequence differences between mtDNA amplicons in an accurate, rapid and costeffective manner that can be automated. Moreover, DHPLC makes it possible to
recover the assayed DNA from the column eluent at the end of an assay. As
currently employed in a variety of biomedical applications, the technique
facilitates discrimination between amplicons that differ in sequence (i.e., single
nucleotide substitutions, insertions, deletions) but which may be identical in
length. When all DNA molecules in a sample are identical, denaturation and
renaturation produce only homoduplices which elute simultaneously to yield a
single chromatographic peak in a DHPLC assay. Conversely, a mixture of nonidentical DNA amplicons yields a combination of homo- and cross-hybridized
heteroduplices. Heteroduplices

elute
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more readily than

homoduplices

(O'Donovan et al., 1998; Hou and Zhang 2000) from the DHPLC DNASep® column.
Thus, sequence non-identity between DNA molecules is readily indicated by the
appearance of one or more early-eluting heteroduplex peak(s) on the resulting
chromatogram (Huber et al., 1993; O'Donovan et al., 1998; Hou and Zhang 2000).
In comparative studies of DHPLC-based detection of sequence
polymorphisms versus alternate approaches such as SSCP and DGGE, DHPLC has
often been found to provide superior sensitivity and accuracy (Abrams et al.,
1990; O'Donovan et al., 1998; Gross et al., 1999). Using carefully designed assay
conditions, the concordance between direct DNA sequencing and comparative
sequence analysis by DHPLC typically ranges from 95-100%. In some cases,
DHPLC has proven to have greater sensitivity than direct DNA sequencing for the
detection of minor component sequence variants. The accuracy and sensitivity
with which sequence variants can be detected by DHPLC can be significantly
influenced by the length, GC content and other thermodynamic characteristics of
the amplicon being assayed. The current study, therefore, investigated the
potential utility of DHPLC to specifically detect sequence variants throughout the
forensically relevant portions of the HV1 and HV2 regions of human mtDNA. A
high degree of concordance between DHPLC and direct sequencing for the
comparative analysis of those amplicons commonly used by forensic
practitioners could facilitate the development of less consumptive approaches to
comparative mtDNA sequence analysis for screening purposes.
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§2-2

Methods
This research was conducted in compliance with U.S. Federal Policy for

the Protection of Human Subjects (56 FR 28003). Blood samples were collected
from 103 unrelated subjects who had provided informed consent, of these, 8
samples were used to generate of mtDNA subclones. All samples were stored at 20°C until DNA extraction.
§ 2 - 2.1

Mitochondrial DNA Extraction from Dried Blood

Total DNA was extracted from dried reference blood stains using a
QIAmp® 96 Well Blood Kit (Qiagen Inc., Valencia, CA) per the manufacturer’s
recommended protocol. For consistency, the extraction was performed using a
Biomek® 2000 automated liquid handler (Beckman Coulter Inc, Fullerton, CA).
Purified DNA was eluted into 200µL of nuclease free ddH2O and stored at -20°C
until PCR amplification.
§ 2 - 2.2

Mitochondrial DNA Amplification and Sequencing

Mitochondrial DNA control region amplification reactions (50μL) were
prepared using 50pmol each of forensically-validated PCR primers (Wilson et al.,
1995; LaBerge et al., 2003) (Table 2.1); 2.25U AmpliTaq GOLD® DNA polymerase
(Applied Biosystems, Foster City, CA) supplemented with 0.25U Pfu DNA
polymerase (Stratagene, La Jolla, CA); AmpliTaq GOLD® Buffer (Applied
Biosystems); 10nmol of each dNTP (Stratagene) and 10μL of an approximately
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Table 2.1: Forensically validated and additional primers developed in-house for
control region amplification. Location indicates strand corresponding to the
primer (L for light strand and H for heavy strand) followed by the nucleotide
position of the 3’ end of the primer.

40

10pg/μL DNA extract. Amplifications were performed on a GeneAmp® 9700
thermocycler (Applied Biosystems) with an initial denaturation at 95°C for 10
minutes, followed by 32 cycles of 95°C for 20 seconds, 60°C for 30 seconds and
72°C for 45 seconds. The final extension at 72°C was for 15 minutes. The resulting
PCR yield for each fragment was then quantified by HPLC under a non-denaturing
column temperature of 50°C. The near perfect regression (R2 = 0.9982) between
chromatographic peak area and DNA quantity made it possible to reliably
determine the DNA quantity from each amplification reaction. This approach,
which requires ≤7 min/assay, has been internally validated for fragments ranging
in size from 200-1000bp and for quantities ranging from 1.25-140ng (data not
shown).
Approximately 0.8ng of amplified DNA was labeled for sequencing using
the BigDye® Terminator v1.1 Cycle Sequencing kit (Applied Biosystems). Labeling
reactions were primed using the PCR primers employed above or additional
internal sequencing primers (HV1R and HV2F) developed in-house (Table 2.1).
Labeled products were purified by ethanol precipitation or on Performa® DTR V3
96-Well Short Plates (Edge BioSystems, Gaithersburg, MD) and then resolved on
a PRISM® 310 Genetic Analyzer (Applied Biosystems) according to the
manufacturer’s protocols using the POP-6™ polymer and 47cm x 50µm capillaries
(Applied Biosystems). The raw electrophoretic traces were analyzed using the KB
Basecaller (Applied Biosystems) together with the appropriate dye set mobility
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file for the v1.1 kit. Appropriate positive and negative controls were included at
all stages of the process to monitor for contamination and reagent integrity. The
resulting sequence data were analyzed using the Sequencher™ v4.2 DNA analysis
software (Gene Codes Corp, Ann Arbor, MI).
§ 2 - 2.3

Mitochondrial DNA Subcloning

Primers A1 and D1 (Table 2.1) were used to amplify an mtDNA fragment
of approximately 1021bp which encompassed both HV1 and HV2. The resulting
amplification products representing eight mtDNA haplotypes were purified using
Wizard® PCR Preps (Promega, Madison, WI), ligated into the pGEM®-T vector
(Promega) and electroporated into DH5α electrocompetent cells. Cells were
selected on LB agar plates containing 50μg/ml ampicillin and screened by PCR to
identify plasmids containing target inserts. Plasmids were isolated from
overnight cultures of these colonies by alkaline lysis and capture on glass-filter
binding plates (Millipore, Bedford, MA). DNA was sequenced as described above.
§ 2 - 2.4 DHPLC-Based Temperature-Modulated Heteroduplex
Analysis (TMHA)
DNA sequence data for each of four forensically-relevant amplicons
(HV1A, 278bp: A1/B2; HV1B, 271bp: B1/A2; HV2A, 278bp: C1/D2; and HV2B,
277bp: D1/C2) (Table 2.1) were compared to identify individuals with different
mtDNA haplotypes (Wilson et al., 1995). Fragments were then combined at a 1:1
molar ratio to generate a series of pair-wise mixtures which were cross42

hybridized by denaturation at 95°C for 4 minutes and gradual cooling (1.5°C/min)
to a final temperature of 25°C (LaBerge et al., 2003).
The cross-hybridized mixtures were analyzed by TMHA (Kuklin et al.,
1997) on a WAVE® 3500HT DNA Fragment Analysis System (Transgenomic Inc.,
Omaha, NE) using a DNASep® analytical column (Huber et al., 1993).
Triethylammonium acetate (TEAA) pH 7.0 at a final concentration of 0.1M served
as an ion-pairing reagent. Cross-hybridized mixtures were analyzed under
partially denaturing conditions at the empirically determined optimal
temperatures for each of the four mtDNA amplicons (i.e., HV1A, 58°C; HV1B,
59.2°C; HV2A, 56.5°C and HV2B, 57°C). The optimal acetonitrile linear gradient
generated from differential mixing of buffer A (0.1M TEAA) and buffer B (0.1M
TEAA, 25% ACN) were a 56% to 65% buffer B increase in 3.5 minutes for HV1A,
HV2A and HV2B and a 55% to 64% buffer B increase in 3.5 minutes for HV1B. All
samples were eluted at a 0.9ml/min flow rate and detected by UV absorbance at
260nm. Standard DHPLC controls included: zero-volume injections to screen for
DNA carryover between assays; no-template PCR controls to check for reagent
contamination; and manufacturer mutation control standards for buffer and
column quality control. Where necessary for enhanced sensitivity, temperate
titrations were conducted in ±0.5°C increments using an integrated oven
accurate to ±0.1°C.
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The resulting chromatograms were visually examined. The presence of a
single homoduplex peak was scored as consistent with sequence identity. The
presence of more than one chromatographic peak or a shoulder on a
homoduplex peak was scored as consistent with the presence of one or more
sequence differences between the two amplicons in the sample being assayed,
i.e., sequence non-identity (O'Donovan et al., 1998; Hou and Zhang 2000).

§2-3

Results and Discussion

§ 2 - 3.1

Essential Modification of Forensically-Validated Protocols

In evaluating the utility of DHPLC for comparative mtDNA sequence
analysis, the current study employed forensically validated oligonucleotide
primer pairs and standard operating procedures (Wilson et al., 1993). Two minor
modifications to these procedures were made, the exclusion of bovine serum
albumin (BSA) from the amplification reaction and the supplementation of
AmpliTaq GOLD® with higher fidelity Pfu DNA polymerase.
The presence of >10% w/v BSA in a sample reduces the functional
lifespan of the DNASep® column. BSA, however, is often used to ameliorate the
effects of endogenous PCR inhibitors in some DNA extracts. These include IgG
and heme in blood (Al-Soud and Rådström 2001), melanin in hair (Eckhart et al.,
2000), collagen in bone (Scholz et al., 1998) and such environmental inhibitors as
humic acid in soil (Watson and Blackwell 2000) which are not efficiently removed
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by inorganic extraction methodologies (e.g., Chelex™). In our laboratory, both
endogenous and environmental inhibitors have been effectively removed from
hair, bone and environmentally contaminated samples by the use of organic
extraction, silica-gel membranes or by systems that employ paramagnetic
particles such as the Qiagen® EZ1 DNA tissue kit.
In the current study, the silica-gel membrane based QIAamp® DNA Blood
purification kit was used to prepare all DNA extracts from whole blood. The
purity of the resulting extracts was evaluated by PCR amplification of mtDNA in
the presence and absence of BSA at a final concentration of 0.16μg/μl. Yields for
individual amplification reactions were generally in the range of 20-25ng/μl as
determined by optical absorbance at 260nm. The amplification of mtDNA from
QIAamp® prepared extracts was equally efficient regardless of whether or not
BSA was added (data not shown). If the use of BSA is unavoidable, purification of
the PCR amplification products by organic extraction or other protein removal
method may be needed prior to DHPLC analysis.
The fidelity of the DNA polymerase used for amplification may also
impact the accurate interpretation of DHPLC chromatograms. The relatively high
nucleotide

misincorporation

rate

of

Taq

DNA

polymerase

(8.0×10-6

mutations/bp/duplication) (Cline et al., 1996) typically produce DHPLC
chromatograms from single sequence samples which erroneously appear to
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indicate a DNA mixture. A mixture of Taq and Pfu DNA polymerases at a 9:1 ratio
effectively eliminates these anomalies. The 3´→5´ exonuclease activity and lower
nucleotide misincorporation rate (1.3×10-6 mutations/bp/duplication) of Pfu
yields greater uniformity in amplification products (Cline et al., 1996).
§ 2 - 3.2

DHPLC Assay Development

Recognizing that mtDNA heteroplasmy is detected by DHPLC as a mixture
of non-identical sequences, the initial optimization of DHPLC assay parameters
was conducted using a group of eight mtDNA subclones as templates for PCR
amplification of the HV1 and HV2 amplicons (Table 2.2). Collectively, these
subcloned sequences differed from each other at an average of 9.4 positions (0-7
positions in HV1A; 0-10 positions in HV1B; 0-5 positions in HV2A; 0-4 positions in
HV2B). The use of subcloned sequences ensured that each sample represented a
single distinct haplotype. This eliminated heteroplasmy as a potentially
confounding variable for the purpose of assay optimization.
§ 2 - 3.3

Optimization of DNASep® Column Temperatures

Comparative DHPLC-based DNA sequence analysis relies on temperaturedependent chromatographic separation of the nucleic acids under partially
denaturing conditions. In accordance with manufacturer recommendations and
empirical observations by the authors and other researchers, optimal resolution
is generally obtained using amplicons of less than 400bp in length and a column
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Table 2.2A: Sequence polymorphisms in HV1 subclones based on the revised
Cambridge Reference Sequence (rCRS).

Table 2.2B: Sequence polymorphisms in HV2 subclones based on the revised
Cambridge Reference Sequence (rCRS).
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temperature where the average of nucleic acid helicity across an amplicon is
approximately 75% to 85% (Cooksey et al., 2002; Transgenomic 2003). Under
these conditions, heteroduplices with a single base mismatch elute from the
DNASep® column before identical-length homoduplices.
The mtDNA primer pairs used in the current study yield amplicons within
a size range that are well suited for DHPLC analysis (i.e., HV1A = 278bp, HV1B =
271bp, HV2A = 278bp, HV2B = 277bp). Although the appropriate partially
denaturing temperature for a given amplicon is approximated by the Navigator™
software based on nearest neighbor interactions (Fixman and Freire 1977), the
optimal temperature must be empirically confirmed. This was done by
monitoring the separation of homo- and heteroduplices in multiple mixed
samples at temperatures flanking the predicted value. The optimal temperature
is that at which the greatest chromatographic resolution is achieved. This is
illustrated in figure 2.1 where the greatest resolution for the mixture of HV1B
amplicons being assayed is at 59.2°C. This is not to suggest that all mixtures of
HV1B amplicons will be optimally resolved at this temperature. Rather, this
represents the optimal initial assay temperature at which mixtures of HV1B
amplicons of unknown haplotype can be screened. Similarly, the optimal initial
assay temperatures for the HV1A, HV2A, and HV2B amplicons were determined
to be 58.0°C, 56.5°C and 57.0°C, respectively.
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Figure 2.1: Empirical determination of the optimal column temperature for
comparative sequence analysis of HV1B. While the hetero- and homoduplices
can be resolved at 58.2°C, optimal resolution is obtained at 59.2°C. At 60.2°C, the
heteroduplices elute too readily to form distinct peaks.
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§ 2 - 3.4

Comparative Sequence Analysis of Subcloned mtDNA

As a preliminary assessment of the accuracy with which DHPLC is able to
detect sequence differences, a matrix of all possible pair-wise combinations (i.e.,
144 mixtures) of mtDNA fragments (i.e., HV1A, HV1B, HV2A and HV2B) was
prepared using the subcloned haplotypes as amplification templates. Following
cross-hybridization and analysis by DHPLC, the resulting chromatograms were
visually examined.
Figure 2.2 presents examples of chromatograms obtained from assays of
27 pair-wise comparisons between non-identical and 9 comparisons between
identical HV2A amplicons. Sequence differences included a single-base insertion
situated near the terminus of the amplicon (e.g., all comparisons with sample 5)
and a variety of single and multiple base substitutions throughout the amplicon.
Single base substitutions in both GC rich and AT rich regions were also assayed.
Combinations of each amplicon with itself, and the identical amplicons
from subclones 2 and 8, yielded chromatograms with a single symmetrical peak
(i.e., the homoduplex species). For two of the pair-wise combinations, nonidentity was indicated by the presence of a shoulder on the homoduplex peak
(e.g., subclones 2 and 4). For 24 of 27 pair-wise combinations of non-identical
amplicons, sequence non-identity was indicated by the presence of early-eluting
and easily discernable heteroduplex peaks. In a few comparisons, the
heteroduplex peak was much smaller than the homoduplex peak (e.g., subclones
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Figure 2.2: Examples of DHPLC chromatograms from pair-wise hybridization of
the HV2A fragment amplified from eight mtDNA subclones. (2A) Sequence
identity is indicated by the presence of a single homoduplex peak. (2B-2E)
Sequence non-identity is indicated by the presence of more than a single peak.
Early eluting peaks represent heteroduplices formed by cross-hybridization
between non-identical amplicons. (2F) Sequence non-identity can also be
indicated by a shoulder on a homoduplex peak which also indicates the presence
of heteroduplices.
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1 and 5) making detection somewhat more challenging. In these cases, the
presence of a heteroduplex peak was more readily discerned by comparing the
chromatograms obtained for injections of each amplicon by itself with the
chromatogram obtained when a mixture of the two amplicons was injected. This
was done by superimposing these three chromatograms on top of each other.
Only the comparison between subclones 2 and 3 failed to show sequence
non-identity by DHPLC at 56.5°C. This was not unexpected since the sequence
difference between these amplicons (73G vs. 73A) was immediately adjacent to a
short GC-rich region of predicted 100% helicity. The thermodynamic stability of
this region is an intrinsic feature of the HV2A amplicon which interferes with the
detection of base changes at position 73.
Pair-wise combinations of HV1A, HV1B and HV2B fragments amplified
from the eight mtDNA haplotype subclones were also assayed for sequence
identity/non-identity by DHPLC. As seen for the HV2A fragment, sequences that
differed by one or more bases were successfully identified by DHPLC either by
the presence of early-eluting heteroduplex peaks or an early-eluting
heteroduplex shoulder on a homoduplex peak. One sequence difference
between subclones 3 and 5 (16362T vs. 16362C) was not readily detected
without overlaying the chromatograms for the individual versus the mixed
amplicons. This was not unexpected given that HV1B has a biphasic melt profile
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and position 16362 is within a region of higher GC-content that remains relatively
stable at the standard assay temperature of 59.2°C.
§ 2 - 3.5
Samples

Comparative Sequence Analysis of mtDNA from Blood

The primary objective of the current study was to evaluate the potential
utility of DHPLC as a means of screening amplified human mtDNA samples for
sequence identity/non-identity in the context of a forensic laboratory. Initial
experiments using subcloned mtDNA haplotypes demonstrated that DHPLC
accurately detects even single base differences between two mtDNA amplicons.
Subclones, however, are artificially pure templates which do not reflect the
molecular complexity of a human tissue-derived DNA extract. Furthermore, the
eight haplotypes used encompass only a small fraction of known variant
positions. To more thoroughly assess the reliability of DHPLC as a tool for
comparative sequence analysis, the approach was tested on blood samples from
95 research volunteers.
Exclusive of length polymorphisms associated with the homopolymeric
cytosine-stretch in HV2, the 95 subjects in the current study represented 83
distinct haplotypes (Appendix A). Seventy-seven of these were unique within the
study population. Of the 6 haplotypes which occurred more than once, the most
common (263G, 315.1C) was observed 8 times while the remaining 5 haplotypes
each occurred twice. Relative to the revised Cambridge Reference Sequence
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(rCRS) (Anderson et al., 1981; Andrews et al., 1999), the haplotypes represented
in the current study encompass 84 polymorphisms in HV1 and 46 polymorphisms
in HV2, including cytosine-stretch length polymorphisms.
Based on pair-wise comparisons, individual haplotypes differed from each
other at 0-22 positions (0-11 in HV1A; 0-13 in HV1B; 0-13 in HV2A; and 0-12 in
HV2B). On average, there were 8.71 positional differences between haplotypes.
In toto, the study population encompasses a broad diversity of haplotypes and
thus is well suited for evaluating the utility of DHPLC for the accurate detection
of sequence polymorphisms throughout the mtDNA control region. This is
essential for the validation of DHPLC as a tool for comparative sequence analysis.
A total of 920 pair-wise combinations of amplicons from the 95
individuals in this study were prepared, denatured and allowed to gradually
reanneal. Of these, 72 (22 in HV1A, 8 in HV1B, 17 in HV2A, and 25 in HV2B)
represented combinations of amplicons that were from different individuals but
which had identical DNA sequences. DHPLC analyses of these samples all
produced clear chromatograms consisting of a single symmetrical homoduplex
peak. This pattern is consistent with sequence identity and is 100% concordant
with direct sequencing data for these amplicons.
To assess the reliability of DHPLC to detect sequence non-identity, 849
combinations of amplicons (209 in HV1A, 222 in HV1B, 213 in HV2A, and 205 in
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HV2B) which differed in sequence were assayed. These differences encompassed
a broad diversity of polymorphisms distributed throughout the HV1 and HV2
regions including transitions, transversions, insertions and deletions (Table 2.3).
Positional differences were located internally as well as near the termini of
amplicons and encompassed regions of varying GC richness. In all, the mixtures
assayed in this study included sequence variants in HV1A, HV1B, HV2A and HV2B
at 39, 62, 38 and 30 different positions, respectively. Figure 2.3 illustrates the
distribution of the variant positions and the frequency with which they were
assayed.
Using the aforementioned initial assay temperature for each mtDNA amplicon,
DHPLC analyses correctly indicated the presence of a mixture of non-identical
amplicons in 836 (209 in HV1A, 222 in HV1B, 203 in HV2A, and 202 in HV2B) of
the combinations tested. The remaining 13 mixtures (10 in HV2A and 3 in HV2B)
of non-identical amplicons, yielded chromatographic traces with a single eluent
peak, a result erroneously suggesting sequence identity. Careful examination of
the amplicon mixtures which were not detected by DHPLC reveals that these
aberrant results are limited to a very small number of challenging positions.
Mirroring results obtained with subcloned mtDNA, it was not possible to detect
as non-identical, combinations of HV2A amplicons that differ only at positions 72
or 73. Taken together, these two positions account for all of the undetected nonidentical mixtures in HV2A.
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Table 2.3: Sequence polymorphisms assayed by DHPLC in the HV1 and HV2
regions as deviations from rCRS.
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Figure 2.3: A histogram showing the distribution of nucleotide positions within
HV1A, HV1B, HV2A and HV2B amplicons (x-axis) and the number of times that
sequence polymorphisms at each position were assayed by DHPLC (y-axis). The
polymorphisms assayed are broadly distributed throughout both GC and AT rich
regions as illustrated by the light gray line which indicates %GC content across
each fragment as determined by the surrounding 10 nucleotides.
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In HV2B, DHPLC was not able to detect as non-identical, combinations of
amplicons that differed only at position 295. This position lies in a narrow stretch
of sequence immediately adjacent to a large GC-rich region. Given the
thermodynamic stability of this region, a single base mismatch may not
sufficiently destabilize the surrounding helix such that an early eluting peak can
be discerned. This is a postulate supported by the observation that mixtures of
amplicons that possess an additional mismatch in this same region are readily
detected.
An inverse relationship was generally observed between the number of
positional differences associated with a given pair of non-identical amplicons and
the relative heights of the hetero- versus homoduplex peak(s). The height and
retention time of a heteroduplex peak is a function of the stability and base
sequence of the helix. The more stable a heteroduplex, the more readily it should
form relative to the competing homoduplices and thus the greater its peak
height (indicative of quantity) on the DHPLC chromatograms. The corollary of this
is that the formation of less stable helices is less favored and should be
associated with smaller and earlier-eluting peaks on the DHPLC chromatograms.
In theory, this could compromise the ability of DHPLC to detect as non-identical
some combinations of amplicons that differ at a large numbers of positions. In
the current study, however, no examples of such “heteroduplex dropout” were
observed.
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§ 2 - 3.6

Heteroplasmy Detection

As a naturally occurring combination of two haplotypes, heteroplasmy
represents an important but potentially confounding factor for DHPLC-based
analyses. Chromatograms obtained from assays of known heteroplasmic samples
typically show the presence of early-eluting heteroduplices. In these cases,
DHPLC can often provide an indication of the nature of the heteroplasmy. Using
either non-denaturing (column temperature = 50°C) or partially denaturing
conditions, length heteroplasmy results in a chromatogram characterized by a
markedly broadened peak often characterized by multiple shoulders (Figure 2.4).
This represents the combination of the various length amplification products and
the characteristic shape of such peaks makes it possible to readily screen for
heteroplasmy associated with the cytosine-stretches of HV1 and HV2B. Using
partially denaturing conditions, point (i.e., base substitution) heteroplasmy can
also be readily detected. It is typically indicated by the presence of a defined
heteroduplex peak or a significant shoulder in association with the main
homoduplex peak.
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Figure 2.4: An example of length heteroplasmy as detected by DHPLC at a nondenaturing DNASep® column temperature of 50°C. Secondary and tertiary length
variants are detected as shoulders prior to the primary length component
represented by the major peak.
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When analyzing questioned samples, however, it is not possible to
reliably distinguish between heteroplasmy and a situational mixture where
mtDNA has been contributed by two or more individuals. Even so, the presence
of heteroplasmy does not necessarily preclude the use of a heteroplasmic
reference sample for comparative sequence analysis by DHPLC. Sequence nonidentity in such cases would be indicated by the presence of additional early
eluting peaks and/or shoulders that were not evident in the chromatogram
generated by cross-hybridization of the heteroplasmic sample with itself.
Conversely, the absence of any additional peaks would be consistent with
sequence identity.
Heteroplasmy, however, can reduce the discriminatory power of DHPLC
in some cases. In the current study, this was most often observed for samples
with significant length heteroplasmy. The broad chromatographic peak
associated with these samples can obscure the presence of additional
heteroduplices formed as a result of cross hybridization between the amplicons
present in the known sample and additional amplicons in the questioned sample.
While DHPLC circumvents many of the limitations of alternate approaches
to mtDNA screening, it is important to consider very carefully the types of
samples for which such an approach might be indicated. Within an mtDNA
sequencing laboratory, screening by DHPLC makes it possible to detect samples
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that contain mixtures of non-concordant amplicons immediately after PCR
amplification and without having to sequence them. For both heteroplasmic and
situational mixtures, this approach would enable the analyst to identify
potentially challenging samples and mark them for “special handling” – whether
that be use of alternate sequencing primers to avoid C-stretch polymorphisms or
the application of emerging technologies for resolving mixed samples (Danielson
et al., 2005; Andreasson et al., 2006; Danielson et al., 2007).
§ 2 - 3.7

DHPLC as a Presumptive Screen for Sequence Identity

It has been reasonably argued by experienced practitioners in the field
that that it is best to avoid the use of mtDNA screening method on limited or
irreplaceable evidentiary material (Divne et al., 2005; Melton et al., 2006). A
presumptive DHPLC screen for mtDNA sequence identity, however, could serve
as a useful tool for investigators in special situations such as the investigation of
property crimes. The limited budgets of many law enforcement agencies make it
extremely difficult for investigators to justify the expense of mtDNA testing in the
majority of criminal offences that do not involve crimes against persons –
particularly when there is no assurance a priori that the test results will
necessarily advance an investigation. A presumptive screen for sequence identity
between a suspect and an item of evidence, however, could provide sufficient
justification to submit the sample for confirmatory analysis by direct sequencing.
Such screening might also help to readily eliminate from consideration such non62

probative samples as hairs consistent with a victim that were recovered from the
victim’s home or vehicle in the case of a burglary or auto theft. In short, this
could help investigators to focus their efforts on the most probative samples and
thereby maximize the efficient use of investigative resources.
Employing a presumptive test of mtDNA sequence identity in the manner
described above shifts the process of DNA extraction from the dedicated mtDNA
sequencing laboratory to the local law enforcement laboratory. This necessitates
that additional consideration is given to the handling of these samples. The
presence of evidentiary material with large quantities of mtDNA (e.g., blood,
saliva and seminal fluids, etc.) in local laboratories can pose a significant risk of
cross contamination. Accordingly, an mtDNA sequencing laboratory accepting a
DNA extract for analysis would almost certainly require the submission of a coextracted reagent blank control that could be tested to detect the presence of
spurious mtDNA contamination. Similarly, the submission of amplified PCR
products for direct sequencing would also need to be accompanied by the
appropriate positive and negative PCR controls.

§2-4

Conclusion
The results of the current study have demonstrated that DHPLC analysis

of pair-wise combinations of identical mtDNA amplicons, accurately and reliably
produces a single chromatographic peak consistent with sequence identity.
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These results were 100% concordant with DNA sequence data. Conversely, in
pair-wise combinations of non-identical amplicons, DHPLC successfully detects a
diversity of sequence differences throughout the HV1 and HV2 regions. These
differences, which include a wide variety of base substitutions as well as
insertions/deletions, are typically indicated by the presence of more than a single
peak in the resulting chromatogram. As such, DHPLC may have significant
forensic utility in several areas. These include: a presumptive test of mtDNA
identity between known and questioned samples; a screen for mixed samples
prior to direct sequencing and; a preparative tool for the physical fractionation of
the individual contributors to an mtDNA mixture prior to sequencing.
Although DHPLC is not a replacement for direct sequencing of mtDNA, it
does offer some advantages as a potential screening tool. First, the assay is
relatively simple and fast. It uses raw PCR products thereby avoiding the time
and expense associated with amplicon cleanup. Following cross-hybridization,
each assay takes only seven minutes to run and interpretation of the results is
straightforward. DHPLC provides a comprehensive assessment of sequence
identity across an entire amplicon without the often challenging task of trying to
obtain quality base sequence information immediately adjacent to primer
binding sites. Finally, the presence of heteroplasmy, while a potentially
confounding variable, does not necessarily preclude comparative sequence
analysis by DHPLC.
64

Compared to

alternate

mtDNA

screening strategies based on

oligonucleotide probes or linear arrays, DHPLC consumes less DNA and is not
limited by the need to design probes for the detection of known mutations at
predetermined polymorphic sites. This reduces the potential for false inclusions
and eliminates the need to design custom probes for unique or rare sequence
variants. Similarly, DHPLC assays are not subject to the “null” or “blank” results
that arise when hybridization of the target sequence is impeded by other nearby
polymorphisms. On the contrary, additional sequence variants typically make it
easier to detect sequence non-identity between two amplicons.
Forensic laboratory implementation of a commercial DHPLC analysis
system can be achieved with minimal training and initial equipment cost of just
over $50K. The $0.50/run operating cost for DHPLC analyses is considerably less
than that for alternative approaches. Depending on the nature of casework being
analyzed and level of throughput, the acquisition of a DHPLC system may be a
fiscally viable option for some forensic laboratories as is already the case in the
molecular diagnostics arena.
Finally, the current study has also demonstrated that DHPLC can be used
to resolve mixtures of non-identical mtDNA amplicons into a series of homo- and
heteroduplex peaks. Since these can be differentially eluted in time, it should be
possible to physically recover and concentrate the DNA contained in any given
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fraction of eluent. Subsequent sequence analysis of the recovered DNA may then
provide a basis for determining the specific haplotype of each of the contributors
to the mixture. The feasibility of this approach has already been demonstrated
(Danielson et al., 2005; Danielson et al., 2007).

§2-5

Chapter Summary
Denaturing High-Performance Liquid Chromatography (DHPLC) was

evaluated as a means of detecting the presence of sequence differences in pairwise mixtures of non-identical amplicons representing hypervariable regions
(HV1 and HV2) of human mitochondrial DNA (mtDNA). The approach is based on
the ability to chromatographically distinguish between PCR products on the basis
of sequence alone. Using forensically-validated primers sets, optimal assay
parameters (e.g., column temperature and acetonitrile gradient) were
empirically determined for each of four D-loop amplicons commonly employed
by forensic mtDNA laboratories. Following extraction of DNA from 95 unrelated
human volunteers, 920 pair-wise combinations were assayed by DHPLC for
sequence identity/non-identity. For the 72 combinations of amplicons that were
from different individuals but which had identical DNA sequences, DHPLC assay
results consistently indicated the presence of sequence identity between the
samples. This result was 100% concordant with direct sequencing data for the
amplicons tested. For the 849 combinations of amplicons which differed in
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sequence, DHPLC correctly detected the presence of sequence non-identity in all
but 13 assays to yield 98.5% concordance with direct sequencing. DHPLC can be
used to detect a diversity of sequence differences (transitions, transversions,
insertions and deletions) at polymorphic sites distributed throughout the HV1
and HV2 regions. The current study demonstrates that DHPLC may have forensic
utility as a presumptive test of mtDNA identity between known and questioned
samples; as a screen for heteroplasmy or situationally mixed samples prior to
direct sequencing and; as a preparative tool for the physical fractionation of the
individual contributors to an mtDNA mixture prior to sequencing.
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Chapter 3: Validation of Simultaneous Purification and
Quantification of PCR Yield by High-Performance
Liquid Chromatography on DNASep® Columns
§3-1

Introduction
High-performance liquid chromatography (HPLC) using an ion-paired

reversed-phase column allows for the high-resolution analysis of nucleic acid
fragments. In recent years, this technology has been widely employed for the
analysis and preparative purification of oligonucleotides; the size fractionation of
double-stranded DNA molecules; and the detection of sequence polymorphisms
under partially denaturing conditions - a process known as denaturing HPLC
(DHPLC). In addition to its use in basic research and molecular diagnostics, the
forensic potential of DHPLC has also been recognized. DHPLC has been
investigated as a means of rapid gender determination, STR sizing and the typing
of Y chromosome biallelic polymorphisms (Underhill et al., 1997; Shinka et al.,
2001; Shi et al., 2007). The greatest forensic interest in DHPLC, however, has
focused on its potential utility in mitochondrial DNA analysis where it has been
used to detect heteroplasmy (Lo et al., 2005; Meierhofer et al., 2005; Jiang et al.,
2006), polymorphisms between individuals (Danielson et al., 2005; Wang et al.,
2006) and as a method to resolve mtDNA mixtures into identifiable haplotypes
(Danielson et al., 2007). Beyond its direct applicability to mtDNA sequence
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analysis, DHPLC may also help to facilitate two other tasks in the processing of
mtDNA samples, namely PCR product cleanup and yield determination.
Following PCR amplification, mtDNA amplicons are purified to remove
unincorporated nucleotides and oligonucleotide primers. PCR cleanup is critical
to obtaining quality sequence data and is often accomplished by use of spin
columns (e.g., Amicon Centricon-50®) (Millipore Corporation, Billerica, MA) or
enzymatic treatment, (e.g., ExoSAP-IT®) (USB Corporation, Cleveland, OH) (Hanke
and Wink, 1994; Werle et al., 1994; Dugan et al., 2002). Spin columns effectively
remove small DNA fragments, such as primers, but are less efficient at removing
larger extraneous amplification products. Additionally, their use has been
reported to be prone to inefficient recovery (30% on average) of the target
amplicon (Dugan et al., 2002). Treatment with ExoSAP-IT® uses exonuclease I to
digest residual single-stranded DNA (e.g., primers and some extraneous
amplification products) and shrimp alkaline phosphatase to remove residual
dNTPs. This enzymatic approach allows for significantly greater rates of product
recovery (78% on average) (Dugan et al., 2002). Both methods, however, are
limited by their inability to distinguish between target PCR amplicons and nonspecific double-stranded amplification products of similar size (Gabriel et al.,
2001). Additionally, casework-type samples may vary in number and/or
extraction volume making it difficult to fully automate the PCR product cleanup
process on a robotic platform. As a result, analysts may need to set up and
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process spin columns or ExoSAP-IT® reactions individually. This can require a
significant amount of hands-on time and corresponding reduction in productivity.
The

accurate

determination

of

DNA

yield

following

sample

amplification/purification is crucial to generating quality sequence data
(Kieleczawa, 2006). Excessive DNA input quantities result in sequence
electropherograms characterized by signal saturation, inconsistent peak heights
and/or premature signal drop off. Conversely, insufficient quantities of input
DNA may be associated with signal degradation and decreased S/N ratios. While
these effects can sometimes be ameliorated by subsequently adjusting
electrokinetic injection times/voltages or by the concentration/dilution of DNA
extracts, such remedies are less desirable than simply using an optimal quantity
of DNA from the start.
PCR yield can be quantified by a number of approaches including UV
spectroscopy, gel electrophoresis, or microchip capillary electrophoresis all of
which have a number of shortcomings. UV spectroscopy cannot distinguish
between an amplified target and residual primers or spurious PCR amplification
products. As a result, the amount of amplified target DNA can be easily
overestimated. Agarose “yield gels”, which are used in many forensic
laboratories are moderately labor intensive and require that samples be
compared to a quantification ladder using either the eyes of a trained analyst or
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pixel counting software. The Agilent 2100 Bioanalyzer Lab Chip capillary
electrophoresis system (Agilent Technologies, Palo Alto, CA) offers greater
accuracy and precision but requires investment in expensive dedicated
equipment, higher consumable costs per sample and a number of sample
handling steps.
The ability to fractionate by size, quantify and physically recover
macromolecules is fundamental to chromatographic techniques (Kalnoski et al.,
1991; Warren and Doniger, 1991; Henninger et al., 1993; Zeillinger et al., 1993;
Katz, 1996) including ion-pair reversed-phase chromatography. Purification of
DNA fragments by HPLC should make it possible to recover target amplicons in a
manner suitable for dye-terminator labeling reactions while circumventing the
limitations of existing reaction cleanup approaches. Additionally, given that
chromatographic peaks reflect the quantity of DNA eluted from the HPLC
column, the height and area of a target DNA peak should provide an accurate
means of assessing PCR yield for a target amplicon. The current study, therefore,
sought to evaluate the potential for use of a commercial HPLC system (WAVE®
3500HT Nucleic Acid Fragment Analysis System, Transgenomic, Inc., Omaha, NE)
to quantify PCR product yield and simultaneously purify target amplicons for
downstream applications such as DNA sequencing. In order to demonstrate the
efficacy of such an approach, the linearity of DNA quantification by HPLC was
assessed across a range of amplicon sizes and concentrations of potential utility
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to forensic analysts. Similarly, the suitability of HPLC as a means of amplicon
purification was assessed in comparison to existing PCR product cleanup
methods employed by forensic laboratories (i.e., ExoSAP-IT® and Amicon
Centricon-50® spin columns).
Given the potential utility of HPLC as a means of detecting and
fractionating mtDNA mixtures (Danielson et al., 2007), the use of the same
platform for PCR yield quantification and reaction cleanup is attractive. This
approach could help to save valuable analyst time, increase productivity and
streamline the processing of casework-type samples for mtDNA sequencing.
§3-2

Materials and Methods

§ 3 - 2.1

DNA Quantification Standards

A commercial DNA quantification standard (MassRuler™ Express DNA
Ladder, LR Reverse, Lot# 00000201) (Fermentas Life Sciences, Hanover, MD) was
used to assess the correlation between DNA quantity and chromatographic peak
height/area. This commercial standard is produced in an ISO9001 certified facility
and the absence of nucleases is confirmed by a direct nuclease activity assay. The
DNA ladder consisted of a mixture of six chromatography-purified and
spectrophotometrically quantified DNA fragments (100, 200, 300, 500, 700 and
1000bp) at a stock concentration of 10ng/µL, 7ng/µL, 5ng/µL, 3ng/µL, 2ng/µL
and 1ng/µL, respectively. The stock concentration and a series of 2-fold serial
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dilutions (1:2 to 1:32768) were prepared in nuclease-free water to yield a series
of quantification standards ranging from 30fg/µL to 10ng/µL.
§ 3 - 2.2

HPLC Quantification Assays

All HPLC quantification assays were performed in quintuplicate using a
DNASep® analytical column packed with alkylated poly(styrenedivinylbenzene)
resin (Huber et al., 1993) installed in a WAVE® 3500HT Nucleic Acid Fragment
Analysis System (Transgenomic Inc., Omaha, NE). Stock and each of the seriallydiluted quantification standards were injected (20µl/injection) at a 0.9ml/min
flow rate and allowed to bind the DNASep® column at 50°C in the presence of
0.1M triethylammonium acetate (TEAA) pH 7.0 as an ion pairing reagent. DNA
fragments were sequentially eluted on the basis of size using a gradient of
increasing acetonitrile produced by differential mixing of buffer A (0.1M TEAA)
and buffer B (0.1M TEAA:25% ACN). Starting with a mixture of 63% buffer A and
37% buffer B, the optimal gradient for the quantification assays employed
stepwise increases to 42.1%, 58.8%, 63.1%, 65.2%, 66.3% and 67.1% of buffer B
in 3.5 min., 2.0 min., 1.6 min., 1.5 min., 1.5 min., and 1.4 minutes, respectively.
Eluted DNA fragments were detected by UV absorbance (260nm) and
fluorescence (ex. 490nm; em. 520nm). Fluorescence detection employed a
proprietary DNA intercalating dye (WAVE® Optimized HS staining solution I)
injected downstream of the UV detector using an inline high sensitivity accessory
(HSX) pump (Transgenomic, Inc.). Due to signal saturation, quantification
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standards at ≥3.75ng/µL DNA were not assayed by fluorescence. The peak height
(mV) and peak area (mV*msec) were determined using the Transgenomic
Navigator™ peak analysis software and DNA quantities based on peak height and
area were determined by regression analysis.
§ 3 - 2.3

Mitochondrial DNA Extraction and Purification

This research was conducted in compliance with U.S. Federal Policy for
the Protection of Human Subjects (56 FR 28003). Casework-type samples were
prepared from buccal swabs, peripheral blood, saliva, semen and a variety of hair
(0.5cm of shaft only) samples collected from individuals who had provided
informed consent to participate in the study. To test the potential impact of
different substrates commonly encountered in a forensic context, DNA extracts
were prepared from biological stains (10μL peripheral blood, semen or saliva)
applied to nylon fabric, synthetic carpeting, leather, unpainted wood or
wallboard. To test the potential impact of environmental insult, DNA extracts
were prepared from 10μL aliquots of peripheral blood, semen or saliva deposited
on Pur-Wraps® sterile cotton tipped applicators (Hardwood Products, Guilford,
ME) that had previously been dipped in a slurry of top soil / nanopure water
(50:50 w/v), laundry detergent, used motor oil, gasoline, 1M sodium hydroxide
or 1M acetic acid and allowed to dry for 2 hours at room temperature. Finally,
DNA was extracted from head hairs (natural, dyed dark brown or permed), axial
hair, pubic hair, a vaginal swab and aged human bone material (bones
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generously provided by Dr. Randall Skelton, University of Montana, Missoula,
MT). Bone samples were cleaned twice in 5% Tergazyme™, sonicated for 30-45
min., rinsed in 95% EtOH, dried overnight at room temperature and then
pulverized with a SPEX CertiPrep 6850 Freezer/Mill in accordance with
manufacturers’ recommended protocol for small bone samples. Three, 4-min.
cycles (2min grinding period, 2min cooling period) yielded a fine bone powder,
200mg of which mixed with 700µL EDTA (0.5M, pH 8.5) and incubated at 37°C for
24 - 48 hours. Total human DNA was then extracted from all samples using the
EZ1 DNA tissue kit on the BioRobot EZ1 DNA extraction robot (Qiagen Inc.,
Valencia, CA); eluted into a final volume of 200μL of nuclease-free water. All
extracts were stored at -20°C until used.
Four forensically relevant regions of the human mitochondrial control
region (i.e., HV1A, HV1B, HV2A and HV2B) were amplified using validated PCR
primers (Wilson et al., 1995; LaBerge et al., 2003); 2.25U AmpliTaq GOLD® DNA
polymerase (Applied Biosystems) supplemented with 0.25U Pfu DNA polymerase
(Stratagene, La Jolla, CA); AmpliTaq GOLD® Buffer with MgCl2 at a final
concentration of 2mM (Applied Biosystems); 10nmol of each dNTP (Stratagene)
and 10μL of an approximately 10pg/μL human genomic DNA extract.
Amplifications were performed on a GeneAmp® 9700 thermocycler (Applied
Biosystems) with an initial denaturation at 95°C for 10 minutes, followed by 32
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cycles of 95°C for 20 seconds, 60°C for 30 seconds and 72°C for 45 seconds. The
final extension at 72°C was for 15 minutes.
Amplified PCR products were purified in preparation for DNA sequencing
using one of three methods: Amicon Centricon-50® centrifugal filtration
(Millipore Corporation, Billerica, MA), ExoSAP-IT® (USB Corporation, Cleveland,
OH), or HPLC purification on the WAVE® 3500HT Nucleic Acid Fragment Analysis
System. Column purification employed two washes (2ml each of nuclease-free
H2O) using the Amicon Centricon-50® spin columns per the manufacturer’s
protocol. ExoSAP-IT® treatment was performed per manufacturer’s protocol
using 2µL of proprietary ExoSAP-IT® reagent / 5µL amplified DNA product and
incubation at 37°C and 80°C for 15 minutes each. HPLC purification employed
5µL and 20µL injection volumes and an optimized gradient (56.5% to 65.5%
buffer B increase in 4.5 minutes) for HV1A, HV2A and HV2B and (56.3% to 65.3%
buffer B increase in 4.5 minutes) for HV1B. Samples were eluted at 0.9ml/min
flow rate, detected by UV at 260nm and quantified based on a MassRuler™
Express DNA Ladder standard curve. Samples containing >200ng were diluted
and reassayed until the chromatographic peak was within the bounds of the
standard curve. Eluted peaks were captured using an automated fraction
collector (Transgenomic, Inc.); dried by vacuum centrifugation for 30 minutes at
50°C followed by a 20-minute cool down to ambient on a CentriVap® Vacuum
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Concentrator (Labconco Corporation, Kansas City, MO). Samples were
resuspended in nuclease-free H2O; and stored frozen until DNA sequencing.
§ 3 - 2.4

Mitochondrial DNA Sequencing

Dye-terminator sequencing was performed using the BigDye® Terminator
v1.1 Cycle Sequencing Kit (Applied Biosystems). Labeling reactions (10µl total
volume) were prepared in accordance with the manufacturer’s protocol using
0.8ng of template DNA. Dye-terminated products were purified by Performa®
DTR V3 96-well short plate purification columns (Edge Biosystems, Gaithersburg,
MD) and resolved on the PRISM® 310 Genetic Analyzer (Applied Biosystems)
according to the manufacturer’s protocols using the POP-6™ polymer and 47cm x
50µm capillaries (Applied Biosystems). The raw electrophoretic traces were
analyzed using the KB Basecaller (Applied Biosystems) together with the
appropriate dye set mobility file for the v1.1 kit. Appropriate positive, negative
controls and reagent blank controls were carried through the entire sample
handling process to monitor for contamination and reagent integrity.
The resulting sequence data were displayed using both the Sequencing
Analysis Software v.5.1.1 (Applied Biosystems) and Sequencher™ v4.2 DNA
analysis software (Gene Codes Corp, Ann Arbor, MI). QV scores were
automatically calculated by the Sequencing Analysis Software using the equation
QV=-10log10(Pe) where Pe is the probability of an error in a base call. While QV
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scores range from 0 to a theoretical maximum of infinity, the sequence analysis
software only reports QV scores within a 1-99 range. In general, QV scores of 120 at pure base positions generally indicate a low-quality base call while those of
20-50 or higher (i.e., QV20+) indicate a high-quality base call. Mixed base
positions typically have lower QV scores than non-mixed positions Sequence
quality was evaluated on the basis of both QV20+ Scores and Trace Scores – the
latter being the average of all QV scores across the entire post-trimmed
sequence. (Biosystems, 2003).
§3-3

Results

§ 3 - 3.1

Quantitation of PCR Yield on a DNASep® Column

Using a non-denaturing column temperature of 50°C, double-stranded
DNA can be readily fractionated to yield a trace in which the height and area of a
chromatographic peak reflect the quantity of eluted DNA. To evaluate the
accuracy and reproducibility of using these peak parameters to calculate PCR
yield, a commercial double-stranded DNA quantification standards and a series
of serial dilutions were fractionated by HPLC using a DNASep® column. Each of
the resulting chromatographic traces was characterized by the presence of six
DNA peaks representing double-stranded fragments ranging in size from 100bp 1000bp, as described above. Based on the quantification standards used, the
lower limit (Mean±SD) for reproducible UV and fluorescence detection was
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1.85±0.56ng and 30.9±1.4pg, respectively based on automated peak detection by
the Navigator™ analysis software (Transgenomic, Inc.).
Figure 3.1 displays the regression between an injected DNA quantity and
either the height or area of the resulting chromatographic peak based on UV
detection at 260nm. The linear regressions for each size standard based on peak
height (figure 3.1A) had coefficients of determination which ranged from 0.960
(1000bp fragment) to 0.999 (100bp and 200bp fragments). The linear regressions
for each size standard based on peak area (figure 3.1B) had coefficients of
determination ranging from 0.908 (1000bp fragment) to 0.999 (100bp, 200bp
and 300bp fragments).
As presented in figure 3.2, a second degree polynomial regression was
found to best delineate the relationship between an injected DNA quantity and
the height or area of the resulting chromatographic peak based on fluorescence
detection data. The coefficients of determination for the polynomial regressions
based on peak height for each size standard (figure 3.2A) ranged from 0.991
(200bp fragment) to 0.999 (700bp and 1000bp fragments). When based on peak
area (figure 3.2B), the coefficients of determination for the resulting polynomial
regressions were 0.998 (100bp and 200bp fragment) to 0.999 (300bp, 500bp,
700bp and 1000bp fragments).
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A

B

Figure 3.1: Linear regression analysis of (A) peak height and (B) peak area data
collected by UV detection at 260nm.
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A

B

Figure 3.2: A second degree polynomial regression analysis of (A) peak height
and (B) peak area data collected by fluorescence detection using a proprietary
DNA intercalating dye and the HSX high sensitivity accessory.
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§ 3 - 3.2

Efficiency of PCR Product Recovery and Sequence Quality

To determine the efficiency of PCR product recovery associated with
DNASep® column purification, 100ng, 70ng, 50ng, 30ng, 20ng and 10ng of the
commercial quantification standards (100bp, 200bp, 300bp, 500bp, 700bp and
1000bp, respectively) were assayed in triplicate. For each size fragment, the DNA
represented by the resulting chromatographic peak was detected by UV,
physically recovered by an automated fraction collector, dried and then
reassayed by HPLC on a DNASep® column and quantified by comparison to the
MassRuler™ Express DNA Ladder standard curve. The average±SD recovery
efficiencies were found to be 72.68±2.6%, 70.05±7.9%, 63.58±5.9%, 69.6±7.7%,
64.9±7.2%, 60.76±8.3% for the 100bp, 200bp, 300bp, 500bp, 700bp and 1000bp
fragments, respectively.
To compare the quality of sequence data obtained from templates
purified by HPLC on a DNASep® column versus alternate cleanup methods
currently used in many forensic laboratories, mtDNA was amplified from extracts
of five dried 10µL spots of whole blood. Aliquots (40µL) of the crude postamplification product were purified by either HPLC using a DNASep® column,
ExoSAP-IT® treatment or Amicon Centricon-50® spin columns. Detail from
examples of sequencing electropherograms generated from dye-terminator
labeling of 0.8ng of purified PCR product are presented in figure 3.3. All three
post amplification cleanup methods yielded full-length sequences (257 bp) with
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Figure 3.3: Examples of sequencing electropherograms generated using the
BigDye® Terminator v1.1 Cycle Sequencing Kit and 0.8ng input DNA. HPLC
purification shows higher signal-to-noise ratio than either Spin column or
ExoSAP-IT® purification methods. Y-axis (max 2000 RFU) is the same for all three
purification methods.
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high quality base calls. Averaged across the five replicate sequencing reactions
for each purification method, the overall trace scores (i.e., average QV for all
bases) were 55.6, 54.6 and 54.4 and the QV20+ scores were 252.4, 251.2, and
251.2 for the samples purified by HPLC, ExoSAP-IT® treatment, and Amicon
Centricon-50® spin columns, respectively. The ratio of sequence signal to
baseline noise across each trace was also assessed as an indicator of sequence
quality. Averaged across the five replicate sequencing reactions for each
purification method, total baseline noise accounted for 4.86±0.69%, 6.04±1.68%
and 6.52±0.54% of total signal for the samples purified by HPLC, ExoSAP-IT®
treatment, and Amicon Centricon-50® spin columns, respectively.
§ 3 - 3.3

Casework type Samples

A diversity of casework type samples (Table 3.1) were employed to assess
the accuracy of using HPLC on a DNASep® column to simultaneously quantify and
purify post-amplification products in preparation for DNA sequencing. For each
sample, the amount of post-amplification product (ng) was determined based on
area of the chromatographic peak. This value was used to determine the volume
of sterile water in which to resuspend the purified mtDNA fragment (1.0µL
ddH2O per 0.8ng of DNA) for dye-terminator labeling. The robustness of this
approach was evaluated on the basis of the quality of the resulting sequence
data. Pristine reference type samples were prepared from dried peripheral blood
or buccal cells on sterile cotton swabs. Recognizing that PCR amplification of
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Table 3.1: Summary of casework-type samples used in the study. Samples were
isolated from a variety of substrates and exposed to a variety of environmental
degradation. DNA yield depended on HPLC injection volumes as well as inhibition
to amplification. QV and QV20+ scores obtained were highly consistent.
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reference samples is typically robust, only 5µL injection volumes were used for
HPLC purification. The amount of purified post-amplification product ranged over
nearly an order of magnitude from 8.6ng (Item 1, buccal swab) to 81.0ng (Item 4,
blood swab). The resulting sequence data were characterized by QV20+ scores of
241 to 256 for sequences having 251 to 258 called bases and high trace scores of
49 to 59 representing an average basecalling confidence level of 99.9987% to
99.99987% across the post-trimmed sequence.
The potential impact of a diversity of substrates (i.e., carpet, blue denim,
leather, nylon fabric, wallboard and wood) from which biological stains (blood,
saliva, and semen) could be collected was also tested. Not knowing the extent to
which a given substrate might influence PCR amplification, 20µL injection
volumes were used for HPLC purification. Following quantification and
purification by HPLC, the recovered post-amplification products were labeled and
sequenced as described above. All samples amplified successfully with yields
ranging from 63.1ng (Item 7, blood on leather) to 443ng (Item 13, saliva on
carpeting). Regardless of the yield of the PCR reaction, the resulting sequence
data generated from DNA quantified and purified by HPLC were of uniformly high
quality. Trace scores ranged from 44 to 50 (i.e., 99.996% to 99.999% confidence)
and QV20+ scores ranged from 233 to 249 for sequences having 251 to 258
called bases.
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To assess the potential impact of common environmental insults (i.e.,
laundry detergent, gasoline, used motor oil, soil, 1M sodium hydroxide and 1M
acetic acid), biological stains intermixed with these contaminants were extracted
and amplified. As before, 20µL injection volumes were used for HPLC
quantification and purification. All samples amplified and yielded from 11.5ng
(Item 27, blood with soil) to 462.6ng (Item 24, blood with acetic acid).
Sequencing of the recovered post-amplification products yielded high quality
results. Trace scores ranged between 45 and 50 (i.e., 99.997% to 99.999%
confidence) and QV20+ scores were between 237 and 250 for sequences having
a total of 251 to 258 called bases.
To test the utility of HPLC quantification and purification with challenging
samples more typically encountered in a forensic mtDNA context, a diversity of
hair shafts (natural, dyed and permed), aged bone samples and vaginal swabs
were also tested (Table 3.2). Vaginal swabs generally yielded the highest
quantities of post amplification product on average and the resulting sequence
quality was excellent with trace scores between 46 and 49 (i.e., 99.9974% to
99.9987% confidence) and QV20+ scores of 248 to 251 out of 257 to 258 bases
called. As expected, amplification yields with hair and bone samples were
frequently lower than with DNA extracts of blood, saliva or semen. Using a 20µL
injection volume, the amplification yield from hair shaft extracts range from
32.9ng (Item 49, permed head hair) to 394.3ng (Item 46, untreated head hair).
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Table 3.2: Summary of hair, bone and vaginal swab samples used to validate
HPLC as a tool for single step purification and quantification. HPLC and dyeterminator sequencing detected mixtures in 4 of 5 bone samples and lengthheteroplasmy in 6 of 19 hair samples.
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Using a 5µL injection volume, the yield of HPLC purified DNA ranged from
14.2ng (Item 42, dyed head hair) to 59.9ng (Item 41, dyed head hair). The lowest
yields were seen with bone samples where a 20µL injection volume yielded as
little as 2.7ng of amplified DNA (Item 33, aged bone) for labeling. Regardless of
the tissue employed, the amplification yield or the injection volume purified, all
post-amplification products that were quantified and purified by HPLC yielded
high quality sequence data characterized by trace scores which, except for
heteroplasmic samples, ranged from 44 to 57 (i.e., 99.996% to 99.9998%
confidence). Similarly, the QV20+ scores for the same samples ranged from 241
to 252 for sequences in which 256 to 258 base calls were made. Although
sequence results from four of five aged bone samples presented as mixtures, the
overall quality of these sequences was still high with trace scores of 46 to 48 (i.e.,
99.9974% to 99.9984% confidence) and QV20+ scores 243 to 248 out of 256 to
258 base calls.
§ 3 - 3.4

HPLC Purification and Length Heteroplasmy

Mitochondrial DNA length heteroplasmy most commonly occurs in
association with the C-stretch motifs in HV1 and HV2B. Length heteroplasmy
arising from insertion/deletion events at other positions may also be
encountered when processing either reference or casework type samples. In the
current study, length heteroplasmy was readily identified during HPLC
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purification and quantification. As illustrated in figure 3.4, each single-base
length variant forms a clearly discernible shoulder adjoining the chromatographic
peak of the primary amplification product (figure 3.4, buccal swab). In cases
where the quantity of a length variant approaches that of the major product, a
separate chromatographic peak forms before or after the major product peak
with shorter or longer variants, respectively (figure 3.4, blood stain). Non-length
(i.e., substitution) variants were not distinguishable from the major product
under non-denaturing conditions used for post-amplification quantification and
purification.
Using casework-type samples, length heteroplasmy was observed in the
chromatographic traces for either the HV1A or HV2B fragment of 6 out of 19
hairs tested. In each case, the resulting sequence electropherograms confirmed
the length heteroplasmy. In no case was heteroplasmy detected by sequencing
but not by HPLC. In terms of sequence quality, heteroplasmic samples tended
toward slightly lower trace scores which ranged from 38 to 48 (i.e., 99.984% to
99.9984% confidence) even for data outside of the region directly impacted by
the length polymorphism. The same was seen in the QV20+ scores which ranged
from 194 to 239 for sequences where 257-258 base calls were made.
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Figure 3.4: An example of length heteroplasmy as detected by HPLC at a nondenaturing DNASep® column temperature of 50°C. Secondary and tertiary length
variants are detected as shoulders prior to the primary length component.
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§3-4

Discussion
Reaction cleanup and yield quantification prior to dye-terminator labeling

is an essential part of obtaining accurate and high quality sequencing
electropherograms. Validation of a highly automated system for quantification,
purification and characterization (i.e., length heteroplasmy) of amplified PCR
products has, therefore, been conducted in order to streamline the processing of
casework-type mtDNA samples. Results of validation studies presented, show
that quantification and purification of crude PCR products can be performed in a
highly automated manner while also differentiating target PCR amplicons from
non-specific double-stranded amplification products.
Quantitation results of PCR yield by HPLC under non-denaturing
conditions are highly consistent across all six tested fragment ranges for both UV
and fluorescence detection. While reported detection limits were determined
using the Navigator™ analysis software’s automated peak detection and analysis,
manual determination of peak appearance and analysis of peak height and peak
area yielded detection limits in accordance with manufacturer’s specifications
(UV: approx. 0.5ng and fluorescence: <10pg, www.transgenomic.com, data not
shown). Regression analyses of both peak height and peak area show that
determination of DNA quantity is highly consistent, although determination of
peak area is more consistent across multiple fragment sizes. With the occurrence
of a secondary peak (due to length heteroplasmy of mtDNA samples) or peak
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broadening, the use of peak height can underestimate the total quantity of PCR
product present in the sample. Realizing that peak height determination is not
always possible, due to various length variants within the same amplification
product, quantity determination using peak area is, therefore, a more reliable
method for quantity determination.
Efficiency of PCR product recovery using DNASep® column purification
was determined to be similar to results reported for ExoSAP-IT® and the
QIAquick PCR Purification columns in Dugan et al., The benefit, however, is that
DNASep® column purification yields information regarding PCR efficiency (e.g.,
target quantity, presence of spurious amplification products, length variants,
etc.) in a single fully automated step.
Sequence quality obtained by dye-terminator labeling using the BigDye®
v1.1 Cycle Sequencing Kit for dried blood spots was slightly higher when purified
by HPLC on a DNASep® column versus alternate cleanup methods. All purification
methods yield high quality electropherograms (with average QV20+ scores above
250 for a 257bp product), although only the HPLC purification allows for definite
determination of low level heteroplasmy at position 292 as compared to the
Cambridge Reference Sequence (Figure 3.3). This is due to the overall greater
signal-to-noise ratio of basecalls for the HPLC purified samples.
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The quality of sequencing electropherograms extends into the casework
type samples employed in this study. Results obtained from a diversity of
casework type samples employed in this study and the overall high quality scores
(QV and QV20+) of electropherograms obtained show that purification of crude
PCR reactions and simultaneous determination of PCR yield by HPLC is a reliable
and

consistent

platform

for

obtaining

quality

mtDNA

sequencing

electropherograms. Additionally, the ability to accurately determine and
standardize the DNA input quantity and not having to subsequently adjust
sequencing run parameters to obtain good quality electropherograms saves
valuable analyst time and increases productivity.
The ability of HPLC to detect length variants expands on the ability of
purification and quantification of crude PCR products. Traditionally, this critical
information is only obtained following direct sequence analysis and requires
additional labeling reactions and often the use of C-stretch flanking primers. By
gaining knowledge of length variants prior to dye-terminator sequencing, the
analyst can setup the sequencing analyses accordingly. This significantly
increases turnaround of challenging mtDNA samples and alleviates repetition of
result analysis.
The current study has validated the utility of HPLC to purify and quantify
mtDNA amplicons in a single step. As an additional step in streamlining mtDNA
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analysis, HPLC also yields length characteristics of mtDNA amplicons prior to dyeterminator sequencing. The quality of mtDNA sequences obtained in this study
show that HPLC purification and quantification outperforms current standards in
mtDNA sample processing.

§3-5

Summary
High-Performance Liquid Chromatography (HPLC) using a DNASep®

column was evaluated as a means of quantifying PCR product yield and
simultaneously purifying target amplicons for downstream applications such as
DNA sequencing. The approach is based on the inherent ability of HPLC to
fractionate by size, quantify and physically recover macromolecules. Using a
commercial six fragment DNA quantification standard, a standard curve was
generated for both UV and fluorescence detection, followed by recovery,
quantification and sequence analysis of a variety of casework and reference-type
samples. Samples purified by HPLC were compared to commonly used forensic
purification methods (i.e., ExoSAP-IT® and Spin column) and yielded improved
sequencing results. Samples purified and quantified by HPLC yielded significantly
improved QV and QV20+ scores over data reported in the general forensic
literature. Determination of length-heteroplasmy within mtDNA amplicons
yielded additional and important pre-sequencing data not seen by other
methods. The current study demonstrates that HPLC has tremendous utility in
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streamlining purification and quantification of target amplicons for downstream
applications and in the same step determining length-heteroplasmy of mtDNA
amplicons.
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Chapter 4: Peak Height Reproducibility as an Indicator of
Mitochondrial DNA Sequence Quality for Forensic
Analyses
§4-1

Introduction
Dye-terminator sequencing is one of the most widely used methods in

modern molecular genetics and medical diagnostics. This approach has also been
established as the technology of choice for typing hypervariable regions 1 and 2
(HV1 and HV2) of the control region of the human mitochondrial DNA (mtDNA)
genome by forensic laboratories. In this context, mtDNA sequencing has been
used to analyze a diversity of evidentiary materials including hair shafts, saliva
and bone even in cases where the biological source material has undergone
significant decomposition or environmental insult (Hagelberg and Clegg, 1991;
Hagelberg et al., 1991; Holland et al., 1993; Allen et al., 1994; Ivanov et al., 1996;
Allen et al., 1998).
Positive, negative and reagent blank DNA amplification/labeling controls
are typically included in the standard operating procedures of forensic mtDNA
laboratories for quality assurance/quality control purposes. These serve to
demonstrate that the reagents used in this process are functional and free of
extraneous contaminating DNA. The resulting DNA sequence data are then
assessed primarily on the basis of basecalling quality scores and the watchful eye
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of trained forensic analysts. A variety of sequence vicissitudes, however, can
often compromise what would otherwise be the straight forward process of
basecalling. These include, differential mobilities of DNA fragments due to
chemical differences among the dye-terminators, differential dye-terminator
incorporation efficiencies (Parker et al., 1996), excessive “noise” from
unincorporated dye-terminators, sequence compressions - especially in area of
GC-richness (Sanger and Coulson, 1975), and a general loss of peak-to-peak
signal resolution with poor signal-to-noise ratios toward the end of long
electropherograms.
Basecalling

software

programs

processes

DNA

sequence

electropherogram files and assign a base quality score to each call using the
equation QV=-10log10(Pe) where Pe is the probability of an error in a base call
(Biosystems, 2003). Based on an examination of peak spacing, the ratio of the
largest uncalled to the smallest called peak and the degree of peak resolution
expected in a given window, it is typically possible to distinguish between errors
and correct base-calls. The “KB” Basecaller from Applied Biosystems (Foster City,
CA) employs such an algorithm.
While base quality scores indicate the confidence with which individual
base calls have been made relative to theoretical optimum, they do not
necessarily serve as a measure of the extent to which the quality of a sequencing
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reaction deviates from what would be seen for an actual reference sample. It is
thus conceivable that base quality scores alone might not readily reflect subtle
differences in the reproducibility of sequencing reactions. Such differences can
be significant in a forensic context when comparing sequence data generated
from different laboratories, different DNA extracts, different input DNA
quantities or different labeling kits. Similarly, base quality scores do not
necessarily compensate for reproducible anomalies (e.g., deviations from the
theoretically optimal base spacing) that are commonly seen in sequence
electropherograms.
In cycle sequencing reactions, the efficiency with which dye-labeled
terminators are incorporated can be highly variable between any two positions
reflecting both the chemical differences between the dye-terminators and the
influence

of

sequence

context

(Khan

et

al.,

1999).

The

resulting

electropherograms, therefore, are typically characterized by a pattern of peaks
that are often significantly uneven in their heights relative to each other. Such
variability can have a negative impact on basecalling confidence with existing
basecalling algorithms. The ability to predict relative differences in peak heights,
however, could be used to improve sequence accuracy. Moreover, if the pattern
of peak height variability were highly reproducible, the pattern itself could be
employed as a parameter for assessing the quality of a given sequencing reaction
relative to an actual reference standard. This has important implications for
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laboratory validation and quality assurance efforts since it would enable analysts
to automatically spot check a sequence to determine whether the global
“electrophoretic pattern” is within an acceptable range of sample-to-sample
variability for a specific amplicon and the instrumentation in a specific
laboratory.
Quantifying the reproducibility of an “electrophoretic pattern” may also
facilitate the analysis of mixed samples including heteroplasmic as well as
situational mixtures of more than one individual. This is based on the reasonable
expectation that after accounting for spectral differences in dye terminator
fluorochromes, relative differences in peak heights are fundamentally a function
of the underlying difference in the quantity of terminated DNA molecules. Thus,
any significant change in the relative height of a given peak should reflect a
change in the underlying quantity of DNA at that position. Some researchers
have attempted to quantify the level of heteroplasmy by comparing the relative
heights of overlapping electrophoretic peaks (Sekiguchi et al., 2003). In the
absence of data on peak height reproducibility, however, such measures are only
rough approximations. In an effort to achieve greater quantitative accuracy,
some researchers have relied on alternative approaches such as quantitative
real-time PCR (Bai and Wong, 2004), pyrosequencing (White et al., 2005) or
endpoint assays that employ densitometry (Tengan et al., 1997). These
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approaches, however, consume additional sample while often being laborious or
requiring instrumentation not typically found in a forensic laboratory.
The first objective of the current study, therefore, was to assess the
quantitative reproducibility of electrophoretic peak heights for the HV1 and HV2
regions of human mtDNA as a function of DNA input quantity, base location and
sequencing chemistry. The second objective was to determine whether a
quantitative pattern of relative peak height differences across a high-quality
reference electropherogram could be used to accurately assess the quality of
DNA sequencing results from subsequent sequencing reactions.

§4-2

Materials and Methods

§ 4 - 2.1

Mitochondrial DNA Extraction and Purification

This research was conducted in compliance with U.S. Federal Policy for
the Protection of Human Subjects (56 FR 28003). Samples were collected from
subjects who were unrelated and had provided informed consent to participate
in the study. Mitochondrial DNA was extracted from buccal swabs using the EZ1
DNA tissue kit on the Qiagen BioRobot EZ1 DNA extraction robot (Qiagen Inc.,
Valencia, CA) according to the manufacturer’s protocol. Briefly, whole swabs
were immersed in 190µL of Qiagen’s proprietary “G2 Buffer” and 10µL of
proteinase K solution (600mAU/mL), vortexed for 10 sec. and incubated at 56°C
for 15 min. The digested supernatant was transferred to a sterile 2mL sample
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tube and loaded onto the BioRobot EZ1 where samples were automatically
extracted using paramagnetic beads and eluted into 200µL DNA free water.
Validated primer pairs and PCR amplification conditions (Wilson et al., 1995;
Budowle et al., 2000) were used to amplify four forensically relevant regions of
the human mitochondrial control region (i.e., HV1A, HV1B, HV2A and HV2B
amplified by primer sets, A1/B2, A2/B1, C1/D2 and C2/D1, respectively) except
that AmpliTaq GOLD® DNA polymerase (Applied Biosystems) was used and
supplemented with high-fidelity Pfu DNA polymerase (Stratagene, La Jolla, CA) at
a 9:1 ratio.
Amplification reactions were purified by denaturing high-performance
liquid chromatography (Huber et al., 1993; Kuklin et al., 1997) on a WAVE®
3500HT Nucleic Acid Fragment Analysis System (Transgenomic Inc., Omaha, NE).
Briefly, unpurified PCR products were bound to a DNASep® analytical column at
50°C in the presence of 0.1M triethylammonium acetate (TEAA) pH 7.0 as an ion
pairing reagent. Target PCR amplicons were selectively eluted using a linear
gradient of increasing acetonitrile produced by differential mixing of buffer A
(0.1M TEAA) and buffer B (0.1M TEAA: 25% ACN). The optimal gradients
employed a 56% to 65% buffer B increase in 3.5 minutes for HV1A, HV2A and
HV2B and a 55% to 64% buffer B increase in 3.5 minutes for HV1B. All samples
were eluted at 0.9ml/min flow rate and detected by UV at 260nm. Eluted peaks
were captured using an automated fraction collector; dried by vacuum
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centrifugation (30 minutes at 50°C, followed by a 20-minute cool down to
ambient temperature); resuspended in ddH2O; quantified by 260/280nm UV
spectrophotometry and stored frozen until dye-terminator labeling.
§ 4 - 2.2

Mitochondrial DNA Sequencing

DNA sequencing reactions were prepared for each of four control region
amplicons. Use of the eight aforementioned PCR primers for labeling allowed
each amplicon to be sequenced in both the forward and reverse directions.
Reactions prepared using the BigDye® Terminator v1.1 Cycle Sequencing Kit
(Applied Biosystems) used five different DNA input quantities (0.1ng, 0.2ng,
0.4ng, 0.8ng and 1.6ng) while those prepared using the BigDye® Terminator v3.1
Cycle Sequencing Kit (Applied Biosystems) used three different DNA input
quantities (0.4ng, 0.8ng and 1.6ng). For all samples and conditions tested, five
independently-labeled replicate 10µl reactions were prepared in accordance
with the manufacturer’s protocol. Appropriate positive and negative controls
were carried through the entire sample handling process to monitor for
contamination and reagent integrity.
Dye-terminated products were purified by Performa® DTR V3 96-well
short plate purification columns (Edge Biosystems, Gaithersburg, MD) per the
manufacturer’s protocol and resolved on a PRISM® 310 Genetic Analyzer
(Applied Biosystems) using POP-6™ polymer and 47cm x 50µm capillaries
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(Applied Biosystems). The raw electrophoretic traces were analyzed using the KB
Basecaller together with the dye set mobility files indicated for the labeling kit
used. The resulting sequence data were displayed using the Sequencher™ DNA
analysis software (Gene Codes Corp, Ann Arbor, MI).
Quantitative data on peak heights for statistical analyses of
electrophoretic patterns were obtained by first analyzing raw electrophoretic
data using the KB Basecaller which is part of the PRISM® 310 Sequencing Analysis
Software version 5.1 (Applied Biosystems). The resulting .scf output file was then
ported to the CEQ™ 8000 Genetic Analysis System version 8.0 software package
(Beckman-Coulter, Fullerton, CA) to allow output of the electrophoretic peak
height data for each channel and time point as a .txt file. Text files were then
opened in Microsoft Excel for subsequent statistical analyses. The height of each
peak in relative fluorescence units (RFU) was compared across the five replicates
for each amplicon, sequencing primer, input DNA quantity, and sequencing
chemistry tested.
§4-3

Results
The reproducibility of electrophoretic traces across the mtDNA HV1 and

HV2 region was evaluated. A total of five different DNA template input quantities
(0.1ng - 1.6ng); encompassing a range frequently encountered by forensic
practitioners were used. For these analyses, each of four forensically-relevant
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mtDNA amplicons was sequenced in both the forward and reverse directions.
The resulting eight dye-terminator labeling reactions were independently
replicated five times each for statistical purposes.
Figure 4.1 presents an example of peak height and statistical variability
data (RFU ± SD) for nucleotide positions 140 - 180 of HV2A at labeling reaction
DNA input quantities of 0.4ng, 0.8ng and 1.6ng. Across these DNA input
quantities, the heights of individual electrophoretic peaks and, therefore, the
overall “pattern of relative peak height differences” was highly reproducible. This
is exemplified by the consistently low peaks for 147C and 164C versus the
consistently high peaks for 143G and 160A. Although the data presented in figure
4.1 represent a small portion of the HV2A amplicon, they are consistent with the
results that have been obtained for the entire HV1 and HV2 region. The
sequencing traces obtained using lower DNA input quantities (0.1ng and 0.2ng)
were similarly consistent (Appendix B).
§ 4 - 3.1

Impact of DNA input quantity on peak height reproducibility

Shown in Table 4.1 are peak height variability data for each of the eight
labeling reactions used to sequence the HV1 and HV2 regions. These values
reflect the variability in peak height averaged across all the peaks in the amplicon
sequenced. Also shown is the combined peak height variability average of all
sequencing reactions at each of five DNA input quantities. In order to
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compensate for the often significant differences in peak heights between any
two positions, variability data were expressed as a percentage of peak height
(i.e.,. Coefficient of variation = SD/mean x 100%).
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Figure 4.1: Reproducibility of electrophoretic peak heights for positions 140 to 180 of the mtDNA HV2A amplicon. The data
represent the mean peak heights ± standard deviations from five independent labeling reactions for each of the three DNA
input quantities. Although there are significant differences in mean peak heights between different nucleotide positions,
the mean peak heights for each individual nucleotide position are highly consistent across the range of DNA input
quantities shown.

Table 4.1: Total variability (coefficient of variation with standard deviation
normalized to individual peak heights) associated with direct sequence
electropherograms for each of the four forensically relevant mtDNA amplicons
which encompass HV1 and HV2.
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Using the BigDye® Terminator v1.1 Cycle Sequencing Kit, 0.8ng of input
DNA yielded the lowest overall variability (±4.0%) across all amplicons. The
lowest input DNA quantity tested (0.1ng) had the highest average peak height
variability at ±6.4%. At lower input DNA quantities (0.1ng and 0.2ng), there was a
marked decrease in the signal-to-noise ratio particularly at the beginning of an
electropherogram. Conversely, electropherograms generated using 1.6ng of
input DNA were frequently characterized by fluorescence signal saturation,
especially of G and T peaks and/or a marked degradation in peak resolution near
the end of the trace.
§ 4 - 3.2 Impact of positional location and sequence context on peak
height reproducibility
To determine whether a base’s positional location within an amplicon has
an influence on electropherogram reproducibility, peak height variability was
compared across the length of each sequenced amplicon at five DNA input
quantities. Although the average variability across an amplicon (Table 4.1) ranged
from ±1.4% (HV2A sequenced using the D2 primer at 0.4 - 0.8ng input DNA) to
±10.0% (HV2B sequenced using the D1 primer at 0.1ng input DNA), variability
was found to be very position dependent. As illustrated by an analysis of HV1A
amplicon sequenced using the B2 primer (Figure 4.2), peak height variability is
typically greatest immediately adjacent to the primer binding site. Variability
decreases steadily towards the center of the amplicon; normally
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Figure 4.2: Variability of electrophoretic peak heights across the HV1A amplicon
sequenced using the B2 primer. To compensate for relative differences in peak
heights, variability data (averaged for groups of ten bases) are expressed as a
percentage of peak height. Values are based on five independent labeling
reactions for each of the three DNA input quantities. Variability which is greatest
adjacent to the primer binding site decreases towards the center of the amplicon
and then rises toward the end of the labeled product. This pattern is more
pronounced at input DNA quantities of 0.1ng and 1.6ng.
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reaching a minimum 85-114bp downstream of the primer binding site. Variability
then rises steadily as one approaches the end of the labeled product. This
phenomenon is generally more pronounced at either low (0.1 - 0.2ng) or high
(1.6ng) input DNA quantities (Appendix B).
Nearest neighbor interactions are important to the thermodynamic
stability of base pairing in nucleic acids. To determine whether this has a
significant impact the efficiency of nucleotide incorporation during dyeterminator labeling, peak height variability was examined as a function of the
preceding base for all HV1 and HV2 amplicons at all five input DNA quantities.
Analysis of the resulting data by two-way non-parametric Kruskal-Wallis test
showed no significant influence or interaction on peak height variability as a
result of the preceding base at any DNA input quantity (H=0.0913, df=8,
P=0.999).
§ 4 - 3.3 Impact of sequencing chemistry on peak height
reproducibility
To determine whether peak height reproducibility is influenced by
sequencing chemistry, two DNA input quantities (0.8ng and 1.6ng) were tested
across the four labeling reactions used to sequence the HV1 region. Peak height
variability averaged across an amplicon was found to be more variable with the
BigDye® Terminator v3.1 than the v1.1 Cycle Sequencing Kit. At 0.8ng of input
DNA, peak height variabilities for HV1 sequencing reactions ranged from 2.5% 111

16.4% with the v3.1 chemistry versus 1.6% - 9.9% with the v1.1 chemistry. Similar
results were obtained at 1.6ng of input DNA where the average peak height
variabilities for HV1 sequencing reactions ranged from 2.6% - 21.5% with the v3.1
chemistry versus 1.4% - 7.5% with the v1.1 chemistry. In addition to being more
consistently reproducible, the v1.1 chemistry also yielded higher quality
sequence data at lower DNA input quantities; provided sequence information
immediately adjacent to the primer binding site and; more clearly resolved peaks
throughout the electropherogram (Figure 4.3).
§ 4 - 3.4 Evaluating sequence data relative to a “reference
electropherogram”
Given the overall reproducibility of “electrophoretic patterns”, it should
be possible to use relative differences in the heights of adjoining peaks to assess
how closely a “questioned electropherogram” conforms to a “reference
electropherogram” and thereby to identify electrophoretic irregularities of
potential interest in a questioned sequence. As an initial test of this approach,
the electropherogram for HV1A (0.8ng of input DNA; A1 primer; the v1.1
chemistry) was selected as a reference sequence. Using a prior moving average
equation:
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Figure 4.3: Examples of DNA sequence electropherograms obtained using
BigDye® Cycle Sequencing chemistries. (3A) The v3.1 chemistry results in
electropherograms characterized by lower quality scores and reduced resolution
between adjoining peaks especially in regions of homopolymeric sequence. (3B)
The v1.1 chemistry results in electropherograms characterized by higher quality
scores and optimal resolution between adjoining peaks.
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where “Q” and “R” are peak heights (RFU) in the questioned and reference
samples, respectively, “P” is the predicted peak height and “n” is the base
position in the electropherogram it is possible to generate a “predicted peak
height pattern” for any questioned electropherogram based on a reference
electropherogram. By comparing the “expected heights” to the actual peak
heights in the questioned sample, it is possible to assess how closely the
questioned electrophoretic pattern corresponds to the reference pattern.
Figure 4.4 illustrates the use of this approach for comparative pattern
analysis between the HV1A reference sequence mentioned above and the
electropherogram for the HV1A region of a questioned sample. Deviations from
the expected peak heights are readily indicated by the presence of “pattern
perturbation spikes” in the comparison plot. In figure 4.4, there are a total of five
spikes which represent deviations from the expected “reference pattern.” Three
of these spikes (16086, 16129 and the compound spike from 16182 - 16186) are
due to the fact that the questioned sample was a two-component (80:20 ratio)
DNA mixture. The spikes reflect changes in the height of the major component
peak where the underlying minor component differs in primary sequence (i.e.,
mixed based positions: 16086C/T, 16129A/G, 16182A/C, 16183A/C and
16184T/C). The spike at 16089 reflects deviations from expected peak heights
due to the proximal influence of the T→C base substitution at position 16086 in
the minor component of this DNA mixture. Similarly, the spike at position 16185
114

115

Figure 4.4: Electrophoretic pattern comparison plot between a reference and a questioned HV1A sample. Spikes
represent deviations in peak height of the questioned electropherogram from expected values. Here, these deviations
reflect: mixed based positions in the questioned sample (16086C/T, 16129A/G, 16182A/C, 16183A/C and 16184T/C);
the influence of a base substitution on proximal bases (e.g., the influence of the 16086T→C substitution on the peak
at 16089); and a suspected anomaly in the basecalling software (position 16048). (*optimal intensity ratios have been
cubed to emphasize outliers (Cramer, D., 1997).

- 16186 results from the proximal influence of the neighboring substitutions at
positions 16182 - 16184. The spike at position 16048 cannot be traced to the
direct/proximal influence of a base substitution and thus represents an “atypical
perturbation spike”. Because they are unattributable to base substitutions,
atypical spikes represent potential sequence electropherogram anomalies of
particular interest. These phenomena will be addressed in the following sections.
In a broader test of comparative electrophoretic pattern analyses, forty
non-identical questioned samples (ten each for HV1A, HV1B, HV2A and HV2B)
were compared to the cognate reference electropherograms pattern. Table 4.2
shows the number of pattern perturbation spikes for each amplicon. These
spikes were categorized as either “base substitution”, “proximal substitution” or
“atypical” spikes. For all amplicons, base substitutions present in the questioned
amplicons accounted, directly or through proximal effect, for 289 of 321 (90.0%)
pattern perturbation spikes. Atypical spikes were less common, accounting for 32
of 321 (10.0%) spikes.
§ 4 - 3.5

Impact of base substitution on proximal peak heights

To assess the impact of base substitution on the overall “pattern” of
relative peak heights, sequencing traces representing each of four mtDNA
amplicons were compared. Each amplicon was sequenced in both the forward
and reverse directions at five different DNA input quantities (0.1ng - 1.6ng).
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Table 4.2: Total number and causal distribution of peak perturbation spikes
detected in pairwise analyses of 40 non-identical samples relative to the cognate
reference sample for each amplicon and labeling primer.
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A base substitution may influence the peak heights of surrounding bases.
Based on analyses of 150 base substitution sites, the height of peaks within a
range of -2 to +5 bases of the substitution site are most typically affected. This is
not to suggest, however, that every peak within this window will necessarily be
affected nor that such proximal effects cannot occur beyond it. Figure 4.5
illustrates this for a T→C base substitution at position 16086. In addition to the
expected change in channel in which the dye terminator fluorochrome is
detected and height of the electrophoretic peak at the substitution point, the
heights of the nearby peaks also showed a reproducible change in height. The
largest changes were seen at 16084G, 16088T and 16089G. The heights of
16084G and 16088T decreased while that of 16089G increased following the
base substitution at 16086. The intervening peak heights for 16085C and 16087A,
by contrast were unchanged.
§ 4 - 3.6

Other anomalous impacts on peak heights

Although the majority of pattern perturbation spikes are attributable to
base substitutions, atypical spikes appear to have a different etiology. Among
atypical spikes in the current study, 75.0% could be traced to poor signal quality
typically at the beginning or end of a sequencing electropherogram. The
remaining 25.0% of atypical spikes, however, were present in regions of high
quality signal. In an effort to elucidate the underlying cause of the remaining
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Figure 4.5: Superimposed electropherograms for a region of HV1A sequenced
using the A1 primer illustrated the influence of a 16086T→C base substitution on
the heights of proximal peaks. The largest changes involved decreases in peak
heights at 16084G and 16088T and an increase at 16089G. This proximal effect
did not impact the heights of the intervening peaks at 16085C or 16087A.
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“atypical spikes”, raw and analyzed electropherograms were compared for these
anomalous positions which were present in all four mtDNA amplicons.
Figure 4.6 shows the analyzed electrophoretic traces for five replicate
sequencing reactions of part of the HV1A amplicon sequenced with the B2
primer. While there is almost complete consistency in the height for each peak
across these independent reactions, the peak corresponding to 16182T has a
significantly reduced height in the fifth replicate sample. This results in an
atypical spike when compared to a reference sequence. Analyses of other
atypical spikes in regions of good signal quality revealed a similar pattern (e.g.,
positions 16182 in HV1A; 16267 and 16284 in HV1B; and 158 in HV2A). In each
case, the anomalous peak was nearly always the second base of a 3 - 5 base
homopolymeric A- or C-stretch; reduced in height relative to the reference
pattern; and did not appear to have any influence on the heights of neighboring
bases.
§4-4

Discussion
Electrophoretic peak heights reflect the underlying quantity of DNA

molecules terminated at a given position during the labeling process. The current
study provides an evaluation of the reproducibility of peak heights in sequence
electropherograms for human mtDNA amplicons commonly employed for
forensic analyses. A thorough understanding of specific factors that may impact
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Figure 4.6: Replicates of five sequencing reactions from HV1A sequenced with
the B2 primer and the overall peak height consistency for each peak across
multiple independent reactions. Note that the 16182T peak (arrow) of the last
replicate is significantly lower than the corresponding peak in the preceding four
replicates.
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the reproducibility of a given electrophoretic trace can make it possible to rapidly
identify genuine sequence irregularities thereby facilitating more efficient and
accurate interpretation of mtDNA sequence data by lab analysts.
DNA template quantities have a significant influence on peak height
reproducibility and sequence quality. Across all four forensically-validated
mtDNA amplicons, 0.4 - 0.8ng of input DNA yielded the lowest average peak
height variability. Electropherograms generated using these optimal input
quantities showed minimal noise associated with unincorporated dyes at the
beginning of the sequence and minimal signal deterioration at the end of the
sequence. Elevated peak height variability and lower signal-to-noise ratios were
frequently seen with low DNA input (0.1 - 0.2ng) while signal saturation at high
input (1.6ng) produced “phantom peaks” due to spectral pull up.
Deconvolution of saturated electrophoretic peaks, which is required for
basecalling, results in both an underestimation of a peak’s true height and
greater peak height variability. Signal saturation also produces pull-up of the
overlapping dye spectra. This artifact remains following application of the dye
matrix and typically results in the appearance of false “phantom peaks”
immediately before or after the saturated peak. Figure 4.7 illustrates this in a
comparison of a 43bp stretch of HV1A sequence data for two DNA input
quantities (1.6ng and 0.8ng). Signal saturation seen in the raw data for the 1.6ng
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Figure 4.7: Comparison of raw and analyzed electrophoretic sequence data for
HV1A sequenced using the A1 primer at two DNA input quantities. (7A) Use of
1.6ng of template DNA in a dye-terminator labeling reaction was associated with:
signal saturation of the raw data; phantom peaks produced by spectral pull-up in
the analyzed data and; frequent low basecall quality scores. (7B) Use of 0.8ng of
template DNA in a labeling reaction eliminated these anomalies in the analyzed
data and resulted in basecall quality scores that were consistently high.

123

reaction (Figure 4.7A) resulted in the appearance of five clearly defined phantom
peaks in the analyzed data – three of which were erroneously called by the
sequencing software. In the absence of signal saturation, these were eliminated
as illustrated by the analyzed data for the 0.8ng reaction (Figure 4.7B). This
underscores the importance of accurate template quantification prior to dyeterminator labeling.
Given the sequence dependent folding characteristics of a DNA molecule,
the context specificity of a base might be expected to influence the
reproducibility of dye-terminator incorporation. Although small differences in
peak height reproducibility were seen as a function of the preceding base, these
differences

did

not

approach

statistical

significance. The

degree

of

electropherogram reproducibility was, however, found to vary as a function of
location within an amplicon. Peak height variability was elevated both in the
region immediately downstream of the labeling primer and at the end of the
amplicon leaving the most reproducible peak heights clustered toward the center
of the amplicon. Although this was seen at all DNA input quantities, use of
optimal input DNA quantities (0.4 - 0.8ng) minimized the phenomenon.
Two BigDye® Terminator Cycle Sequencing chemistries (v1.1 and v3.1) are
commercially available for forensic applications. Although most forensic
laboratories employ the v1.1 chemistry for mtDNA sequencing, the v3.1
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chemistry has also been used for forensic casework (Cruz et al., 2004). On the
basis of both reproducibility and peak quality, the v1.1 kit demonstrated superior
performance. Quantitatively, electropherograms produced using the v1.1 kit
were nearly twice as reproducible. Qualitatively, interpretable sequence reads
typically began almost immediately after the primer and the resolution between
peaks was greater – especially in homopolymeric regions (Figure 4.3). More
critically for forensic laboratories, the v1.1 kit yields high quality sequence
information at half the DNA input quantity required with the v3.1 kit. This is an
advantage in cases where only minute quantities of DNA are recovered (e.g.,
degraded biological material).
Given the reproducibility of sequencing electropherograms and having
characterized the impact of DNA input quantity, positional location and
sequencing chemistry, it may be possible to develop algorithms capable of
assessing sequence quality relative to a reference electropherogram. In the
current study, reproducible differences in the heights of neighboring
electrophoretic peaks were used as a basis for comparison. When the height of
an electrophoretic peak was either significantly higher or lower than what was
expected based on the electropherogram from a corresponding reference
sample, that peak resulted in the formation of a “pattern perturbation spike” as
described previously. A number of factors, many of potential interest to a
forensic analyst, can cause an electropherogram to deviate from the expected
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reference pattern. These include base substitutions, mixed base positions and
changes in the heights of peaks in the vicinity of a base substitution (i.e.,
“proximal affects”).
The approach may also facilitate the detection of subtle sequence
anomalies that are not evident from base quality scores. In the current study, for
example, the occurrence of some “atypical spikes” revealed the presence of
anomalies that were not linked to base substitutions, mixed base positions or
regions of elevated peak height variability. Figure 4.8 highlights two bases
(16267C and 16284A) which were found to be independently associated with
atypical spikes. In figure 4.8A, the height of the 16267C peak is consistent with
expectations based on the reference electrophoretic pattern while 16284A is
abnormally low. Conversely, in figure 4.8B, this relationship is reversed such that
16267C is abnormally low while the 16284A peak is consistent with the reference
electrophoretic pattern. These anomalously low peaks, however, showed no
corresponding indication of an anomalously low fluorescence signal in the raw
data. Rather, the raw data appears indistinguishable between “normal” traces
and those in which an atypical spike was seen. Furthermore, there does not
appear to be an increase in noise or an obvious change in peak morphology that
could account for this anomaly. Re-analysis of the same data set using a
difference basecaller (i.e., ABI basecaller) eliminated the anomaly, suggesting a
software problem. In consultation with software engineers at Applied
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Figure 4.8: Illustration of the independent occurrence of two peak height
anomalies within the same region of two of five replicates sequencing reactions.
(8A) A low peak height anomaly is present at position 16267C while the peak
height for 16284A is within expected values. (8B) A low peak height anomaly is
present at position 16284A while the peak height for 16267C is within expected
values. Although the anomalies are clearly evident in the analyzed data,
comparison of the corresponding peaks in the raw data traces show no
significant difference in peak height suggesting that the anomaly is due to a
factor other than a reduction in fluorescence signal.
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Biosystems, the consensus opinion is that the anomaly is likely the result of an
unidentified bug within the KB Basecaller (Applied Biosystems, personal
communication). The potential for this to adversely impact basecalling accuracy
has not been determined. The fact that its occurrence can be detected through
pattern analysis may assist analysts by focusing their attention on potentially
problematic sequence data.
The algorithm employed for the current study represents only one
possible approach to the quantitative comparison of electrophoretic patterns.
The results presented, while encouraging should not be interpreted at indicating
that alternative algorithms might not provide superior detection of regions of
sequence data that deviate from that of a reference pattern. The development
and validation of an optimal algorithm was beyond the scope of the current
study but represents an important focus for future research.
Comparative analysis of electrophoretic patterns may have important
potential as an added computational tool for forensic analysts working with
mtDNA. First, the entire process can be readily automated and as a result may
help to more readily direct an analyst’s attention to regions of sequence data
worthy of heightened scrutiny. By using a known sample as the reference
electropherogram, it could enable an analyst to more quickly and confidently
include or exclude a questioned sample. From a laboratory QA/QC perspective
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this approach may be useful as a rapid and reliable means of monitoring
sequencing kit integrity and instrument performance based on pattern
concordance with a laboratory reference standard.
§4-5

Conclusion
DNA sequencing analysis is among the most comprehensive genetic

analysis tools currently used in molecular biology. For forensic applications, it
remains the gold standard for mtDNA haplotyping. To date, however, the
assessment of DNA sequence quality has relied almost exclusively on the
experienced eye of forensic analysts and the use of base quality scores. The
results of the current study have evaluated the reproducibility of sequencing
electropherograms and quantitatively characterized the impact of DNA input
quantity, peak location, sequencing chemistry and base substitution on peak
height variability. This study has potential benefits for forensic practitioners in
that the data presented may facilitate the development of computational
approaches to aid in the laborious process of reviewing mtDNA sequence
electropherograms. This can speed the turnaround of mtDNA samples while
allowing for greater confidence in base calls and quicker disposition of forensic
cases. Ongoing studies seek to develop and ultimately validate statistically
grounded algorithms in conjunction with software for automated data analysis.
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§4-6

Summary
The review of dye-terminator sequencing electropherograms is central to

forensic mtDNA haplotyping. The assessment of DNA sequence quality relies
heavily on the experienced eye of the forensic analyst and the use of basecall
quality scores. The current study sought to assess the quantitative reproducibility
of electrophoretic peak height patterns for forensically relevant regions of
human mtDNA. The impact of DNA input quantity, base location and sequencing
chemistry on peak height variability and the potential utility of comparative
electrophoretic pattern analysis was evaluated. DNA template quantities used in
dye terminator labeling reactions were found to significantly influence sequence
quality and reproducibility. DNA input quantities of ≤0.2ng resulted in elevated
peak height variability and lower signal-to-noise ratios while input ≥1.6ng
produced signal saturation associated with false peaks. Peak height variability
was position dependent across all amplicons being lowest in the center and
highest adjacent to the primer binding site. With regard to sequencing
chemistries, the BigDye® Terminator v1.1 Cycle Sequencing chemistry
demonstrated superior performance on the basis of peak height reproducibility,
electropherogram quality and optimal DNA input quantity.
The reproducibility of “electrophoretic patterns” makes it possible to use
relative differences in the heights of adjoining peaks to assess how closely a
“questioned electropherogram” conforms to a “reference electropherogram”
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and thereby to identify electrophoretic irregularities of potential interest in a
questioned sequence. A comparative analysis of forty, non-identical samples
representing the HV1A, HV1B, HV2A and HV2B amplicons accurately identified
deviations from reference electrophoretic patterns which resulted directly or
indirectly from base substitutions, the presence of mixed base positions in
situational mixtures and a possible anomaly in the basecalling software.
Comparative analysis of electrophoretic patterns may have important potential
as computational tool for forensic analysts. Such an approach may help analysts
to more rapidly identify sequence irregularities; thereby facilitate more efficient
and accurate interpretation of mtDNA sequence data.
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Chapter 5: Quantitative Determination of Mixed Nucleotide
Populations in Mitochondrial DNA Sequencing
§5-1

Introduction
There has been significant discussion regarding mtDNA and the

importance of characterizing heteroplasmy and situational mixtures in the
forensic and other scientific literature (Ivanov et al., 1996; van Den Bosch et al.,
2000; Melton et al., 2005). Much of the discussion has focused on the basic
detection of heteroplasmy; the potential value of being able to quantitatively
assess heteroplasmic ratios. It has been proposed that the availability of
quantitative information might aid human identification (Gill et al., 1994),
disease diagnostics (Harrigan et al., 1998; Nurpeisov et al., 2003) and the ability
to determine the individual mtDNA haplotypes of the contributors to a mtDNA
mixture (Danielson et al., 2005). Dye-terminator sequencing has through the
years been considered to be the most accurate method of DNA sequence
analysis in molecular genetics and molecular diagnostics. As new terminator
chemistries have been developed, consistency in peak height and reliability of
base calls have become a major focus of scrutiny in dye-terminator sequencing.
Individual peak heights across a sequencing electropherogram are highly variable
relative to one another. This is due to differences in the incorporation rates of
individual dye-terminator nucleotides at a given base position and the spectral
132

properties of their associated fluorochromes. For any specific base position,
however, peak heights are highly consistent across multiple sequencing reactions
(Chapter 4).
In dye-terminator sequencing, the appearance of a heterozygous loci or a
mixture of two or more DNA molecules is characterized by one or more
overlapping electrophoretic peaks. This typically results in ambiguous basecalls at
mixed sites. In the case of a length variant, a completely unreadable sequencing
electropherogram is produced starting at the point where the two variants fall
out of register with each other. The quantitative ratio of the contributors to a
mixture should be reflected by differences in the peak heights at mixed-base
positions. Since peak height is governed in part by the relative incorporation
efficiencies of individual nucleotides, the ratio of one peak to another at a mixedbase position is not a direct reflection of the relative DNA quantity contribution
of two or more contributors to a mixture. (Danielson et al., 2007). As a result,
mixed-base positions in sequencing electropherograms from forensic casework
samples are generally omitted from the reported haplotype analysis. This
exclusion of data decreases the power of discrimination of the analyzed sample.
In spite of these limitations, some researchers have attempted to use
peak height data to follow the spread of drug resistant mutations associated with
human immunodeficiency virus type 1 (HIV-1) (Harrigan et al., 1998; Nurpeisov et
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al., 2003) and the spread of mutations in hepatitis B virus polymerase (Olivero et
al., 2006). This approach relies on a comparison of relative peak heights for the
variants of interest at mixed-base positions from samples taken at different time
points. An increase in nucleotide peak height associated with the
resistant/disease strain along with a corresponding decrease in peak height
associated with the wild type nucleotide suggests an increase in the prevalence
of the resistant/disease strain between the samples being assayed.
Additional methods for the detection of these mutations have been
developed. These include line probe assays (Stuyver et al., 1997) (Innogenetics,
Gent, Belgium) and detection by real-time PCR (Affigene, Sangtec Molecular
Diagnostics AB, Bromma, Sweden). Although these approaches work well when
dealing with known genetic markers, they require the design of new nucleotide
specific probes whenever a new sequence variant is discovered. An added
concern is that line probe assays are associated with a high level of false negative
results (Servais et al., 2001). Real-time PCR assays are accurate and highly
reproducible but the detection of mutations at multiple different sites
necessitates the design and costly optimization of numerous assays. In a forensic
context, these methods can consume a significant amount of often precious
evidentiary material.
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The ability to extract quantitative information on DNA mixtures from the
direct analysis of peak height ratios at mixed-base positions in sequencing
electropherograms would make it possible to circumvent these limitations. Such
an approach would allow for analysis of known and novel polymorphisms
regardless of location within an amplicon. Furthermore, quantitation analyses
could be conducted without the need for any additional sample manipulation.
Finally, sequencing analyses require significantly lower template quantities than
a single line probe assay and can be completed at significantly lower cost than
either of the aforementioned method.
Although dye-terminator sequencing has, in general, been very successful
for accurate DNA haplotyping of single source samples, the interpretation of DNA
heteroplasmy and the analysis of mixtures of two or more individuals have
proven to be significantly more difficult. Due to context specificity of nucleotide
incorporation efficiencies, the reliable determination of relative DNA quantity
associated with each component of a mixture has until now been unattainable.
The ability to accurately interpret DNA mixtures would have significant benefits
for basic research, disease diagnostics and forensic investigations involving
mtDNA or other sequence-based analyses such as those based on biallelic
markers. The objective of the current study was, therefore, aimed at determining
the extent to which a change in the relative quantities of input DNA for two
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amplicons correlated with a change in ratio between the resulting
electrophoretic peak heights across a range of mixed-base positions.

§5-2

Materials and Methods
This research was conducted in compliance with U.S. Federal Policy for

the Protection of Human Subjects (56 FR 28003). Individual buccal swabs were
collected from 45 unrelated subjects of diverse ethnicity who had previously
provided informed consent to participate in the study. All samples were stored at
-20°C until DNA extraction.
§ 5 - 2.1

Mitochondrial DNA Extraction and Purification

Mitochondrial DNA was extracted from buccal swabs using the EZ1 DNA
tissue kit on the Qiagen BioRobot EZ1 (Qiagen Inc., Valencia, CA) according to the
manufacturer’s recommended protocol. Four forensically relevant regions of the
human mitochondrial control region (i.e., HV1A, HV1B, HV2A and HV2B) were
amplified in 50μL reactions, using 50pmol each of forensically-validated PCR
primers (Wilson et al., 1995; LaBerge et al., 2003); 2.25U AmpliTaq GOLD® DNA
polymerase (Applied Biosystems, Foster City, CA) supplemented with 0.25U Pfu
DNA polymerase (Stratagene, La Jolla, CA); AmpliTaq GOLD® Buffer (Applied
Biosystems); 10nmol of each dNTP (Stratagene) and 10μL of an approximately
10pg/μL human DNA extract. Amplifications were performed on a GeneAmp®
9700 thermocycler (Applied Biosystems) with an initial denaturation at 95°C for
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10 minutes, followed by 32 cycles of 95°C for 20 seconds, 60°C for 30 seconds
and 72°C for 45 seconds. The final extension at 72°C was for 15 minutes. PCR
amplicons were purified and quantified at 50°C on a WAVE® 3500HT DNA
Fragment Analysis System (Transgenomic Inc., Omaha, NE) containing a DNAsep®
analytical column packed with alkylated poly(styrenedivinylbenzene) resin
(Huber et al., 1993) using previously established methods (Chapter 3).
§ 5 - 2.2

Mitochondrial DNA Sequencing

Mixture templates were prepared at thirteen stepped quantity ratios
ranging from 99:1-1:99 (i.e., 99:1, 95:5, 90:10, 80:20, 70:30, 60:40, 50:50, 40:60,
30:70, 20:80, 10:90, 5:95, 1:99) at 0.4ng/µl. Sequencing reactions were prepared
in triplicate 10µl reactions, using the previously mentioned forensically-validated
primers. For each labeling reaction, 0.8ng of input DNA was used in order to
obtain optimal peak height consistency as described previously (Chapter 4).
Samples were extended using the BigDye® v1.1 Dye Terminator Cycle Sequencing
kit (Applied Biosystems) according to the manufacturer’s protocol. Dyeterminated products were purified using Performa® DTR V3 96-well Short Plate
Kit (Edge BioSystems, Gaithersburg, MD) according to the manufacturer’s
protocol and resolved on the PRISM® 310 Genetic Analyzer (Applied Biosystems).
Appropriate positive and negative controls were carried through the entire
sample handling process to minimize cross contamination and to monitor
amplification efficiency.
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Sequence data was analyzed with Sequencing Analysis Software v.5.1.1
(Applied Biosystems). The resulting .scf output file was then ported to the CEQ™
8000 Genetic Analysis System version 8.0 software package (Beckman-Coulter,
Fullerton, CA) to allow output of the electrophoretic peak height data as a .txt
file. Text files were then opened in Microsoft Excel for statistical analyses or
displayed using the Sequencher™ v4.2 DNA analysis software (Gene Codes Corp,
Ann Arbor, MI).

§5-3

Results and Discussion

§ 5 - 3.1

Reproducibility of Peak-Height Ratios

Representatives of each of the four forensically validated mtDNA
amplicons (i.e., HV1A, HV1B, HV2A and HV2B) that collectively encompassed 100
variant sites across these regions were originally examined. During the course of
theses analyses, it was noted that the relationship between relative quantities of
input DNA and the ratio of the resulting electrophoretic peak heights at mixedbase positions was not identical when sequenced in the forward and reverse
directions. In discussions with forensic practitioners, a more rigorous approach
was taken to demonstrate the relationship between relative quantities of input
DNA and the ratio of electrophoretic peak heights at mixed-base positions by
including an additional 102 mixed-base positions in the reverse sequencing
direction (i.e., a total of 202 mixed-base positions, Table 5.1). In addition, 5
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Table 5.1: Sequence polymorphisms in the HV1 and HV2 regions assayed in twocomponent mixtures at 13 different DNA quantity ratios. Nucleotide differences
are noted as deviations from the revised Cambridge Reference Sequence.
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mixtures assayed that represented different combinations of mixed-bases within
the 202 positions included in the study.
Given the reproducibility of inter-individual differences in relative peak
heights, it is reasonable to suggest that a change in the relative molar ratio of
one component to another in a mixture will be reflected by a corresponding
change in ratio of overlapping fluorescence signals at all mixed-base positions.
The relationship between different molar ratios of two contributors to a mixture
and the corresponding electrophoretic peak height ratios at mixed-base positions
(182 T/C; 186 A/C; 189 C/A; 195 C/T; 198 T/C; 200 G/A) is illustrated in figure 5.1.
As the molar ratio between the two contributors in this HV2A mtDNA mixture
was varied in a stepwise manner, from a 90:10 to a 50:50 ratio of contributor 1
to contributor 2, there was a coordinated shift in the ratio of overlapping
electrophoretic peaks at nucleotide positions where the two contributors differ
from each other. In this example, six peaks representing nucleotides associated
with contributor 1 (182 T; 186 A; 189 C; 195 C; 198 T; 200 G) display a
coordinated decrease in fluorescence intensity relative to the peaks associated
with contributor 2 (182 C; 186 C; 189 A; 195 T; 198 C; 200 A). Figure 5.2
illustrates the excellent peak height reproducibility within overlapping
electrophoretic peaks. Shown are the peak heights and associated error bars for
mixed-base position 182 T/C across nine of the DNA quantity ratios tested in
triplicate. As expected, peak height consistencies, for this and the other 201
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Figure 5.1: Fluorescence peak height ratios at six mixed-base positions as a
function of stepwise changes in the quantity DNA input to the dye-terminator
labeling reaction. Shown are mixture ratios ranging from a 90:10 mixture to a
50:50 mixture of two HV2 DNA amplicons.
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Figure 5.2: Peak height reproducibility at nt182 for three replicate labeling
reactions at nine contributor DNA quantity ratios. Both components of the
mixture show highly reproducible peak heights (as represented by the error bars)
across all input quantity ratios tested.
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mixed base positions included in this study, were highly consistent across three
replicates. This confirms previously reported data on the global consistency of
peak heights in sequencing electropherograms (Chapter 4). Furthermore, these
results indicate that it should be possible to deconvolve the individual haplotypes
of two-component mixtures.
§ 5 - 3.2 Correlation Between DNA Quantity and Fluorescence
Intensity Ratios
The analyzed peak height data for 347 nucleotide mixtures revealed a
highly significant correlation between changes in DNA input quantity ratio for a
DNA mixture and changes in electophoretic peak height ratios. Consistent with
the high degree of reproducibility that was observed previously for relative
differences in electrophoretic peak heights (Chapter 4), a change in the molar
ratio of one contributor to another was found to correlate nearly perfectly (R =
0.9998) with the change in relative fluorescence of overlapping peaks at mixedbase positions (Figure 5.3). This is not to suggest that all mixed-base positions are
identical with respect to the relationship between a given peak height ratio and a
given DNA quantity ratio. Instead, the relative peak height ratios observed at
different nucleotide positions displayed highly reproducible context-specific peak
height relationships.
This is best demonstrated by the highly reproducible differences seen in
electrophoretic peak height ratios at a variety of nucleotide positions where
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Figure 5.3: A graph illustrating the strong correlation (R = 0.9998) between a
change in the molar ratio of DNA amplicons input to a dye-terminator labeling
reaction and a change in peak height ratios at mixed-base positions. The plot
consists of averages obtained from 74,952 data points (changes in peak height
fluorescence). A total of 347 mixed nucleotide positions were assayed at 9 molar
ratios of mixed mtDNA templates. The dashed line indicates the statistical line of
best fit to the data.
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equivalent DNA input quantities were assayed. Figure 5.4 illustrates the broad
range of fluorescent peak height ratios observed at mixed-base positions in
sequencing electropherograms when an equimolar mixture of two DNA
amplicons is used for the labeling reaction. The displayed histogram shows the
fluorescence contribution of the lower of the two peaks detected at each mixedbase position to the combined fluorescence signal of the overlapping peaks. Also
shown is the frequency that each level of fluorescence was detected in the 347
assays of mixed-base positions that were analyzed. In the majority of cases
(69.5%), the labeling of an equimolar DNA mixture was associated with a
fluorescent peak height ratio that fell within ±10% of the ideal 50:50 ratio. There
were a large number of cases that displayed significant discordance between an
equimolar DNA input to the labeling reaction and the resulting fluorescence ratio
at a mixed-base position. In the most extreme cases, the fluorescence ratio was
strongly and reproducibly skewed to yield a 21:79 peak height ratio. Accordingly,
for the 202 positions analyzed, one may reasonably assign a major and minor
contributor on the basis of peak heights alone at mixed base positions providing
that the major component peak exceeds 80% and the minor peak base call is less
than 20% of the total fluorescence at a mixed base position.
§ 5 - 3.3

Impact of Peak Overlap on Fluorescence Intensity Ratio

Direct sequence analysis of mixed mtDNA templates yields overlapping
peaks in the analyzed electropherogram at all positions where the templates
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Figure 5.4: Frequency of minor peak contribution to total fluorescence at an
equimolar (i.e., 50:50) ratio of two contributors to a DNA mixture. In 69.2% of
equimolar mixtures, the contribution of the minor peak to the total fluorescence
at mixed base positions was within 10 percentage points of the idealized 50%
value. In 30.8% of cases, however, the minor peak accounted for only 21% to
39% of total fluorescence at mixed base positions even though an equimolar
mixture of amplicons was labeled. This phenomenon was highly reproducible
across replicate reactions.
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differ in primary sequence. In most cases, peaks representing these mixed base
positions overlap completely (i.e., peak maxima occur at the same sampling
point). However, on occasion the minor peak at a mixed base position may be
shifted significantly upstream or downstream of the major peak. When analyzed,
this shift can result in an underestimation of the height of the minor component
peak. At affected positions, this phenomena is highly consistent across all ranges
of DNA input quantities (e.g., position 200G/A in Figure 5.1) and has been noted
to a varying degree at a number of different locations.
Figure 5.5A illustrates an extreme example of apparent minor component
peak shifting for the 239A nucleotide of the minor component in a 60:40 mixture
of 239G/A sequenced with the D2 primer. The sequence analysis algorithm
places the 239A minor component peak between the 238T and 239G peaks
creating an erroneous insert in the electrophoretic trace. The practical
implications of this are significant. In a putative single-source DNA sample, such a
peak shift could mistakenly be reported as an insertion. The risk of making such
erroneous base calls underscores the importance of sequencing templates in
both directions since this phenomenon has yet to be demonstrated in both
directions. One possible explanation for this shift may be reproducible anomalies
that exist in the spacing of some dye terminated chains. Figure 5.5B, illustrates
this by showing that even in the absence of a 239A peak, the 239G peak is still
shifted asymmetrically toward the 240T peak. It could be postulated that this
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A

B

Figure 5.5: Positional shifting of a minor contributor peak relative to the major
component peak in the HV2A amplicon sequenced with the D2 primer. 5A
illustrates a phantom insertion of 239A prior to the genuine 239G peak and an
ambiguous base call (239K) a result of the inserted minor component peak. 5B
illustrates the peak spacing in the same region obtained with a single source
sample. This demonstrates that even in a single source sample, 239G is
positioned asymmetrically toward 240T. This could predispose mixtures at this
position to phantom insertions.
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asymmetry predisposes this position to such phantom insertions. Accordingly,
analysts may be able to use base spacing in some cases as a potential indicator of
whether a questioned insert is genuine or not.
§ 5 - 3.4

Minor contributor identification in low level mixtures

Direct sequence-based mixture determinations have generally been
classified as any secondary/minor peak having a fluorescence intensity >10% of
that of the major component. Although generally true, a number of factors can
cause a mixed-base position to either under- or over-represent the relative
quantity of DNA contributed by the secondary component. Analysis of 202
unique low-level mixed-base positions by direct DNA sequencing yielded a shift
in fluorescence intensities for several tested positions. A total of 694
comparisons were performed at each of thirteen quantity ratios (i.e., the
aforementioned 99:1 through 1:99 range). At a quantity ratio of 20:80, 3.6% of
minor component peaks yielded a fluorescence intensity ratio lower than the
cutoff for calling mixed nucleotide positions (>10% major component peak
height). At the 30:70 quantity ratio, however, no minor component peaks fell
below the 10% mixture call threshold. As a result, some mixtures in which the
minor contributor represents less than 30% of the total DNA quantity will be
associated with selective peak dropout in the analyzed electrophoretic data even
though the minor component itself accounts for >10% of the total input DNA
quantity. In other words, some low level mixtures may yield a minor component
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haplotype where one or more nucleotide substitutions are not detected. This has
significant implications for haplotype determination of the minor component in
mtDNA mixtures. In these cases, fractionation of cross hybridized PCR products
by denaturing high performance liquid chromatography (DHPLC) can be
employed to enrich for the minor contributor so as to avoid erroneous peak
dropout (Danielson et al., 2007).
These results beg the contrary question of how often a two-contributor
mixture with a DNA input quantity ratio of 5:95 yields a fluorescence intensity
ratio for the minor component that is greater than the 10% cutoff for mixed
nucleotide detection. Out of 694 comparisons performed, 15.6% of minor
components yielded a fluorescence intensity ratio greater than the 10% cutoff.
While a small fraction of these can be traced to sequencing noise, the observed
deviation between the DNA input quantity ratios and the corresponding
fluorescence intensity ratio accounts for the majority of these cases. The obvious
implication of this phenomenon is that a sample which may appear to be
heteroplasmic at a single site, in reality, contains a low-level secondary
component. Again, employing DHPLC fractionation can aid in detecting these
types of low-level mixtures by enriching for the minor component. This will make
it possible, in many cases, to determine the complete haplotype of the minor
contributor. Alternatively, DHPLC could be used to purify away the minor
component/contaminant to yield a clean sequence for the major contributor. In
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all cases, knowledge of nucleotide incorporation rates associated with mixture
determination is imperative.
§ 5 - 3.5

Additional Considerations

Previous published studies on relative peak height ratio determinations
presented data from mixtures generated prior to PCR amplification (Harrigan et
al., 1998; Nurpeisov et al., 2003). This assumes that both contributors to the
mixture will amplify at equal efficiency regardless of template quantities present
from each contributor. Where near equimolar quantities of each contributor are
used it is probably reasonable to assume that the amplification efficiency of each
contributor’s amplicon will be approximately equivalent. This may not be as
reasonable an assumption in cases where there is a great difference in the
relative input quantities of two contributors. In fact, there may potentially be
significant differences in amplification efficiency due to a relative scarcity of the
minor component amplicon. This may skew the apparent contributor ratio
towards the major contributor giving an inaccurate representation of the actual
ratio that existed in the original mixture.
To demonstrate the extent to which this may present a point of concern,
several two-contributor mixtures were prepared. Half of these mixtures were
prepared before PCR amplification, and the remainder was prepared by mixing
together stocks of DNA that had already been PCR amplified and quantified from
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individual contributors. These mixtures were then dye-terminator labeled and
the resulting relative peak height fluorescence ratios at 9 mixed base positions
were analyzed. Figure 5.6 illustrates the results obtained at the mixed-base
position 195C/T. The pre-amplification generated mixture shows a steeper slope
across the mixture ratios assayed than was observed for the post-amplification
generated mixture. The results obtained for the other 8 mixed base positions
formed between these amplicons yielded similar results.
The results show that a bias in amplification efficiency exists toward the
major component in non-equimolar ratio mixtures. Therefore, these results
suggest that when determining peak height ratios in actual forensic mixture
samples, these will nearly always tend to overestimate the major contributor to
the mixture and underestimate the minor contributor.

§5-4

Concluding Remarks
The current study provides a comprehensive analysis of changes in

relative peak heights at mixed base positions as a function of changes in relative
DNA input quantities to dye-terminator labeling reactions. Previous studies have
demonstrated the highly reproducible nature of peak height patterns in
sequencing electropherograms (Chapter 4). Due to the sequence context
dependence of electrophoretic peak height at individual base positions, peak
height alone cannot generally be used to accurately determine the relative
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Figure 5.6: A range of DNA quantity ratios generated from pre- and post PCR
amplification mixtures. Mixtures prepared prior to PCR amplification (solid lines)
showing a steeper slope than mixtures prepared after PCR amplification of the
contributors individually. This may be due to amplification bias against the less
abundant of the target amplicon (i.e., minor contributor) during PCR.

153

quantity of individual amplicons when present in a mixture. However, the strong
statistical correlation between changes in the relative quantity of two amplicons
and changes in the resulting ratio of overlapping fluorescent peaks at mixed base
positions provides a potential means for accurately determining the relative
quantities and thus the haplotypes of individual amplicons in a mixed sample.
This is of particular utility to some efforts aimed at monitoring disease
progression, the onset and spread of drug resistant strains of pathogens and
mtDNA mixture analysis in forensics.
As an example of how changes in relative peak height ratios at mixedbase positions can be used to indentify individual haplotypes, consider the
following. Given a change in the quantity of one contributor relative to another
(e.g., from a 90:10 ratio to a 70:30 ratio of contributor “1” to contributor “2”), a
decrease will be observed in the peak height of all bases associated with
amplicon “1” relative to amplicon “2”. Conversely, an increase will be observed in
the peak height of all bases associated with amplicon “2” relative to amplicon
“1”. By analyzing such shifts in relative peak heights at mixed-base positions, it
should be possible to clearly and reproducibly determine the primary DNA
sequence of (e.g., the haplotype in the case of mtDNA) for each contributor to
the mixture. Especially in cases where the minor contributor accounts for 20% or
less of a mixed sample, accurate haplotype determination is often not possible
due to potential peak dropout. In these cases, fractionation and enrichment of
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individual contributors by DHPLC is indicated (Danielson et al., 2007). It is
expected that this approach will allow for the accurate determination of the
linkage phase (i.e., the DNA sequence) for individual contributors.
Using the mixture analysis strategy presented here, it should be possible
to accurately deconvolve the DNA sequences of virtually all two-contributor
mixtures. Moreover, the extensive body of information that is presented in this
study in conjunction with the results of previous studies on peak height
reproducibility as a function of DNA input quantity will facilitate the development
of statistically supported interpretation guidelines for the analysis of mixed DNA
samples.

§5-5

Summary
In dye-terminator sequencing, the appearance of a heterozygous locus or

a mixture of two or more DNA molecules is characterized by overlapping
electrophoretic peaks at all positions where the amplicons in a mixture differ in
primary sequence. This results in ambiguous basecalls at mixed sites or
unreadable sequencing electropherogram, in the case of indel-associated length
variations between DNA molecules. The ability to accurately resolve DNA
mixtures will have significant benefits for basic research, disease diagnostics and
forensic investigations involving mtDNA analysis.
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In mixed amplicon populations, the ratio between overlapping
electrophoretic peaks at mixed base positions shifts as the molar ratio of the
input DNA between individual contributors changes. If shown to be
quantitatively reproducible, this phenomenon may provide a means of
deconvolving the sequence electropherograms generated by sequencing DNA
mixtures.
The objective of the current study, therefore, was to determine the
extent to which a change in the relative quantities of input DNA from two
amplicons correlated with a change in the ratio between overlapping
electrophoretic peaks at mixed base positions. The current study presents peak
height ratio data for 202 mixed base positions at thirteen different DNA quantity
ratios. The base positions analyzed were distributed across the region of the
human mtDNA genome most often examined by forensic analysts. Analyses of
peak height ratios revealed a highly significant correlation (R = 0.9998) between
a change in the molar ratio of contributor DNA in a mixture and a change in peak
height ratios in the resulting electropherogram. This strong correlation supports
the use of comparative sequence analysis to determine the linkage phase (i.e.,
the primary DNA base sequence) of the individual amplicons in a mixture.
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Chapter 6: Separation of Mitochondrial DNA Mixtures by
Denaturing High Performance Liquid
Chromatography and Linkage Phase Analysis
§6-1

Introduction
Dye-terminator sequencing of DNA from hypervariable regions 1 and 2

(HV1/HV2) of human mtDNA is the current method of choice for the analysis of
human mtDNA. A mixture of different mtDNA molecules in a single sample,
however, presents a significant obstacle to successful mtDNA analyses by
standard forensically validated methods. For example, an individual can naturally
possess more than one mtDNA haplotype (i.e., heteroplasmy) (Lightowlers et al.,
1997). Alternately, forensic analysts often encounter mixtures of DNA-containing
samples from separate individuals (i.e., a “situational” mixture). The ability to
accurately determine the specific haplotypes of individual contributors to a DNA
mixture can provide valuable investigative information.
While the size variation of short tandem repeats can facilitate the
interpretation of nuclear DNA mixtures, this is not the case with mtDNA
haplotypes differ primarily by base substitution or by only very small differences
in length - most often arising from the insertion or deletion of a single base pair.
Such subtle variations in sequence typically produce ambiguous base calls due to
overlapping electrophoretic peaks. Similarly, variations in the length of mtDNA
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molecules, such as those commonly associated with the cytosine stretches in
both HV1 and HV2 result in long stretches of unreadable electropherograms. This
reflects the fact that dye-terminated chains fall out of register with each other
starting at the position of the insertion or deletion responsible for the length
variant. In these cases, additional sequencing primers targeted to flank the
heteroplasmic cytosine stretch must be used to obtain readable sequence.
Unfortunately, this reduces the total amount of sequence data that can be used
to characterize a given mitochondrial amplicon (Holland and Parsons, 1999). The
ability to accurately resolve and interpret these types of samples in a timely and
cost efficient manner would substantially increase the power of mtDNA analysis
by allowing its use in cases where the current approach yields results that are of
limited or no utility.
There are a number of molecular strategies that have been proposed to
separate DNA mixtures. These include denaturing gradient gel electrophoresis
(DGGE), single-strand conformational polymorphism (SSCP) analysis and
subcloning into bacterial vectors (Hanekamp et al., 1996; Barros et al., 1997;
Steighner et al., 1999). Both DGGE and SSCP require manual recovery of
fractionated DNA from polyacrylamide gels and PCR reamplification to generate
enough template for DNA sequencing. Subcloning represents an even more time
and labor-intensive approach. Furthermore, it would require forensic scientists
to screen and sequence DNA from multiple transformed bacterial colonies to
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ensure that observed sequence differences reflect genuine contributors to the
starting template rather than artificial variants that were introduced as a result
of DNA nucleotide misincorporation by Taq polymerase. Taken together, these
shortcomings pose significant obstacles to the adoption of these technologies by
forensic laboratories.
Pyrosequencing™ has recently been proposed as an alternate method for
mixture analysis (Andreasson et al., 2006). Pyrosequencing™ relies on the
sequential addition of nucleotides to the reaction mixture resulting in light
emission of the incorporated nucleotide (Ronaghi, 2001). In a mixed sample, a
complicated pattern of peaks may allow for the determination of individual
components of a mixture. Concerns regarding pyrosequencing™, however,
include limited sequence reads (approx. 60-70bp) and, therefore, significant
consumption of valuable sample in order to obtain complete coverage of the
hypervariable region.
By comparison, denaturing high performance liquid chromatography
(DHPLC) as described previously (Chapter 1) is a rapid and cost-effective method
for physically fractionating mtDNA mixtures and then recovering amplicons for
characterization by direct DNA sequencing (Emmerson et al., 2003; Etokebe et
al., 2003). While doing so, DHPLC addresses the limitations of alternative
strategies.
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The underlying principle of DHPLC that is central to any effort to resolve
an mtDNA mixture is Temperature Modulated Heteroduplex Analysis (TMHA)
(Hou and Zhang, 2000). Briefly, when a mixture of two (or more) DNA amplicons
is heat denatured and then allowed to slowly reanneal a combination of homoand heteroduplices are formed. The homoduplices represent the original
components of the mixture while the heteroduplices are generated by crosshybridization of DNA strands from the different contributors to the mixture.
Under partially denaturing conditions and an increasing gradient of a non-polar
solvent (e.g., acetonitrile), it is possible to physically separate the heteroduplices
and the homoduplices from each other (Huber et al., 1993). Heteroduplices, are
inherently less stable as the result of one or more base pair mismatches and thus
they appear as early eluting peaks in the chromatographic trace of an DHPLC
assay (Huber et al., 1995; O'Donovan et al., 1998). The sensitivity of DHPLC to the
thermodynamic stability of a DNA amplicon ensures that even very subtle
sequence differences (i.e., single nucleotide substitutions, insertions, deletions)
between components of a mixture will be readily detected and fractionated in
time (Kuklin et al., 1997; Underhill et al., 1997).
Analysis of PCR products by DHPLC integrates seamlessly into the
established protocols for mtDNA sequencing used by the forensic community.
Once fractionated, the recovered DNA requires no PCR reamplification, post PCR
cleanup or quantitation by yield gel since PCR yield can be directly determined
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from the height of the chromatographic elution peak (Chapter 3). Samples
fractionated by DHPLC yield highly purified amplicons void of PCR amplification
primers, enzymes or salts. Finally, sequencing results obtained from DHPLC
purified samples result in highly reproducible electrophoretic peak patterns
(Chapter 4), essential for accurate determination of DNA sequence identity.
Previous studies (Danielson et al., 2007) have reported a correlation
between the change in ratio of two contributors to a DNA mixture and the
corresponding change in the ratio of electrophoretic peak heights at mixed-base
positions. In the current study, the efficacy of DHPLC for the fractionation of
mtDNA mixtures and automated recovery of sequence-ready DNA is
investigated. Furthermore, a statistical analysis-based approach has been
developed, which allows for the accurate determination of coordinated shifts in
peak height ratios at mixed base positions (i.e., linkage phase analysis). This
serves as the basis for the determination of the haplotypes of the individual
contributors to an mtDNA mixture.

§6-2

Materials and Methods

§ 6 - 2.1

Mitochondrial DNA Extraction and Quantification

This research was conducted in compliance with U.S. Federal Policy for
the Protection of Human Subjects (56 FR 28003). Individual buccal swabs were
collected from 46 unrelated subjects of diverse ethnicity who had previously
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provided informed consent to participate in the study. Individual buccal swabs
were incubated for 15min. in 10µL proteinase K (600mAU/ml) (Qiagen Inc.,
Valencia, CA) at 37°C, followed by DNA extraction using the EZ1 DNA Tissue kit on
the BioRobot EZ1 DNA extraction robot (Qiagen Inc.) in accordance with the
manufacturers’ recommended protocol. Purified DNA was eluted into 200µL of
nuclease free ddH2O and following visual inspection and subsequent removal of
residual paramagnetic beads, which have the potential to interfere with
quantitative real-time PCR (qRT-PCR), samples were stored at -20°C.
All samples used in this study were quantified by qRT-PCR using
previously published amplification primers and probe (Andreasson et al., 2002)
on a PRISM® 7900HT Sequence Detection System (Applied Biosystems, Foster
City, CA). Quantification standards were prepared by serial dilution in
T10E0.1/Glycogen buffer (10mM Tris-HCl pH 8.0; 0.1mM EDTA; 20µg/mL glycogen)
of a previously subcloned 143bp mtDNA fragment encompassing the primer and
probe binding sites. Seven serial dilutions ranging from 2.16x10 7 – 2.1x101 in tenfold increments were used. Optimization of reaction conditions yielded a
quantification assay in a total volume of 10µL containing 5µL TaqMan® Universal
Master Mix – AmpErase® UNG (Applied Biosystems), 2µL DNA extract, 130nM
probe and 100nM each primer. Samples were loaded onto MicroAmp® Optical
96-Well reaction plates and sealed using Optical Adhesive Covers (Applied
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Biosystems). PCR amplification was initiated with 10 min incubation at 95°C
followed by 45 cycles of 95°C for 15 sec and 60°C for 1 min.
All standards were assayed in triplicate and all experimental samples
were assayed in duplicate for statistical accuracy. Standard curves were
generated and amplification plots were used to compare individual PCR reaction
consistency, efficiency, and results. No-template DNA and reagent blank controls
were also included in each assay.
§ 6 - 2.2

Mitochondrial DNA Amplification and Purification

Two-contributor mitochondrial DNA mixtures prepared at various
quantity ratios ranging from 95:5-5:95 as determined by quantitative real-time
PCR. Four forensically relevant regions of the human mitochondrial control
region (i.e., HV1A, HV1B, HV2A and HV2B) were amplified in 50μL reaction
volumes. Each reaction was was prepared using 50pmol each of forensicallyvalidated PCR primers (Wilson et al., 1995; LaBerge et al., 2003); 2.25U AmpliTaq
GOLD® DNA polymerase (Applied Biosystems) supplemented with 0.25U Pfu DNA
polymerase (Stratagene, La Jolla, CA); AmpliTaq GOLD® Buffer (Applied
Biosystems); 10nmol of each dNTP (Stratagene) and 10μL of an approximately
10pg/μL human DNA extract. Amplifications were performed on a GeneAmp®
9700 thermocycler (Applied Biosystems) with an initial denaturation step at 95°C
for 10 minutes, followed by 32 cycles of 95°C for 20 seconds, 60°C for 30 seconds
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and 72°C for 45 seconds. The final extension at 72°C was for 15 minutes. PCR
amplicons were purified and quantified at 50°C on a WAVE® 3500HT DNA
Fragment Analysis System (Transgenomic Inc., Omaha, NE) containing a DNASep®
analytical

column

(Transgenomic

Inc.)

packed

with

alkylated

poly(styrenedivinylbenzene) resin (Huber et al., 1993). DNA quantity was
determined using peak area standard curve obtained from a dilution series of a
six fragment quantitiation ladder (Chapter 3).
§ 6 - 2.3

DHPLC Mixture Fractionation

Cross-hybridization of mixed mtDNA amplicons was performed by
denaturation at 95°C for 4 minutes and renaturation by gradual cooling
(1.5°C/min) over a 45 minute period to reach a final temperature of 25°C
(LaBerge et al., 2003). Cross-hybridized mixtures were analyzed by TemperatureModulated Heteroduplex Analysis (TMHA) (Kuklin et al., 1997) at empirically
predetermined optimal temperatures for each of the four forensic mtDNA
amplicons (HV1A, 58°C; HV1B, 59.2°C; HV2A, 56.5°C and HV2B, 57°C.) The
optimal acetonitrile linear gradients, generated from differential mixing of buffer
A (0.1M TEAA) and buffer B (0.1M TEAA, 25% ACN), were 56% to 65% buffer B
increase in 3.5 minutes for HV1A, HV2A and HV2B and a 55% to 64% buffer B
increase in 3.5 minutes for HV1B. All samples were eluted at 0.9ml/min flow rate
and detected by UV absorbance at 260nm. Eluted peaks were captured using an
automated

fraction

collector

(Transgenomic,
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Inc.);

dried

by

vacuum

centrifugation for 30 minutes at 50°C followed by a 20-minute cool down to
ambient on a CentriVap® Vacuum Concentrator (Labconco Corporation, Kansas
City, MO). Samples were resuspended in nuclease-free H2O; and stored frozen
until DNA sequencing. Standard DHPLC controls included: zero-volume injections
to screen for residual DNA carryover from the column matrix, no-template PCR
controls to check for amplification contamination and manufacturer-supplied
mutation control standards for buffer and column quality control.
§ 6 - 2.4

Mitochondrial DNA Sequencing

Sequencing reactions were prepared using the appropriate forensicallyvalidated amplification primers. For greatest peak height consistency as
previously determined (Chapter 4), 0.8ng total input DNA quantities were used
for all labeling reactions and amplicons were extended according to the
manufacturer’s protocols using the BigDye® v1.1 Dye Terminator Cycle
Sequencing kit (Applied Biosystems). Dye-terminated products were purified by
Performa® DTR V3 96-well short plate purification columns (Edge BioSystems,
Gaithersburg, MD) according to the manufacturer’s protocol and resolved on a
PRISM® 310 Genetic Analyzer (Applied Biosystems). Appropriate positive and
negative controls were carried through the entire sample handling process to
minimize cross contamination and to monitor amplification efficiency. The
resulting sequence data were analyzed using the Sequencing Analysis Software
v.5.1.1 (Applied Biosystems). The resulting .scf output file was then ported to the
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CEQ™ 8000 Genetic Analysis System version 8.0 software package (BeckmanCoulter, Fullerton, CA) to allow output of the electrophoretic peak height data as
a .txt file. Text files were then opened in Microsoft Excel for statistical analyses or
displayed using the Sequencher™ v4.2 DNA analysis software (Gene Codes Corp,
Ann Arbor, MI).

§6-3

Results

§ 6 - 3.1

Statistical Analyses of Mixture Ratios

A near perfect correlation (R = 0.9998) exists when mixtures are analyzed
for changes in relative DNA quantities between two contributors versus changes
in electrophoretic peak height ratios at mixed base positions (Chapter 5). This
demonstrates that a change in peak height ratio of two components in a mixture
is a reflection of an underlying change in relative DNA quantity at any mixed base
position.
In these analyses, the relative shift in peak height fluorescence was
calculated by comparing triplicate fluorescence intensity ratios across thirteen
DNA quantity ratios (99:1 – 1:99) for each of 202 mixed nucleotide positions.
Based on these data, exhaustive statistical analyses were performed using
Tukey’s honestly significant differences (HSD) test:
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is the mean square
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environment
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computing

and

graphics”

(http://www.r-project.org/), confidence levels were obtained for the 27,066
probability values.
The results of these analyses indicate an even tighter statistical
correlation than presented above and have made it possible to precisely
determine the level of statistical confidence associated with any detectible shift
in electrophoretic peak height ratios. The calculated significance values for
27,066 comparisons of peak height fluorescence ratios illustrate the reliability of
this relationship (Figure 6.1, Table 6.1). Based on these statistical calculations, as
little as a 6% shift in fluorescence intensity of one contributor relative to the
other makes it possible to accurately determine the linkage phase of the
questioned mixture with a >99% confidence. Enrichment by 17% increases the
statistical confidence of linkage phase to >99.9%.
§ 6 - 3.2

Linkage Phase Analysis of a Two-Component mtDNA Mixture

Because of the strong correlation between a change in the ratio of DNA
quantities within a mixture and a change in the ratio of overlapping
electrophoretic peaks, the linkage phase of individual amplicons present in a
two-component mixture can be readily determined. This holds true even in cases
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Figure 6.1: Tukey HSD confidence associated with changes in electrophoretic
peak height ratios at mixed base positions. Shown are average and minimum
confidence values (left y-axis) as a function of the percentage change in peak
height fluorescence (x-axis) along with the number of data points behind each
calculation (right y-axis). Greater than 99% confidence is obtained for a ≥6% shift
in fluorescence while greater than 99.9% confidence is obtained for a ≥17% shift
in fluorescence.
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Table 6.1: Peak height enrichment and corresponding Tukey HSD confidence
values. Shown for peak height enrichment level (measured as a percent) are the
corresponding average and minimum Tukey HSD statistical confidence levels for
linkage phase determination (i.e., confidence that the shift represents an actual
amplicon enrichment rather than stochastic peak height variation) as well as the
number of comparisons performed for each enrichment percentage level.
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where complete separation of individual components of a mixture cannot be
achieved. In such cases, the linkage phase of each component of the mixture is
determined by tracking the ratio of overlapping fluorescent peaks at all mixed
base positions between two or more DHPLC fractions. The observation of
coordinated shifts in the relative fluorescence ratios for a given set of nucleotides
is consistent with them being in the same linkage phase and thus representing
the same amplicon. Figure 6.2 represents the complete process of DHPLC
fractionation followed by linkage phase analysis (LPA) of mixed nucleotide
positions detected as a result of dye-terminator sequencing. A two-component
mixture of HV2A amplicons containing ten mixed nucleotide positions (73G/A,
151T/C, 152T/C, 182T/C, 186A/C, 189C/A, 195C/T, 198T/C, 200G/A and 247A/G)
was purified and fractionated into 16 individual fractions by DHPLC (Figure 6.2A).
Five of the captured fractions (10-14) were sequenced and the mixed nucleotide
positions were analyzed for relative peak height shifts (Figure 6.2B).
Subsequently, these fractions were analyzed by LPA for determination of
nucleotides corresponding to each contributor (Figure 6.2C). Separation of mixed
nucleotides based on LPA identified the individual haplotypes of each of the two
contributors to the mixture with greater than 99.99% average basecalling
confidence. The haplotype of contributor 1 was 73A, 151C, 152T, 182C, 186C,
189A, 195T, 198C, 200A and 247G while that of contributor 2 was found to be
73G, 151T, 152C, 182T, 186A, 189C, 195C, 198T,
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Figure 6.2: (A) Denaturing HPLC chromatogram, showing collected fractions,
including those fractions used for dye-terminator sequencing (i.e., fractions 1014). (B) Radar graphs showing relative quantitation of fluorescence peak height
ratios (y-axis) for 10 mixed base positions from sequence electropherograms
representing DNA recovered from five DHPLC fractions (x-axis). (C) Linkage phase
analysis determination and identification of individual contributors to a twocomponent mixture. Results are based on shifts in relative fluorescent intensity
at all mixed base positions between DHPLC fractions 11 and 14.
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200G and 247A. Although figures 6.2B and 6.2C illustrate only results obtained in
the forward sequencing direction, confirmatory results were obtained when the
same samples were sequenced in the reverse direction.
§ 6 - 3.3 Linkage Phase Analysis of Minor-Component mtDNA
Mixtures
In forensic casework, mtDNA samples are not generally considered
mixtures unless two or more nucleotide positions yield a secondary peak having
a height of >10% that of the major component nucleotide. Based on results
described in chapter 5, a 10% secondary peak height, however, can represent a
molar mixture ratio of two contributors ranging anywhere from a 95:5 to 70:30
due to context specific incorporation of dye-terminators.
A known 95:5 mixture of HV2A, which appeared to be a single-source
sample with a single heteroplasmic site, as determined by direct DNA
sequencing, was separated into ten fractions by DHPLC and analyzed by LPA. Two
of the isolated fractions yielded no mixture at all, while 5 yielded apparent
heteroplasmy at one site as determined by the 10% threshold for secondary peak
height. However, two of the fractions yielded 8 mixed-base positions where the
height of the secondary peak ranged from 15% - 53% of that of the major peak.
LPA analysis confirmed the existence of a mixture at all eight sites with an
average confidence of 99.985%.
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§ 6 - 3.4

Two-Component mtDNA Mixtures Analyzed by LPA

Individual mtDNA haplotypes for all samples used in this study were
determined by dye-terminator sequencing prior to mixture generation. Thirteen
samples, each of which represented a unique haplotype, were used to determine
the accuracy of LPA for HV2A, (Table 6.2). Two-component mixtures were
generated at multiple molar ratios ranging from 50:50 to 95:5 of contributor 1 to
2, respectively. All mixtures generated were PCR amplified and then fractionated
by DHPLC. Selected fractions were then dye-terminator sequenced and the
resulting electropherograms were then used for LPA. In every case, the results
were in complete concordance with the known sequences from each
contributor. Across all mixtures assayed, amplicon enrichment by DHPLC (as
measured at individual mixed base positions) ranged from as little as a 2.1% to as
much as a 92.3% shift in peak height fluorescence between individual DHPLC
fractions (Table 6.3).
§ 6 - 3.5

Three- or More Component Mixtures

Mitochondrial DNA mixtures comprising three or more contributors are
readily detected by DHPLC but yield significantly more complicated
chromatographic traces than two-component mixtures. This reflects the
significant increase in the number of heteroduplices that can be formed with
each additional contributor. A total of 32 mixtures containing three to five
distinct amplicons at various molar DNA input ratios were fractionated by
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Table 6.2: The HV2A control region sequences of the samples used in the current
study, shown as deviations from the revised Cambridge Reference Sequence
(rCRS) (excluding 263A/G since all samples used in the study are 263G).
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Table 6.3: Summary of HV2A mtDNA mixtures analyzed by DHPLC illustrating
nucleotide enrichment and Tukey HSD-derived confidence ranges of mixednucleotide positions detected. Contributors identified in each mixture refer to
the sequences characterized in table 6.2.
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DHPLC. These multi-component mixtures yielded 4 to 10 clearly discernible
chromatographic peaks.
Sequencing results and subsequent LPA of three component mixtures
have shown that determination of one or two contributors can be achieved.
However, application of statistical analyses for these samples remains difficult
since shifting in peak height fluorescence ratio can be skewed as a result of
multiple overlapping nucleotide contributions at any one mixed site. Reliable
protocols for the resolution of three to five component mixtures by LPA,
therefore, have not been developed.
§ 6 - 3.6

Identification of Heteroplasmic Components by LPA

Identification of heteroplasmy in mtDNA sequencing analysis has been
proven to be of tremendous utility for human identification (Ivanov et al., 1996).
Due to the nature of DNA sequencing, low level heteroplasmic identification can
often prove difficult to distinguish from underlying sequence chatter and noise.
Utilizing DHPLC fractionation and LPA, identification of these can be made
significantly easier, allowing for confirmation of suspected heteroplasmy in
difficult samples. One sample displaying a broadened DHPLC profile revealed low
level heteroplasmy at 16183. This sample was subjected to DHPLC fractionation
and LPA, resulting in 25.6% and 24.0% enrichment of the minor component,
depending on the direction of sequencing. This confirmed the existence of a
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heteroplasmic 16183C/A with an average confidence of 99.973±0.091% and
99.968±0.077% depending on sequencing direction.

§6-4

Discussion
Based on aforementioned studies (Chapter 2) the accuracy of mixture

screening by DHPLC is fully concordant with the detection of mixtures by direct
sequencing. Furthermore, DHPLC may facilitate the detection of mixtures at
ratios that might be missed by direct sequencing, i.e., in cases where the quantity
of the minor component is less than 10% that of the major component. The
current study illustrates the potential utility of DHPLC in combination with LPA to
resolve detected mixtures involving mtDNA amplicons commonly used by
forensic analysts. DHPLC fractionation of a two-component mixture is
independent of the initial screening of a sample to determine whether or not it
consists of a mixture of non-identical amplicons.
DHPLC, allows an analyst to fractionate any DNA sample, regardless of
whether it is a mixture or not. Subsequent sequencing analysis of the isolated
fractions then allows for identification of the linkage phase of individual
contributors and/or the detection of sequencing anomalies, e.g., unincorporated
dye blobs or suboptimal signal to noise ratio. Although fragment resolution by
DHPLC, is a function of amplicon length and/or differences in primary sequence,
it is difficult to predict a priori the characteristics of the chromatographic trace
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that will result from DHPLC analysis of a specific mixture. Optimal separation and
recovery is achieved when a two-component mixture can be resolved into four
discernible peaks (i.e., fully separated homo- and heteroduplices). This minimizes
co-elution of incompletely resolved amplicons. When this is achieved,
subsequent electropherograms are generally of good quality and are free of
underlying electrophoretic signal from a second contributor. In practice,
however, optimal chromatographic resolution is uncommon, and this typically
results in the co-elution of target and non-target DNA amplicons. This produces a
series of DHPLC fractions that are enriched for one contributor versus the other
but which are not free of the second contributor. In the absence of complete
separation, sequence electropherograms show signal from both contributors. As
a consequence of this, overlapping electrophoretic peaks are produced at those
nucleotide positions where the two amplicons differ in primary sequence.
Based on statistical analyses using Tukey’s HSD test as little as a 6% shift
in relative peak height fluorescence at mixed nucleotide positions is required to
obtain a 99% statistical confidence in the linkage phase determination while a
17% shift in peak height ratio yields 99.9% confidence. Therefore, only a slight
shift in peak height fluorescence is required in order to obtain a highly
statistically significant linkage phase determination of a mixture. It is worth
noting that the majority of mixtures analyzed to date show a >17% enrichment of
one contributor over the other based on peak height shifts; thereby allowing for
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>99.9% confidence in the resolution of the haplotypes of the individual
contributors to two-component mtDNA mixtures. In the current study, all
mixtures analyzed by LPA, including those showing as little as 2% enrichment,
were accurately resolved albeit with reduced statistical confidence levels.
In the HV2A amplicon, two nucleotide positions within a single mixed
sample were found after DHPLC fractionation to yield a <6% shift in peak height
fluorescence. Even in this case however, LPA correctly determined the
haplotypes of the two contributors. While, the average enrichment levels for the
other three amplicons (HV1A, HV1B and HV2B) were lower than that of the HV2A
amplicon, only 4 mixed-nucleotide positions, out of a total of 182 assayed, were
resolved by LPA at a calculated confidence level of <99% (data not shown). In all
cases, these represented mixtures where the ratio of the major to the minor
contributor was 95:5, demonstrating that separation of these types of low-level
mixtures cannot be obtained with high statistical confidence in every case. As a
standard safeguard, therefore, enrichment of amplicons yielding a <6% (i.e.,
<99% confidence) shift in peak height ratios should be treated with caution.
The tremendous value of DHPLC in combination with LPA is further
demonstrated by the use of this approach to identify low level mixtures that
might not be evident based on direct sequencing alone. By using DHPLC to
selectively detect and enrich for minor contributors, it is possible to determine
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not only that the original sample was a mixture, but also to determine the
haplotype of the minor contributor to a high degree of statistical significance.
One of the most important impacts of this in a forensic context is that samples
thought to be of a single source or only slightly heteroplasmic as determined
solely by direct DNA sequencing might actually contain low levels of a secondary
contributor’s DNA that can be enriched by DHPLC to provide potentially
probative information. Until now, it has only been possible to identify the
presence of additional contributors in these types of cases by the laborious
process of subcloning mixed templates – a process that has not been forensically
validated nor passed legal muster for courtroom admissibility. Based on the
current studies, however, DHPLC represents the first reliable and forensicallyvalidated method available to address low-level mixtures.
Studies to date on the use of DHPLC in combination with LPA for the
deconvolution of three or more component mixtures make it possible in some
cases to determine one and sometimes two major contributors. Because of
skewed peak heights at mixed base positions, however, it has not been possible
to reliably assign a concrete level of statistical confidence to the haplotype
determinations in these cases. Further validation studies and development of
more advanced LPA algorithms to handle multicomponenet mixtures are
ongoing. DHPLC analysis of these types of mixtures, however, can yield
significant information on the overall complexity of a mixture. From these
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results, a forensic analyst can then determine whether to proceed with DHPLC
fractionation and downstream sequencing. By giving analysts an early indication
of the molecular complexity of a sample, it enables them to make informed
decisions on whether or not to proceed with the more time, labor and cost
intensive direct sequencing analyses and interpretation.
Although mtDNA analyses are generally only resorted to in cases where
nuclear DNA analyses fail, DHPLC and LPA of mtDNA mixtures can be used to
compliment short tandem repeat (STR) typing results obtained from mixtures. In
cases where the minor contributor to a mixture only displays a partial profile,
mtDNA mixture separation will yield confirmatory information regarding the two
contributors to the mixture, regardless of their ratio. This can provide
investigators with greater confidence in STR typing results from mixed
populations.
Mixtures of mtDNA molecules have traditionally been viewed as
irresolvable by the forensic community. The development of DHPLC fractionation
of PCR products followed by LPA as a means of assigning a level of statistical
confidence in the results obtained will have significant benefits for forensic
practitioners. Courtroom admissibility of this approach, however, will rest upon
exhaustive validation studies, including analyses of mixtures: consisting of DNA
from a variety of tissue sources; recovered from a broad diversity of substrates
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and; subjected to environmental insults likely to be encountered in a forensic
context. Finally, the computationally tedious nature of LPA analyses have
prompted the development of automated computer software for the
identification and quantization of mixed nucleotide positions and the application
of LPA statistics.

§6-5

Summary
A mixture of different mtDNA molecules in a single sample presents a

significant obstacle to successful mtDNA analyses by standard forensically
validated methods. The ability to accurately resolve and interpret these types of
samples in a timely and cost efficient manner would substantially increase the
power of mtDNA analysis by allowing its use in cases where the current approach
yields results that are of limited or no utility. DHPLC is a rapid and cost-effective
method for physically fractionating mtDNA mixtures; thereby allowing for
amplicon recovery and subsequent characterization by direct DNA sequencing.
This is achieved without the need for additional purification or re-amplification.
The current study illustrates the efficacy of this approach. Further, a statistical
analysis-based approach is presented (i.e., linkage phase analysis), which allows
for accurate determination of coordinated shift in peak height fluorescence at
mixed base positions. This allows for identification of individual contributors to
an mtDNA mixture with a high degree of statistical significance. The development
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of linkage phase analysis in conjunction with DHPLC and direct DNA sequencing
will have significant benefits for forensic practitioners working on mtDNA
mixtures and will thereby increase the potential probative value of this class of
physical evidence.
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Chapter 7: Validation of Mitochondrial DNA Mixture
Separation by Linkage Phase Analysis
§7-1

Introduction
The use of mitochondrial DNA sequencing has been proven to be of

tremendous utility in forensic investigations and has been admitted to court on
several occasions (See www.denverda.org). Until recently, however, mixtures of
two or more contributors would have complicated mitochondrial DNA haplotype
analysis and would have often yielded uninformative sequencing data. This has
limited the statistical power of discrimination of mtDNA analyses. Fractionation
of mtDNA mixtures by Denaturing High Performance Liquid Chromatography
(DHPLC) and subsequent Linkage Phase Analysis (LPA) has demonstrated the
reliability and effectiveness by which mixed samples can be resolved.
The use of DHPLC has been shown to facilitate the fractionation and
recovery of PCR amplicons and in some cases has yielded complete separation of
the individual components of mixtures of two mtDNA contributors. This is
achieved without reamplification or excessive processing of PCR products as to
minimize cross contamination or amplification of contaminating components. In
cases where only partial separation of the individual contributors to a mixture is
achieved, LPA can be used to deconvolve mixed nucleotide positions. This allows
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for the identification of individual haplotypes in the mixture (Chapter 6). The
method also allows for a statistical weight to be assigned to base calls associated
with the separated mixtures.
The aim of the current study, therefore, was to validate the use of DHPLC
fractionation and LPA of sequencing results obtained from these fractions as a
combined method for mtDNA mixture analysis. This study was performed using a
variety of commonly encountered forensic samples as well as environmentally
insulted samples to facilitate the use of this technology in a forensic context. This
study was in accordance with the DNA Advisory Board (DAB) developmental
validation standards for sensitivity, reproducibility, accuracy, etc. Furthermore,
recognizing that Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 59394 (1993), Frye’s “general acceptance” test, Frye v. United States, 293 F. 1013,
1014 (D.C. Cir. 1923) and federal rules of evidence specifically Rules CRE 403 and
CRE 702 provide the standard for admitting scientific evidence in the federal
courts. The experimental design of the validation assays was planned with both
the Frye and Daubert standards in mind.
The current study shows that mtDNA mixture fractionation by DHPLC and
sequence analysis by LPA is a valid, highly reliable and rapid method for mtDNA
mixture separation and subsequent haplotype determination of individual
contributors to a mixed sample.
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§7-2

Materials and Methods

§ 7 - 2.1

Sample Preparation and DNA Extraction

This research was conducted in compliance with U.S. Federal Policy for
the Protection of Human Subjects (56 FR 28003). Individual samples, including
blood, saliva, semen and hair were collected from unrelated subjects who had
previously provided informed consent to participate in the study. The mtDNA
haplotypes of all sample donors were determined separately by sequencing of
individual buccal swabs. No two donors had identical mtDNA sequences for the
hypervariable regions used in the study.
Combinations of undiluted body fluid mixtures (i.e., blood, saliva and
semen) (5µL each) were used to stain a variety of substrates including denim,
leather, wood, carpet, nylon and wallboard. All samples were aged for four
weeks at room temperature, prior to DNA extraction. In order to assess the
potential impact of environmental contaminants, combinations of undiluted
body fluid mixtures, (i.e., blood, saliva and semen) (5µL each) were applied to
Pur-Wraps® sterile cotton tipped applicators (Hardwood Products, Guilford, ME)
that had previously been dipped in gasoline, a slurry of sterile water and soil,
used motor oil, laundry detergent, 1N sodium hydroxide and 10% glacial acetic
acid and allowed to dry for 2 hours.
Hair samples (natural, dyed dark brown or permed, axial hair, pubic hair;
2cm; without root) were mixed with 10µL whole blood, semen or saliva prior to
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two 56°C, six hour incubations. Aged human bones (generously provided by Dr.
Randall Skelton, University of Montana, Missoula, MT) were cleaned twice in
25ml of 5% Tergazyme™ and sonicated for 30-45 min.. After rinsing in 95% EtOH
the bones were allowed to dry overnight at room temperature. All bone samples
were then pulverized using the SPEX CertiPrep® 6850 Freezer/Mill in accordance
with manufacturers’ recommended protocol for small bone samples. Briefly,
samples were placed in SPEX CertiPrep® 6751 grinding vials and frozen in liquid
nitrogen for 10min. Samples were then pulverized in three 4min. cycles (2min
grinding period, 2min cooling period). Following retrieval from the grinding vial,
200mg of bone powder was mixed with 700µL EDTA (0.5M, pH 8.5) and
incubated at 37°C for 24 - 48 hours. Equal amounts of bone powder (200g)
obtained from additional samples or 20µL of whole blood were mixed together
along with 20µL proteinase K (600mAU/mL) (Qiagen, Inc.) and incubated at 56°C
for at least 3 hours.
All DNA samples were extracted on the BioRobot EZ1 using the EZ1 DNA
tissue kit (Qiagen Inc., Valencia, CA) in accordance with the manufacturers’
recommended protocol for DNA extraction from trace samples. In order to
maximize DNA recovery, all samples used in this study were incubated for 15min.
at 56°C in 190µL of G2 Buffer and 10µL proteinase K (600mAU/mL) (Qiagen, Inc.)
prior to extraction, unless otherwise noted. Extracted DNA was eluted into 200µL
of nuclease free ddH2O and stored at -20°C until PCR amplification.
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§ 7 - 2.2

Mitochondrial DNA Amplification and Purification

Mitochondrial DNA hypervariable region amplification reactions (50μL)
were prepared using 50pmol each of forensically-validated PCR primer pairs for
relevant regions of the human mitochondrial control region (i.e., HV1A, HV1B,
HV2A and HV2B amplified by primer sets, A1/B2, A2/B1, C1/D2 and C2/D1,
respectively) (Wilson et al., 1995; Budowle et al., 2000). For each reaction, 2.25U
AmpliTaq GOLD® DNA polymerase (Applied Biosystems, Foster City, CA)
supplemented with 0.25U Pfu DNA polymerase (Stratagene, La Jolla, CA);
AmpliTaq GOLD® Buffer (Applied Biosystems); 10nmol of each dNTP (Stratagene)
and 10μL of an approximately 10pg/μL DNA extract were used. Amplifications
were performed on a GeneAmp® 9700 thermocycler (Applied Biosystems) with
an initial denaturation at 95°C for 10 minutes, followed by 32 cycles of 95°C for
20 seconds, 60°C for 30 seconds and 72˚C for 45 seconds. The final extension at
72°C was for 15 minutes. PCR amplicons were purified and quantified at 50°C on
a WAVE® 3500HT DNA Fragment Analysis System (Transgenomic Inc., Omaha,
NE) containing a DNAsep® analytical column packed with alkylated
poly(styrenedivinylbenzene) resin (Huber et al., 1993) using previously
established methods (Chapter 3).
§ 7 - 2.3

DHPLC Mixture Fractionation

Cross hybridization of mixed amplicons was performed by denaturation at
95°C for 4 minutes and renaturation by gradual cooling (1.5°C/min) over a 45
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minute period to reach a final temperature of 25°C (LaBerge et al., 2003). Cross
hybridized

mixtures

were

then

analyzed

by

Temperature-Modulated

Heteroduplex Analysis (TMHA) (Kuklin et al., 1997) using a DNASep® column in
the presence of 0.1M triethylammonium acetate (TEAA) pH 7.0 as an ion pairing
reagent. Empirically predetermined optimal temperatures for each of the four
forensic mtDNA amplicons (HV1A, 58°C; HV1B, 59.2°C; HV2A, 56.5°C and HV2B,
57°C) were used for each assay. The optimal acetonitrile linear gradients
generated from differential mixing of buffer A (0.1M TEAA) and buffer B (0.1M
TEAA, 25% ACN) were 56% to 65% buffer B increase in 3.5 minutes for HV1A,
HV2A and HV2B and a 55% to 64% buffer B increase in 3.5 minutes for HV1B. All
samples were eluted at a 0.9ml/min flow rate and detected by UV absorbance at
260nm. Eluted peaks were captured using an automated fraction collector
(Transgenomic, Inc.); dried by vacuum centrifugation for 30 minutes at 50°C
followed by a 20-minute cool down to ambient temperature on a CentriVap®
Vacuum Concentrator (Labconco Corporation, Kansas City, MO). Samples were
resuspended in nuclease-free H2O; and stored frozen until DNA sequencing.
Standard DHPLC controls included: zero-volume injections to screen for residual
DNA carryover from the column matrix, no-template PCR controls to check for
amplification contamination and manufacturer provided mutation control
standards for buffer and column quality control.
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§ 7 - 2.4

Mitochondrial DNA Sequencing

DNA sequencing reactions were prepared using the appropriate
forensically-validated amplification primers. For greatest peak height consistency
as previously determined (Chapter 4), 0.8ng total input DNA quantities were
used for all labeling reactions and amplicons were extended according to the
manufacturer’s protocols using the BigDye® Terminator v1.1 Cycle Sequencing Kit
(Applied Biosystems). Dye-terminated products were purified by Performa® DTR
V3 96-well Short Plate Kit (Edge BioSystems, Gaithersburg, MD) according to the
manufacturer’s protocol and resolved on a PRISM® 310 Genetic Analyzer
(Applied Biosystems) using POP-6™ polymer and 47cm x 50µm capillaries
(Applied Biosystems). Appropriate positive and negative controls were carried
through the entire sample handling process to minimize cross contamination and
to monitor amplification efficiency. Raw electrophoretic traces were analyzed
using the KB Basecaller (Applied Biosystems) together with the appropriate dye
set mobility file for the v1.1 kit using Sequencing Analysis Software v.5.1.1
(Applied Biosystems). The resulting sequence data were analyzed using the
Sequencher™ v4.2 DNA analysis software (Gene Codes Corp, Ann Arbor, MI) and
individual peak height values obtained using the CEQ™ 8000 Genetic Analysis
System version 8.0 software package (Beckman-Coulter, Fullerton, CA)
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§ 7 - 2.5

Linkage Phase Analysis

Mixed nucleotide positions were considered to be any positions
characterized by a primary peak and an underlying secondary peak having a
height >10% that of the major peak as determined by inspection of the relative
fluorescent units (RFU) in the analyzed data. Corresponding mixed nucleotide
positions were analyzed between fractions and LPA was used to resolve mixtures
based on a comparison of those fractions showing the greatest average change in
fluorescence ratio across all mixed base positions. For each mixed nucleotide
position, the change in the base fluorescence ratio corresponds to a change in
amplicon quantity between the two components that make up the mixture. The
statistical confidence of this relationship was derived from statistical analyses of
data gathered during the developmental validation study. These data were
obtained from 347 comparisons of 13 different contributor ratios at 202 unique
nucleotide positions across the hypervariable region of the mtDNA genome, for a
total of 27,066 data points (Chapter 6).

§7-3

Results and Discussion

§ 7 - 3.1 Efficiency of Component Identification as a Function of
Chromatographic Trace Characteristics
As a reflection of chromatographic separation of non-identical amplicons,
DHPLC trace characteristics should be correlated with the efficiency of mixture
resolution. Mixture analysis by TMHA, yields chromatographic traces ranging
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from a major peak complimented by a significant shoulder, to multiple peaks
representing each of the homo- and heteroduplices formed during denaturation
and subsequent renaturation of the DNA present in the sample. In a twocomponent mixture, the optimal DHPLC trace displays complete separation of
each homo- and heteroduplex peaks.
Two-component mixtures which display optimal four peak resolution,
where the two homoduplices resolve into two distinct peaks of close or equal
height, generally yield fractions that, when sequenced, display the most
pronounced coordinated shift in peak height fluorescence ratios. Figure 7.1
illustrates the fractionation and LPA analysis of a two-component mixture with
four peak resolution. The two homoduplices were captured by automated
fraction collection (Figure 7.1A) and peak height ratios determined by dye
terminator sequencing (Figure 7.1B). Pair-wise comparison of fluorescence ratios
at mixed base positions across all fractions (66 comparisons among the 12
fractions recovered), yielded an average peak height ratio shift of 34.2 ± 21.1%.
Of these, the comparison of fractions 7 and 11 yields the greatest coordinated
shift in peak height fluorescence ratios across all mixed bases, with an average of
81.8 ± 1.5%. This was associated with linkage phase determination where the
base calling confidence was greater than 99.99% for all mixed base positions
(Figure 7.1C). Comparison of fractions 11 and 12 yields the least shift in peak
height fluorescence ratios, with a mixed base average of 0.77 ± 0.47%. The
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Figure 7.1: (A) Denaturing HPLC chromatogram, showing the twelve collected
fractions all of which were used for dye-terminator DNA sequencing. (B) Relative
quantitation of fluorescence peak height ratios (y-axis) for eight mixed base
positions from sequence electropherograms representing DNA recovered from
all DHPLC fractions collected (x-axis). (C) Use of linkage phase analysis to
determine the haplotypes of the individual contributors to this two-component
mixture. This analysis is based on shifts in peak height ratios at mixed base
positions between DHPLC fractions 7 and 11.
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particularly low shift in peak height ratio between fractions 11 and 12 is due to
the fact that both of these fractions represent the near complete isolation of a
single contributor to the mixture – the same contributor in both cases. A
comparison between these two fractions, therefore, adds no value to the overall
analysis of the mixture. Furthermore, the shift in peak height between fractions
11 and 12 is comparable to the internal variability noted in replicate sequencing
reactions of mixtures consisting of the same amplicon ratios (Chapter 5) as well
as the inherent peak height variability of individual peaks in any sequencing
reaction (Chapter 4).
Although fractions 7 and 11 yielded the greatest amount of fluorescence
ratio shift across all mixed nucleotides, LPA of the majority of fraction
comparisons (49 out of 66) yielded linkage phase determinations with an average
base calling confidence greater than 99.9%. The remaining 17 fraction
comparisons, where average base calling confidence was less than 99.9%,
reflected two phenomena. The first of these is the comparison of adjoining
fractions containing very similar molar ratios of mixed amplicons (e.g., fractions 6
and 7), or fractions flanking the same peak which again would be expected to
possess similar amplicons ratios (e.g., fractions 5 and 8).
Table 7.1 illustrates the results obtained from 51 two-component
mixtures at component molar ratios ranging from 50:50 to 95:5. These samples
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Table 7.1: Summary of mtDNA mixtures ratios analyzed by DHPLC including
change in peak height ratios attained and base calling confidence ranges for
linage phase determination at mixed nucleotide positions.
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display a range of DHPLC trace characteristics, from one major peak and a
corresponding shoulder, to complete separation of all four homo- and
heteroduplex peaks. All amplified samples were fractionated accordingly by
DHPLC under partially denaturing conditions. Three to twelve fractions for each
sample were then labeled for direct sequencing. All sequenced fractions were
analyzed for mixed base positions. These were compared across fractions by LPA
in order to identify those bases that displayed coordinated shifts in peak height
fluorescence ratios. Eighty-two percent of analyzed mixtures yielded linkage
phase determinations with average base calling confidence of greater than
99.9%, when the fractions that were compared were those that displayed the
greatest shift in peak height fluorescence. Of the nine remaining mixtures, only
two yielded linkage phase determinations with an average base calling
confidence of less than 99% (CS-38; 98.922% and CS-49; 98.557%).
Analysis of sample CS-38 by DHPLC using TMHA (Figure 7.2) was
characterized by separation of the homoduplices into a major peak and a trailing
shoulder (separated into six 50µL fractions). The heteroduplices (not captured)
formed to only a minimal degree as evidence by their low elution peak heights.
The major reason for this lack of apparent separation for CS-38 when analyzed by
LPA is that the trailing edge of the shoulder was not sequenced (fractions 5 and
6). When compared to sequencing results obtained from the opposite
sequencing primer (CS-42; where fractions 1-5 were sequenced), the shift in
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Figure 7.2: Analysis of sample CS-38 by TMHA, showing separation of individual
homoduplices into a major peak (fractions 1-3) and a trailing shoulder (fractions
5 and 6). Also shown is the formation of minor heteroduplices (not captured) at
a retention time of approximately 3.9 minutes. Linkage phase analysis of
fractions 1 and 4 yielded separation of the two contributors to the mixture with
an average base calling confidence of 98.922%. Analysis of fractions 1 and 5
yielded an average confidence of 99.976%.
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peak height fluorescence was significantly greater. These results illustrate that,
while blind fraction sequencing yields significant information as to the
haplotypes comprising the mixture, considerably improved results are attained
when strategic fraction sequencing is performed.
Analysis of sample CS-49 by TMHA (Figure 7.3) shows the separation and
capture of a single broad homoduplex peak (fractions 4-7) preceded by a single
heteroduplex peak (fractions 1-2). This was primarily due to the nature of the
mixture itself (a 95:5 component ratio) in which the major contributor peak
masks the minor contributor peak. As a result, comparisons of mixed base
positions in the sequencing data obtained from these fractions revealed only
small shifts in peak height ratios. Of these, the largest coordinated shift in peak
height fluorescence ratios was seen between fractions 4 and 7. LPA of these
fractions, allowed for the determination of the linkage phase of each of the two
contributors to this mixture. This illustrates, that the broad nature of the
homoduplex peak is due to a slight difference in the retention times between the
two homoduplices present in the mixture. The LPA results clearly indicate that
even when retention time differences are not readily apparent (as the minor
component homoduplex is hidden by the major component peak), the subtle
variation in retention time can be detected by LPA of the sequences obtained
from these fractions.
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Figure 7.3: Analysis of sample CS-49 by TMHA, showing separation and capture
of a single broad homoduplex peak (fractions 4-7). This major peak is preceded
by a separate single heteroduplex peak (fractions 1-2). Based on analyses of the
sequencing electropherograms, the greatest shift in peak height ratios was
between fractions 4 and 7. LPA of these fractions made it possible to determine
the haplotypes of the individual contributors to this mixture with an average
basecalling confidence of 98.557%.
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Of the samples displayed in table 7.1, those displaying two, three and
four peak resolution by DHPLC account for 29.4%, 21.6% and 47.1% of the
samples tested. Comparison to a larger study of 849 mixtures subjected to
DHPLC profiling across all four forensically relevant regions of the human mtDNA
(Chapter 2) reveals a slight decrease in the amount of samples yielding two and
three peak resolution. In that study, samples displaying two, three and four peak
resolution comprised 50.3%, 36.6% and 11.6% of all samples tested, respectively.
This discrepancy may reflect differences in the specific sequences analyzed and
the number of each sequence analyzed. In the current validation study,
sequences were selected to incorporate a broad diversity of mixed base positions
across the HV1 and HV2 regions. The larger study included numerous more
similar amplicons which may be less likely to yield cross hybridization products
capable of being fractionated into four clearly discernible chromatographic
peaks.
§ 7 - 3.2 Efficiency of Component Identification as a Function of
Mixture Ratio
Comparison of multiple mixture ratios for a two-component mixture
yielded information on which fraction comparisons generate the most
informative and consistent coordinated shifts in peak height fluorescence.
Analysis of samples CS-8, CS-20, CS-21, CS-38 and CS-39 sequenced with the C1
primer and samples CS-15, CS-25, CS-26, CS-42 and CS-43 sequenced with the D2
200

primer made it possible to determine which fraction comparisons yielded the
largest and the smallest coordinated shifts in the fluorescence ratios of linked
bases. In all cases, the homoduplicies formed during cross hybridization of the
amplified PCR products resolve into two distinct peaks, each representing one
contributor. If the first peak is the tallest, the greatest coordinated shift in peak
height fluorescence is achieved by comparing the lagging edge of the second
peak to the top of the first peak (Figure 7.1A; fractions 7 and 11). If the second
peak is the tallest, the same can be achieved by comparing the leading edge of
the first peak to the top of the second peak. As described above, comparison of
adjacent fractions tends to yield only limited shifts in peak height fluorescence
ratios due to the fact that adjacent fractions are likely to be characterized by
smaller changes in the underlying molar ratios of one contributor to the other.
When homoduplices are not resolved into separate peaks, comparisons
between the heteroduplex peaks and the top or lagging edge of the homoduplex
peak generally yields the greatest coordinated shift in peak height fluorescence.
This can be illustrated when comparing fractions sequenced for CS-29 (Figure 7.4;
fractions 1-3 compared to fractions 11-13). Here, a large shift in peak height
fluorescence ratio was consistently observed when comparing a number of
fractions on the lagging side of the heteroduplex peak to the top or lagging side
of the homoduplex peak. When this is done, a consistent 20% - 30% coordinated
shift is noted for all fraction comparisons performed between the homo- and
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Figure 7.4: Analysis of sample CS-19 by TMHA, showing separation and capture
of a single very broad homoduplex peak (fractions 6-13) preceded by a separate
single heteroduplex peak (fractions 1-3). A consistent 26% - 32% coordinated
shift in peak height fluorescence ratio is observed when comparing fractions on
the lagging side of the heteroduplex peak (fractions 2 or 3) to the homoduplex
peak (fractions 7-13). Based on analyses of the sequencing electropherograms,
the greatest shift in peak height ratios was between fractions 2 and 8. LPA of
these fractions made it possible to determine the haplotypes of the individual
contributors to this mixture with an average basecalling confidence of 99.982%.
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heteroduplex peaks. Only when fluorescence ratios were compared between
fractions from the same peak was there a low shift in peak height fluorescence
ratios.
§ 7 - 3.3

Body Fluid Mixtures

Thirty six two-component body fluid mixtures were stained onto a variety
of substrates intended to simulate forensic casework. These included denim,
fabric, leather, wood, synthetic carpeting, nylon and wallboard. Samples were
aged at room temperature for four weeks followed by DNA extraction. No two
donor samples used in this study had identical mtDNA haplotypes as previously
determined by sequencing analysis of known buccal swabs (Table 7.2).
Amplification of HV1 and HV2 region fragments was performed on a subset of
questioned mixtures using forensically validated primer sets and conditions. All
amplified samples were then fractionated by DHPLC under partially denaturing
conditions. Five to nine fractions for each sample were analyzed by direct
sequencing, followed by LPA of mixed base locations. DNA sequencing yielded
clean base calls for all but mixed nucleotide positions, which were characterized
by overlapping fluorescent peaks. Identification by LPA of the haplotypes of the
individual contributors that comprised each of the 18 mixtures tested was
achieved in all cases for a success rate of 100%. All identified haplotypes were in
full concordance with sequence data obtained from sequencing of single source
representative samples from each contributor. The linkage phase of individual
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Table 7.2: The mtDNA control region sequences of the body fluid samples used in
the current study. Sequences are shown as deviations from the revised
Cambridge Reference Sequence (rCRS).
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contributors was determined with a high degree of base calling confidence.
Depending on substrate and the nucleotide position, the mean confidence of
base calling by linkage phase analysis ranged from an average of 99.926% to
99.994% (Table 7.3). In all cases, linkage phase analysis was performed on those
DHPLC fractions which showed the greatest shift in peak height fluorescence
ratios.
Comparison of all fractions sequenced yielded an average change in peak
height fluorescence ratio ranging from 7.7% - 24.5%, with fractions neighboring
each other yielding the lowest shift in peak height fluorescence (0.2% - 2.7%).
The largest shift in peak height fluorescence ratio ranged from 16.3% - 51.5%.
Those fraction comparisons that tended to yield the most optimal results were
consistent with the aforementioned results of the studies in this chapter that
examined the relationship between DHPLC trace characteristics and the
efficiency of mixture resolution by DHPLC in combination with LPA.
§ 7 - 3.4

Environmental Insult Mixtures

Thirty six two-component body fluid mixtures were subjected to a variety
of environmental insults designed to simulate forensic casework type samples.
These included gasoline, soil, laundry detergent, used motor oil, sodium
hydroxide and acetic acid. Following DNA extraction, amplification of mtDNA HV1
and HV2 regions was performed on a subset of mixtures using forensically
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Table 7.3: Casework-type mtDNA samples analyzed by DHPLC and LPA including
changes in peak height ratios attained and base calling confidence ranges for
linkage phase determination at mixed nucleotide positions.
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validated primer sets and amplification conditions. All amplified samples were
fractionated by DHPLC under partially denaturing conditions. Five to nine
fractions for each sample were then analyzed by direct sequencing, followed by
LPA of all mixed base positions.
DNA sequencing yielded good quality base calls for all but mixed
nucleotides positions which, as anticipated, were characterized by overlapping
fluorescent peaks. For each of the 18 amplified mixtures, the haplotypes of the
individual

contributors

was

determined

by

LPA

of

the

sequence

electropherograms. All identified haplotypes were in full concordance with
sequencing results obtained from single source reference samples of the same
contributors. Thus a success rate of 100% was achieved for the resolution of the
18 mixtures that were fractionated. Moreover, the average base calling
confidence (depending on substrate and nucleotide position) ranged from
99.926% to 99.993% (Table 7.3). This was achieved when the DHPLC fractions
that were compared were those that displayed the greatest shifts in peak height
fluorescence.
Pairwise comparisons of all fractions sequenced yielded an average
change in peak height fluorescence ratio across all mixed base positions ranging
from 8.0% - 23.2%. As expected and as demonstrated previously, adjoining
fractions yielded the lowest shift in peak height fluorescence ratios (0.3% - 1.7%).
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The largest shifts in peak height fluorescence ratios ranged from 12.2% - 49.9%.
Those fraction comparisons that tended to yield the most optimal results were
consistent with the aforementioned results of the studies in this chapter that
examined the relationship between DHPLC trace characteristics and the
efficiency of mixture resolution by DHPLC in combination with LPA.
§ 7 - 3.5

Hair and Bone Mixtures

Hair shafts as evidentiary material are commonly encountered in forensic
contexts. Because of the paucity of nuclear DNA typically recovered from these
samples mtDNA analysis often represents an investigator’s most promising
opportunity to obtain potentially probative biological information. Accordingly,
31 hair samples were contaminated with various body fluids. Head, axial and
pubic hairs were immersed in blood, semen and saliva and allowed to air dry.
DNA was extracted from all samples, yielding a total of 9 hair shaft body fluid
mixtures which were detected and subsequently fractionated by DHPLC.
Sequence data from the recovered DNA fractions were subjected to LPA in an
effort to determine the haplotypes of the individual contributors to the mixtures.
For each of the 9 mixtures that were fractionated and analyzed, LPA correctly
identified the contributor haplotypes in 100% of the cases. All identified
haplotypes were in full concordance with sequencing results obtained from
single source reference samples of the same contributors. Haplotypes were
determined with a high base calling confidence which (depending on the specific
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mixture and nucleotide position) ranged from an average of 99.84% to 99.99%
(Table 7.3). This was achieved when the DHPLC fractions that were compared
were those that displayed the greatest shifts in peak height fluorescence.
Pairwise comparison of all fractions sequenced yielded an average change
in peak height fluorescence ratio ranging from 5.2% - 18.5%. As before, adjoining
fractions yielded the lowest shift in peak height fluorescence (0.2% - 2.5%). The
largest shifts in peak height fluorescence ratios ranged from 11.0% - 44.5%. As
has been seen with all other mixed samples, the fraction comparisons that
tended to yield the most optimal results were consistent with the
aforementioned results of the studies in this chapter that examined the
relationship between DHPLC trace characteristics and the efficiency of mixture
resolution by DHPLC in combination with LPA.
Human bone samples obtained from the University of Montana’s
Department of Anthropology were pulverized and then processed to extract
amplifiable mtDNA. One bone sample yielded no amplifiable product even
following a second round of extraction and amplification, while two of the
samples yielded a mixed mtDNA profile. The lack of amplifiable product for one
of the bone samples was most likely due to a number of factors. These may
include but are not limited to extensive degradation of the DNA present in the
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bones which had been stored for years at room temperature and/or chemical
treatments used to prepare the material for storage.
A second bone (Item-37) did yield amplifiable mtDNA. As is typical, the
porous nature of many aged bone samples makes them conducive to
contamination by extraneous DNA, e.g., from comingling with other remains or
excessive handling by unrelated individuals. Initial analysis of the amplified
mtDNA by DHPLC under partially denaturing conditions suggested that the
amplified product consisted of a mixture of two non-identical amplicons.
Fractionation of this sample by DHPLC yielded six fractions from which DNA could
be recovered and sequenced. Pairwise comparisons of the resulting sequence
data from these fractions revealed a two-component mixture with five mixednucleotide positions. The largest shift in the peak height ratios among the
fractions compared was 48.7% - 61.6% depending on the mixed nucleotide
position being examined. LPA of the sequence data from these fractions resulted
in an average base calling confidence of greater than 99.99% across all five mixed
base positions.
A third bone (Item-38), also presented as a likely two-component mixture
upon examination of the DHPLC trace characteristics under partially denaturing
conditions. Fractionation of this sample by DHPLC yielded six fractions from
which DNA could be recovered and sequenced. Shifts in peak height fluorescence
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ratios that were evident in pairwise comparisons of sequence data from these six
fractions revealed a total of five mixed-base positions. Subsequent LPA, of the
mixed-base positions however, revealed that while shifts in peak height ratios
made it possible to determine the linkage phase of one contributor, there was
not a corresponding linkage phase at these same positions for the second
contributor. Rather, coordinated shifts in peak height ratios at only two of the
five mixed nucleotide sites appeared to constitute the linkage phase of a second
contributor (average base calling confidence >99.9%). Shifts in peak height ratios
at the remaining three mixed base position appeared to constitute the linkage
phase of a third contributor (average base calling confidence >99.9%). While the
third component was not identified in the initial screen by DHPLC, this was most
likely due to the low concentration of the third contributor in this mixture. The
presence of the third contributor, however, was evident in the DNA sequencing
electropherograms and was resolved through LPA.
Although a three-contributor mixture was discovered and resolved for
this particular sample during LPA, extensive studies on three or more component
mixtures at varying contributor ratios remain a significant challenge. This is due
to the difficulty that is typically encountered in attempting to deconvolute mixed
nucleotide positions where all three contributors differ (Chapter 6).
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Neither chromatographic trace characteristics nor the number of variant
positions between the amplicons comprising a mixture revealed any significant
trends in the efficiency of separation for any of the samples tested in this study.
In fact, two-peak DHPLC traces yielded both the lowest and greatest averages
with regard to the observed shifts in peak height ratios. It is recognized,
however, that based on an inspection of the results reported from this study,
mixtures of amplicons sequenced using the C1 primer tended to yield a lower
shift in peak height ratios and therefore a lower efficiency of mixture separation.
This trend, however, is most likely due to the specific mixtures employed in this
study. This is supported by the results obtained for the control samples
presented in Table 7.1 and data previously reported on concentration and
sequencing reproducibility (Chapter 4) where this trend was not evident.

§7-4

Conclusion
Mitochondrial DNA sequencing analysis is now a widely used

methodology for the identification of sequence polymorphisms both in the
medical and forensic communities. While mtDNA sequencing analyses of samples
containing single contributors have been rigorously tested and validated,
analyses of the electrophoretic trace characteristics of mtDNA mixtures have,
until now, never been thoroughly studied. Alternative methods for mixture
separation (e.g., DGGE, pyrosequencing) have previously been proposed as
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means for separating mtDNA mixtures. Use of DGGE, however, is extremely labor
intensive, requires significant sample manipulation, re-amplification of captured
PCR products and is not easily amenable to automation (Danielson et al., 2005).
Pyrosequencing yields very short sequence reads (~70bp) and consumes
significant amounts of sample due to multiple synthesis reactions. Further,
mixture separation capabilities of pyrosequencing have yet to be put through the
rigors of forensic validation and pyrosequencers remain more of a research
novelty than a realistic option for forensic practitioners. The significant cost of
the requisite instrumentation presents an additional barrier.
Although mtDNA sample contamination by even minor extraneous
sources of human DNA remains high due to its environmental persistence and
abundance in terms of copy number, proper handling procedures and vigorous
quality control measures can significantly reduce the occurrence of cross
contamination. In the current study, no mixture component was traced back to
individuals not originally added to the mixture. Not even in the case of Item-38,
was the third component traced back to any individual present in the
laboratory’s internal exclusion database. This database includes not only all
laboratory employees, but also all human DNA samples located in the laboratory.
In the current study, the analysis of mtDNA mixtures from twocontributor samples was evaluated using DHPLC fractionation and LPA of
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sequencing results obtained from captured fractions. Using this approach, a total
of 101 mixtures have been analyzed and the haplotypes determined for
individual contributors to each mixture. In all cases, linkage phases at mixed-base
positions were determined with a high degree of base calling confidence.
Nucleotides determined to be in linkage phase with each other were, in all cases,
fully concordant with sequencing results obtained from non-mixed reference
samples. Results from the current study therefore, demonstrate the usefulness
and reliability of this approach through the use of both control and simulated
casework samples.

§7-5

Summary
Mixtures of two or more contributors decrease the reliability and

usefulness of mtDNA haplotyping, due to the unavoidable generation of
ambiguous and often uninformative sequencing data. Fractionation and recovery
of PCR amplicons by DHPLC has made it possible to separate and identify
individual contributors to a mixture without reamplification or excessive
processing of PCR products. Statistical analysis using linkage phase analysis adds
statistical weight to separated mixtures allowing for the confidence of mixed
nucleotide separation to be determined. This study presents results of mixture
resolution by DHPLC in combination with LPA using a variety of commonly
encountered and environmentally insulted samples as well as hair, bone etc.
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designed to simulate evidentiary material consistent with forensic casework.
These validation studies have been designed to facilitate the adoption of this
technology by forensic practitioners. The current study shows that mtDNA
mixture fractionation by DHPLC and sequence analysis by LPA is a rapid, highly
reliable and forensically valid method for mtDNA mixture separation and
subsequent haplotype determination of individual contributors to a mixed
sample.
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Chapter 8: Validation of Denaturing High-Performance Liquid
Chromatography for Forensic mtDNA Casework
Analysis
§8-1

Introduction
Denaturing high-performance liquid chromatography (DHPLC) is a rapid

ion-paired reversed-phase HPLC method used to detect variations in DNA
sequence in identical length amplicons. The use of DHPLC has in recent years
been proposed as a method for a variety of forensic applications. These methods
include but are not limited to detection of single nucleotide polymorphisms (Shi
et al., 2001), sex identification (Shinka et al., 2001), heteroplasmy determination
(van Den Bosch et al., 2000; Biggin et al., 2005), short tandem repeat (STR)
analysis (Zhu et al., 2006) and mtDNA screening and mixture resolution
(Danielson et al., 2007).
In DHPLC, cross-hybridized PCR products interact with the hydrophobic
column matrix through a triethylammonium acetate buffer and are eluted
through an increasing gradient of acetonitrile (Huber et al., 1993). Under partially
denaturing conditions less stable heteroduplices elute prior to the more stable
homoduplices allowing for identification of sequence variation (O'Donovan et al.,
1998; Hou and Zhang 2000). Under non-denaturing conditions, samples of
varying length are easily separated, allowing for sample purification and
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determination of amplicon size and quantity in a similar manner as other HPLC
systems (Warren and Doniger 1991; Henninger et al., 1993; Zeillinger et al., 1993;
Katz 1996).
While new protocols for analysis and processing of evidentiary material
employing DHPLC analysis have been reported (Danielson et al., 2003; Danielson
et al., 2005; Danielson et al., 2007), forensic validation studies of the WAVE®
3500HT DNA Fragment Analysis System (Transgenomic, Inc., Omaha, NE)
employed for DHPLC analysis have until now not been carried out. This has
limited DHPLC use to non-caseworking applications. The aim of the current study
was, therefore, to demonstrate the reliability, sensitivity and consistency of the
WAVE® 3500HT DNA Fragment Analysis System in combination with the
DNASep® column (Transgenomic, Inc.). The results of this study demonstrate that
the combination of WAVE® 3500HT DNA Fragment Analysis System and DNASep®
column provides a platform for consistent and reliable analysis of crosshybridized PCR products with unparalleled detection sensitivity.

§8-2

Materials and Methods

§ 8 - 2.1

Mitochondrial DNA Extraction

All aspects of this research were conducted in compliance with U.S.
Federal Policy for the Protection of Human Subjects (56 FR 28003). Individual
buccal samples were collected from unrelated subjects who had previously
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provided informed consent to participate in the study. Total human DNA was
extracted using the EZ1 DNA tissue kit on the Qiagen BioRobot EZ1 DNA
extraction robot (Qiagen Inc., Valencia, CA) according to the manufacturer’s
protocol. Samples were eluted into 200µl of nuclease-free water and then stored
at -20°C until PCR amplification.
§ 8 - 2.2

Mitochondrial DNA Control Region Amplification

Forensically validated protocols (Wilson et al., 1995; LaBerge et al., 2003)
were used to amplify the four forensically relevant regions (HV1A: 278bp; HV1B:
271bp; HV2A: 278bp; HV2B: 277bp) of the human mitochondrial genome.
Amplification reactions (50μL) were prepared using 50pmol each of forensicallyvalidated PCR primers at final concentration of 1μmol/L (Wilson et al., 1995;
LaBerge et al., 2003); 0.45 U/10μL AmpliTaq GOLD® DNA polymerase (Applied
Biosystems, Foster City, CA); 0.05 U/10μL PFU DNA polymerase (Stratagene, La
Jolla, CA); 10X AmpliTaq GOLD® Buffer (Applied Biosystems) and 200μmol/L of
each dNTP (Stratagene) with 2μL of an approximately 10pg/μL DNA extract.
Amplifications were carried out on a GeneAmp® 9700 thermocycler (Applied
Biosystems) with an initial denaturation at 95˚C for 10 minutes, followed by 32
cycles of 95˚C for 20 seconds, 60˚C for 30 seconds and 72˚C for 45 seconds,
followed by a final extension at 72˚C for 15 minutes.
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§ 8 - 2.3 DHPLC-Based Temperature-Modulated Heteroduplex
analysis (TMHA)
Amplified fragments were combined at a 1:1 molar ratio to generate a
series of pair-wise mixtures which were cross-hybridized by denaturation at 95°C
for 4 minutes and gradual cooling (1.5°C/min) to a final temperature of 25°C
(LaBerge et al., 2003). Cross-hybridized amplification reactions were assayed by
DHPLC (Kuklin et al., 1997) on a WAVE® 3500HT DNA Fragment Analysis System
(Transgenomic Inc., Omaha, NE) containing a DNASep® analytical column (Huber
et al., 1993). Products were bound to the resin in an aqueous buffer containing
0.1M triethylammonium acetate (TEAA) pH 7.0 as an ion-pairing reagent. Crosshybridized mixtures were analyzed under partially denaturing conditions at the
empirically determined optimal temperatures for each of the four mtDNA
amplicons (i.e., HV1A, 58°C; HV1B, 59.2°C; HV2A, 56.5°C and HV2B, 57°C). All
samples were eluted at 0.9ml/min flow rate and detected by UV absorbance
(260nm). The optimal acetonitrile linear gradient generated from differential
mixing of buffer A (0.1M TEAA) and buffer B (0.1M TEAA, 25% ACN) were 56% to
65% buffer B increase in 3.5 minutes for HV1A, HV2A and HV2B and a 55% to
64% buffer B increase in 3.5 minutes for HV1B. Eluted peaks were captured by
automated fraction collection and then evaporated by vaccum centrifugation
using a Centrivap Mobile Concentrator System (Labconco Corp, Kansas City, MO).
Each sample was then resuspended in ddH2O and stored at -20°C until assayed.
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§ 8 - 2.4

Mitochondrial DNA Subcloning and DHPLC Analysis

Primers mt-8294F (5’-CCACTGTAAAGCTAACTTAGCATTAACC-3’) and mt8436R (5’- CCATACTCCTTACACTATTCCTCATCAC-3’) were used to amplify a 143bp
mtDNA coding region fragment (Andreasson et al., 2002). The resulting
amplification products were purified using Wizard® PCR Preps (Promega,
Madison, WI), ligated into the pGEM®-T vector (Promega) and electroporated
into DH5α electrocompetent cells. Cells were selected on LB agar plates
containing 50μg/ml ampicillin and screened by PCR to identify plasmids
containing target inserts. Plasmids were isolated from overnight cultures of these
colonies by alkaline lysis and capture on glass-filter binding plates (Millipore,
Bedford, MA). The aforementioned primers were used to amplify the 143bp
fragment from isolated plasmids using conditions described above.
Amplification reactions were assayed by DHPLC under non-denaturing
conditions (50°C) and differential mixing of buffer A and buffer B, where buffer B
increased from 49.3% to 58.3% in 4.5 minutes. Samples were detected by UV
absorbance (260nm) and fluorescence (ex. 490nm, em. 520nm). Fluorescence
detection was made possible by employing a proprietary DNA intercalating dye
(Transgenomic Inc.), injected after the eluent had passed the UV detector using
an inline high sensitivity accessory (HSX) pump (Transgenomic, Inc.). Eluted peaks
were captured by automated fraction collection and then evaporated by vaccum
centrifugation.
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§ 8 - 2.5

Dye-Terminator Sequencing

Dye-terminator sequencing was performed using the BigDye® Terminator
v1.1 Cycle Sequencing Kit (Applied Biosystems). Samples were prepared in 10µL
reaction volumes according to the manufacturer’s protocols using the maximum
available DNA input quantity up to a maximum of 0.8ng. Dye-terminated
products were purified on Performa® DTR V3 96-Well Short Plates (Edge
Biosystems, Gaithersburg, MD) and resolved on a PRISM® 310 Genetic Analyzer
(Applied Biosystems) according to the manufacturer’s protocols using the POP6™ polymer and 47cm x 50µm capillaries (Applied Biosystems). The raw
electrophoretic traces were analyzed using the KB Basecaller (Applied
Biosystems) together with the appropriate dye set mobility file for the v1.1 kit
using Sequencing Analysis Software v.5.1.1 (Applied Biosystems). The resulting
sequence data were aligned using the Sequencher™ v4.2 DNA analysis software
(Gene Codes Corp, Ann Arbor, MI).
Appropriate positive and negative controls were carried through the
entire sample handling process to enable the detection of any cross
contamination and ensure proper dye-terminator incorporation efficiency.
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§8-3

Results and Discussion

§ 8 - 3.1

Sample Cross Contamination

Sample cross contamination as a function of injection-to-injection
carryover was determined by capture of zero-volume injections (i.e., DNA-free
samples) following the injection of amplified PCR samples. In these assays,
samples containing high quantities (approx. 550ng) of amplified 143bp DNA
fragment (from previously subcloned mtDNA coding region) were injected onto
the DNASep® column yielding a single peak with maximum absorbance at 3.82 ±
0.05 min. This was followed by 5 zero-volume injections. The column eluent
(flow path buffer) was then collected for the same time frame where DNA from
the initial injection had eluted (i.e. 3.0 - 4.5 min). Sample detection by UV
absorbance revealed no evidence of DNA carryover in any of the zero-volume
injections performed. However, the use of a DNA intercalating dye and detection
by fluorescence revealed DNA carryover in the initial zero-volume injection,
ranging from approx. 35pg - 125pg. Four subsequent zero-volume injections
yielded approx. 17pg, 14pg, 9pg and 8pg, respectively, as determined by
extrapolating data from a fluorescence quantitiation standard curve determined
from DNA quantities ranging from 0.625ng - 200ng (R2 = 0.995) (Chapter 3).
Eluent captured from the zero volume injections was evaporated by
vaccum centrifugation and resuspended in 10µL of ddH2O, followed by dyeterminator labeling of 2µL of the resuspended product. The dye-terminator
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sequencing reactions from the captured time period yielded no detectable
sequence (data not shown). It is worth noting, that although injection-toinjection carryover was seen in the current study, the amount of DNA injected
onto the DNASep® column (550ng) was significantly higher than the quantity of
amplified mtDNA from reference samples which typically range from 50ng 200ng. When sample quantities are in this more casework-realistic range, no
injection-to-injection carryover is observed by UV or fluorescence detection.
In routine DHPLC analysis of over 30000 injections of research and
forensic validation samples, evidence of cross contamination between injected
samples was not observed. Only in the case of column saturation, as reported
above, has there been identifiable column carryover between repeat injections.
In an effort to completely eliminate any potential for injection cross
contamination, following injections of large quantities of PCR products, the
column can be washed with 75% acetonitrile for 10-15min. This removes any
spurious amplification products that might remain in the system.
Per the recommendation of the manufacturer (Transgenomic, Inc.)
columns were regularly inspected for integrity of the column matrix by injecting a
set of calibration standards. This ensures also that the oven, which the column is
housed in, is performing according to manufacturers’ specifications. Regularly
each column was purged of additional amplification materials (i.e., polymerase)

224

which bind to the anterior side of the column. This was done by reversing the
column within the flow path and purging it with 100% ACN at 70°C.
§ 8 - 3.2

Amplification reproducibility

In an effort to demonstrate the reproducibility of DNA analysis by DHPLC,
ten replicates of all four forensically relevant mtDNA amplicons were amplified
using previously validated protocols. The resulting PCR products were crosshybridized at equal contributor ratios, and sequentially assayed under partially
denaturing conditions by DHPLC. The resulting data indicate that DHPLC
resolution is highly reproducible for each of the tested amplicons. Both the
maximum peak height (Figure 8.1) and retention time for each peak height
maxima (Figure 8.2) were determined for the four forensically relevant
amplicons. Assay-to-assay variability was found to be negligible among
independent amplification reactions as evidenced by the small standard
deviations for each peak among the replicates. Variability as determined by peak
retention time for the 10 replicate amplification reactions ranged from ±0.2 to
±0.8%. Variability as determined by peak height across all replicate amplification
reactions ranged from ±3.1 to ±14.1%. Differences in maximum peak height may,
however, be attributed to variables other than DHPLC, such as the efficiency of
the amplification reaction itself.
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Figure 8.1: Peak heights (Mean ± SD) determined from chromatographic traces of
representative 50:50 mixtures across all four forensically relevant amplicons
under partially denaturing conditions. The results demonstrate the low level of
assay-to-assay variability among ten independently replicated amplification
reactions sequentially assayed by DHPLC.
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Figure 8.2: Retention times (Mean ± SD) determined from chromatographic
traces of representative 50:50 mixtures across all four forensically relevant
amplicons under partially denaturing conditions. The results demonstrate the
low level of assay-to-assay variability among ten independently replicated
amplification reactions sequentially assayed by DHPLC.
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§ 8 - 3.3

Injection-to-injection reproducibility

To demonstrate the reproducibility of DHPLC for independent injections
of identical DNA samples, four forensically relevant mtDNA amplicons were
amplified (HV1A, HV1B, HV2A and HV2B). The resulting products were crosshybridized at equal contributor ratios, and sequentially injected ten times under
partially denaturing conditions by DHPLC. The resulting data indicate that
sequential injections of cross-hybridized products are highly reproducible for
each of the forensically relevant amplicons. Maximum peak heights (Figure 8.3)
and peak retention times (Figure 8.4) were determined for each of the four
amplicons. Assay-to-assay variability was found to be negligible among
independent amplification reactions as evidenced by the small standard
deviations for each peak among the replicates. Variability as determined by peak
retention time for the 10 replicate amplification reactions ranged from ±0.1 to
±2.4%. Variability as determined by peak height across all replicate amplification
reactions ranged from ±0.2 to ±1.8%.
§ 8 - 3.4

Column-to-column reproducibility

Reproducibility of DHPLC across multiple DHPLC DNASep® columns was
determined using ten two-component cross-hybridized mixtures. The mixtures
were sequentially injected onto ten different DNASep® columns and analyzed
under partially denaturing conditions. The results show that DHPLC assay results
are highly reproducible even when comparing across multiple DNASep® columns.
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Figure 8.3: Peak heights (Mean ± SD) determined from chromatographic traces of
representative 50:50 mixtures across all four forensically relevant amplicons
under partially denaturing conditions. The results demonstrate the low level of
assay-to-assay variability among ten replicate injections of a single amplification
reaction assayed sequentially by DHPLC.
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Figure 8.4: Retention times (Mean ± SD) determined from chromatographic
traces of representative 50:50 mixtures across all four forensically relevant
amplicons under partially denaturing conditions. The results demonstrate the
low level of assay-to-assay variability among ten replicate injections of a single
amplification reaction assayed sequentially by DHPLC.
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Variability as determined by peak retention time for the replicate injections onto
10 individual DNASep® columns ranged from ±10.4 to ±23.5%. Although columnto-column retention times are relatively large compared to amplification and
injection reproducibility, variability determined by comparison of relative
retention times of each peak to any other peak detected in the mixture, was
significantly smaller (Figure 8.5). Variability as determined by relative retention
times of each peak to any other peak detected in the mixture ranged from ±1.5
to ±8.4%. Fluctuations in peak height absorbance were minimal although, in one
case, the observed baseline was slightly above the mean for the other nine
columns (data not shown). This was most likely an artifact of equilibration time
as it disappeared with additional injections onto the column.
The DNASep® column is guaranteed by the manufacturer to last 6000
injections and can be routinely checked for peak resolution integrity. Qualitative
assessment of DNASep® column integrity and resolution capabilities is performed
by routine injection of column integrity standards. A number of compounds are
known to have detrimental effects on DNASep® column performance. These
include, but are not limited to bovine serum albumin (BSA), mineral oil,
formamide, polyethylene glycol (PEG), glycerol, DMSO and a variety of
detergents. Degradation of the column matrix can also occur as a result of
improper storage, such as not storing it in 75% acetonitrile or letting the column
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Figure 8.5: Average peak-to-peak spacing (Mean ± SD) determined from
chromatographic traces of representative 50:50 mixtures across the two HV2
forensically relevant amplicons assayed on ten independent DNAsep® columns
under partially denaturing conditions. The results demonstrate that when
normalized on the basis of relative peak-to-peak retention times, column-tocolumn variability is minimized.
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run dry. Degradation is observed by decreased resolution of standards peaks,
given that oven temperatures are accurate.
§ 8 - 3.5

Negative and Reagent Blank Control Screening

Due to excessive time and sample handling cost associated with the
sequencing of negative controls and reagent blanks in mtDNA casework analysis,
HPLC represents an attractive alternative for the analysis of negative and reagent
blank controls. UV and fluorescence detection limits using the DNASep® column
have previously been determined and validated (Chapter 3, automated peak
detection using the DHPLC Navigator™ Software: UV = 1.85±0.56ng; fluorescence
= 30.9±1.4pg, manual peak detection: UV = approx. 0.5ng; fluorescence = <10pg).
HPLC detection of the minimum amount of mtDNA amplicon required by dyeterminator sequencing was carried out by serial dilutions of purified HV2A
mtDNA fragments at quantities frequently encountered by forensic practitioners.
Replicate fragment quantities of 32.5pg, 62.5pg, 0.125ng, 0.25ng, 0.5ng, 1ng and
2ng were sequentially injected in triplicate onto the DNASep® column and
analyzed using non-denaturing conditions. Injected amplicon quantities lower
than 0.5ng showed no detectable deviation from baseline as observed by UV
absorbance for any of the replicate injections (Figure 8.6). The slight absorbance
increase observed over time in the UV baseline is a function of increase in
acetonitrile concentration as the gradient gradually shifts from low to high
concentrations of acetonitrile. All injected quantities of amplicon onto the
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Figure 8.6: Representative layered chromatogram showing the lower limits of UV
detection of a serially diluted DNA sample injected onto a DNASep® column.
Injected amplicon quantities lower than 0.5ng showed no detectable deviation
from baseline.
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DNASep® column were detected by DNA intercalating-dye fluorescence
detection (data not shown), consistent with results obtained for the crosscontamination study described above and results obtained in Chapter 3. All
injected samples were also subjected to dye-terminator sequencing analysis for
correlation purposes. Samples labeled with 2µL of 0.0125ng/µL (corresponding
to the 62.5pg HPLC injection of 5µL of the same sample) repeatedly failed to
yield any detectable sequence data (using 30sec dye-terminator sample injection
times).
Based on these data, analysis of negative and reagent blank controls by
HPLC can, therefore, be performed using fluorescence detection and the HSX
inline accessory due to the superior detection capabilities. Given that quantities
of amplificed product in a negative or reagent blank control don’t exceed the
0.0125ng/µL needed to successfully obtain a detectable sequence there is no
need to waste valuable time and reagents in confirming the absence of
sequencing data.

§8-4

Summary
Denaturing High-Performance Liquid Chromatography (DHPLC) was

validated as a tool for casework analysis of mtDNA amplicons. The WAVE®
3500HT DNA Fragment Analysis System in combination with the DNASep®
column was evaluated based on its reliability, sensitivity and consistency of
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analysis of cross-hybridized PCR products. Using subcloned mtDNA fragments,
the WAVE® 3500HT DNA Fragment Analysis System was tested for run-to-run
sample cross-contamination as detected by UV and fluorescence detection
methods. Only at DNASep® column saturation was cross-contamination detected
by high sensitivity fluorescence detection. Capture of run-to-run carryover
products, however, yielded DNA quantities below that required for dyeterminator sequencing. Repeated amplification, injection-to-injection and
column-to-column reproducibility were also determined by serial injections of
mtDNA amplicons. Variability in peak height and peak retention times was
negligible as evidenced by the small standard deviations recorded. Column-tocolumn variability was slightly higher, although comparison of relative retention
times of each peak to any other peak detected in the mixture was negligible.
HPLC screening of negative and reagent blank controls, routinely used in
casework analysis, was evaluated as a means for reducing dye-terminator
sequencing load in a forensic context. Negative or reagent blank controls yielding
less than 0.0125ng/µL were confirmed as not yielding a detectable sequence
data.
The results of this study demonstrate that the combination of WAVE®
3500HT DNA Fragment Analysis System and DNASep® column provides a
platform for consistent and reliable analysis of cross-hybridized PCR products
with unparalleled detection sensitivity. Additionally, the use of WAVE® 3500HT
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DNA Fragment Analysis System and DNASep® column streamlines mtDNA
analysis by combining sample purification, quantification and lengthcharacterization into a single step.
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Chapter 9: Streamlining Mitochondrial DNA Sequencing
Analysis for Forensic Casework Samples
§9-1

Introduction
In recent years, the number of forensic evidentiary samples that are

submitted for DNA analysis have increased dramatically. This is in part due to
significant increase in knowledge of DNA capabilities in the law enforcement
community and general acceptance of DNA evidence in court. Forensic scientists
have, therefore, focused significant effort on not only developing new methods
for retrieving and analyzing DNA evidence (e.g., low copy number (LCN), severely
degraded remains), but also streamline and enhance methods already in use by
the forensic community. This has resulted in significant advances in automated
robotics, sample handling methods and data analysis.
When traditional short tandem repeat (STR) DNA analyses fail,
mitochondrial DNA (mtDNA) sequence analysis may provide investigators with
useful information. This can help to advance criminal investigations (Allen et al.,
1994; Allen et al., 1998) or give emotional closure to families by identifying the
remains of loved ones (Holland et al., 1993). Mitochondrial sequence analyses,
however, do have limitations. Due to its strict maternal inheritance, lack of
recombination and inability to identify single individuals, mtDNA analysis cannot
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offer the kind of discrimination power that is seen when STR data are obtained.
Furthermore, mixtures of mtDNA are frequently observed. These mixtures can
exist within a single individual (i.e., heteroplasmy) or as situational mixtures. This
negatively impacts the value of mtDNA sequence analysis in two ways. First, it
lowers the power of discrimination because mixed nucleotide positions must
either be excluded from the reported results (e.g., length heteroplasmy) or used
in calculations of the number of possible haplotypes represented by the
sequence data. Second, the observation of a mixture in the resulting sequence
data is most typically reported as uninterpretible. A means of accurately and
readily resolving mixtures in a forensic context would have important
ramifications for the forensic community by allowing otherwise uninterpretible
samples to be analyzed.

§9-2

The Process of Mitochondrial DNA Analysis

§ 9 - 2.1

DNA Extraction and Amplification

The labor intensive manner of DNA extraction by Chelex™ or Phenol
Chloroform has prompted the development of faster robotic platforms. The
BioRobot EZ1 DNA extraction robot (Qiagen Inc., Valencia, CA), presents small to
medium size forensic laboratories with a new, easy to use platform that allows 16 samples to be extracted simultaneously in about 15 minutes. Each sample uses
a dedicated extraction channel, pipette tip and extraction cartridge as to
minimize the potential for cross-contamination. This significantly cuts down
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dedicated analyst time and yields DNA of significantly higher purity than existing
traditional methods (Montpetit et al., 2005).
Traditional

mtDNA

analysis

of

forensic

evidence

employs the

amplification of the mitochondrial control region (D-loop). Due to significant
degradation of genetic material observed when mtDNA sequencing analysis are
performed, this is generally achieved in four separate amplification reactions,
each amplifying a small segment of the control region (i.e., HV1A, HV1B, HV2A
and HV2B) (Wilson et al., 1995). When amplification of these fragments fail, the
analyst can further shorten the amplification target by employing a “miniprimer” set (Gabriel et al., 2001b). These targets divide the traditional amplicons
into two fragments each, possibly yielding results for severely degraded
evidentiary material.
§ 9 - 2.2 Purification and Yield Determination of Amplified PCR
Products
Following amplification, a host of methods exist for purifying amplified
PCR products. In forensic mtDNA laboratories this is typically accomplished by
use of spin column purification or nuclease/alkaline phosphatase treatment,
(e.g., ExoSAP-IT®) (Werle et al., 1994; Dugan et al., 2002). While these methods
are effective at removing small DNA fragments, such as primers, they are less
efficient at removing larger spurious amplification products. In addition, these
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methods have the limitation that they cannot distinguish between target PCR
amplicons and similar size spurious amplification products.
PCR amplification yield can be quantified by a number of approaches
including UV spectroscopy, gel electrophoresis, or microchip capillary
electrophoresis, all of which have a number of shortcomings. UV spectroscopy
cannot distinguish between an amplified target and residual primers or spurious
PCR amplification products resulting in the overestimation of the actual amount
of amplified target DNA. Agarose “yield gels”, are moderately labor intensive and
require crude comparisons of samples to a quantification ladder. Capillary
electrophoresis systems offers greater accuracy and precision but requires more
sample handling steps, investment in expensive dedicated equipment and higher
consumable costs per sample.
Purification

of

DNA

fragments

by

High

Performance

Liquid

Chromatography (HPLC) produces suitably purified target amplicons for use in
labeling reactions for DNA sequencing. Additionally, the height and area of DNA
fragment peaks on a chromatographic trace is a function of the quantity of DNA
detected. The use of HPLC, therefore, allows for combination of purification and
quantification into a single step. This effectively eliminates the need for yield gels
or other quantification methods, while also yielding information about the
presence and quantity of spurious co-amplified products (Chapter 3).
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In addition, HPLC can effectively be used to determine contamination
levels in negative control and reagent blank samples. Due to the sensitivity of
fluorescence detection based on the use of a DNA intercalating dye, picogram
quantities of amplified DNA can be detected. This can eliminate the need for
downstream sequencing analysis of negative controls and reagent blanks,
thereby, saving valuable time and money on samples which most of the time
yield no sequencing results at all.
§ 9 - 2.3

Mitochondrial DNA Characterization

To date, no method for mtDNA characterization (i.e., the presence of
heteroplasmy or multi-contributor mixture), prior to dye-terminator sequencing,
has been validated for use in the forensic community. A variety of methods have
been investigated, such as hybridization to linear arrays of sequence-specific
oligonucleotides (SSO) (Reynolds et al., 2000; Gabriel et al., 2001a); denaturing
gradient gel electrophoresis (DGGE) (Hanekamp et al., 1996); single-strand
conformational polymorphism (SSCP) analysis (Alonso et al., 1996; Barros et al.,
1997; Steighner et al., 1999); time-of-flight mass spectrometry (Butler et al.,
2001); and microarray-based analysis (Fukushima, 1999). These approaches,
suffer from a number of limitations which include: the interrogation of only a
subset of variant sites; cross-hybridization to non-target sequences; laborious
manipulations of gels (Meyers et al., 1988; Reynolds et al., 2000); and
interference by primer impurities (Butler et al., 2001). Most critically, however,
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these approaches suffer from the fact that they consume often precious forensic
evidence while not necessarily providing a reliably comprehensive assessment of
all possible sequence differences across the entire amplicon.
Denaturing HPLC (DHPLC) circumvents these limitations while offering the
potential to characterize mtDNA amplicons in an accurate, rapid and costeffective manner that can be easily automated. Moreover, DHPLC makes it
possible to recover the assayed DNA from the column eluent at the end of an
assay. The accuracy and sensitivity with which sequence variants can be detected
by DHPLC can be significantly influenced by the length, GC content and other
thermodynamic characteristics of the amplicon being assayed (Chapter 2). Using
carefully designed assay conditions the concordance between direct DNA
sequencing and comparative sequence analysis by DHPLC typically ranges from
95-100%. In some cases, DHPLC has proven to have greater sensitivity than direct
DNA sequencing for the detection of minor component sequence variants.
Mitochondrial DNA characterization allows for determination of sample
complexity prior to costly dye terminator sequencing and time consuming
analysis. The analyst can, therefore, gain valuable information on whether a
sample contains base heteroplasmy, or worse yet, is a mixture of two or more
contributors. In addition to characterization, and in cases where samples contain
mtDNA from more than one source, the analyst can divide the mixture into a
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series of fractions in an attempt to separate individual contributors. The isolated
fractions can then be subjected to direct dye-terminator sequencing analysis
without the need to re-amplify the captured PCR product.
§ 9 - 2.4

Sequencing Analysis

§ 9 - 2.4.1

Single Contributor mtDNA Analysis

The profiling of human mtDNA is achieved by comparison of DNA
sequence data to the revised Cambridge Reference Sequence (rCRS) (Anderson
et al., 1981; Andrews et al., 1999). Differences are noted and reported by
indicating the nucleotide position and the identity of the altered base. In cases of
heteroplasmy, a base is indicated either as the combination of the two mixed
bases (e.g., a mixture of nucleotides “A” and “G”, is reported as “R”), or as
undetermined (“N”).
§ 9 - 2.4.2

Mitochondrial DNA Mixture Analysis

Samples considered true mixtures by forensic interpretation standards
are those which display mixed nucleotides at two or more positions. In forensic
mtDNA analysis, mixed nucleotide positions are generally labeled undetermined
(“N”), eliminating the nucleotide from the overall analysis. This can prevent an
analyst from being able to determine the true level of discrimination between
sequences that are thought to “match” (Fourney, 1998). Although strategies for
separating mtDNA mixtures have been proposed (Alonso et al., 1996; Hanekamp
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et al., 1996; Hatsch et al., 2007), all display significant obstacles for
implementation by forensic laboratories.
Denaturing HPLC in combination with Linkage Phase Analysis (LPA) allow
for separation and statistical analysis of mtDNA mixtures in a manner that
circumvents the limitations of alternative methods. The sensitivity of DHPLC for
identification and fractionation of non-identical samples and the capability of LPA
to analyze peak height ratio changes of mixed nucleotides from multiple
sequencing electropherograms allow for the identification of individual
contributors to a mixture. Depending on the shift in peak height ratio between
electropherograms obtained from different fractions, identification of individual
contributors to the mixture can be achieved with high degree of statistical
significance (>99%) (Chapter 6).
§ 9 - 2.4.3 Fractional Linkage Phase Analysis Resource Software
(FLiPARS)
Due to the time consuming and tedious nature of sequencing analysis a
software application has been developed to streamline and speed identification
of mixed nucleotides and LPA of mixed mtDNA samples. The software application
initially aligns all imported sequence data to the revised Cambridge Reference
Sequence (rCRS) using the Needleman-Wunsch global alignment algorithm
(Needleman et al., 1970). It then scans each analyzed sequencing
electropherogram, identifying all nucleotide positions which have a secondary
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peak height above 10% of that of the major component consistent with existing
interpretation standards for forensic laboratories. The identified nucleotide
positions are consolidated into a table where the analyst can select which
nucleotides are used for LPA. The two sequencing electropherograms which yield
the greatest shift in peak height fluorescence across all mixed nucleotides
positions are then used to: calculate the shift in peak height fluorescence for
each mixed positions; determine the confidence of separation based on the shift
in peak height fluorescence; and identify the two contributors to the mixture. In
addition to this, the user interface displays the number of data points behind the
statistical determination performed. Furthermore, confidence of separation is
indicated for each base next to the confidence and base determination tables. A
green indicator reveals ≥17% shift in peak height fluorescence and ≥99.9%
confidence in separation. A yellow indicator reveals ≥6% shift in peak height
fluorescence and ≥99% confidence in separation, while a red indicator reveals
<6% shift in peak height fluorescence and <99% confidence in separation.
The software application has been tested on 43 blind samples using
results obtained during the manually analyzed validation studies of LPA (Chapter
6). Figure 9.1 illustrates results obtained using the manual calculation method
(Figure 9.1A) and FLiPARS (Figure 9.1B) for a HV2A mtDNA mixture with 8 mixed
nucleotides. For all eight mixed positions, fluorescence ratio shift comparison for
fractions 7 and 11 are identical, resulting in consistent determination of
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Figure 9.1: Linkage phase analysis results obtained for a two-component HV2A
mtDNA mixture containing eight mixed nucleotide positions. (A) LPA performed
using a manual calculation method. (B) LPA performed using an automated
software application method (FLiPARS). Comparison of linkage phase results
yields no differences between the two methods used and complete concordance
in the contributor haplotypes identified.
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contributor nucleotides and associated confidence of separation. In all mtDNA
mixtures analyzed by LPA to date, 100% concordance exists between results
analyzed manually and those analyzed by FLiPARS (Table 9.1).
This being said, subtle differences do exists in determinations of linkage
phase between the manual calculation and those analyzed using FLiPARS. These
exist purely as programming issues, the potential significance of which is not
entirely known. Briefly though, sequencing of mixed templates yields two
overlapping peaks at mixed-base positions which typically overlap completely. In
some cases, however, the minor component peak is shifted slightly up- or
downstream of the maximum fluorescence peak of the major component.
FLiPARS compensates for this variability by analyzing ±3 data points (±9.28sec)
away from the maximum fluorescence of the major component, in attempt to
determine the maximum peak height for the minor component. However, if the
minor component peak height maximum falls outside this window, the minor
components true peak height will be underestimated. As the shift in minor
component peak increases the larger the underestimation in peak height ratio.
Any future modifications to the software will have to address this issue, by either
allowing the user to manually widen the peak crest scanning range or by
developing an algorithm which detects shifts in secondary component peaks and
modifies the peak crest scanning range accordingly.
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Table 9.1: Comparison of LPA for 47 simulated casework samples using the
manual linkage phase determination and FLiPARS. Deviation in mixture
separation confidence shows minimal differences between the two analysis
methods.
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In addition to the essential modification to the detection of shifted peak
crests, the ability to view sequencing electropherograms and modify miscalled
nucleotides would be a welcomed addition to FLiPARS. This would eliminate the
need for secondary electropherogram viewing/editing applications such as
Sequencher™ (Gene Codes Corp, Ann Arbor, MI) or Lasergene® (DNASTAR, Inc.,
Madison, WI) and significantly speed analysis of mtDNA mixtures. Finally, the
ability to compare sequence quality, based on optimal intensity ratio (Chapter 4)
relative to a pristine reference electropherogram, would allow for a quick quality
control assessment of questioned electropherograms.
§ 9 - 2.5

Streamlining of mtDNA Analysis

Obtaining an mtDNA haplotype from forensic samples is a very labor
intensive process which requires multiple handling steps (Figure 9.2). Currently,
mtDNA analyses require that an analyst use separate methods for PCR product
purification and quantification. Determination of low level amplification in
negative controls and reagent blanks currently cannot be obtained until results
from dye-terminator sequencing are analyzed. Determination of whether a
sample contains multiple starting templates or is site or length heteroplasmic is
currently not possible until dye-terminator sequencing analyses are performed.
Furthermore, low level mixtures can go unnoticed or misinterpreted as being
heteroplasmic due to differential incorporation of dye-terminators. All of these
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Figure 9.2: Sample process flow for traditional mtDNA dye-terminator
sequencing based analysis. Two different techniques are used for sample
purification and quantification. Currently no method is available for detecting the
presence of mixed templates, screening negative controls and reagent blanks or
identifying the haplotypes of individual contributors to mtDNA mixtures.
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factors have prompted the development and implementation of mtDNA analysis
by DHPLC for forensic samples.
Analysis of mtDNA amplicons using the demonstrated diversity of DHPLC
applications streamlines the overall process of PCR product purification,
quantification and allows for mixture detection prior to dye-terminator
seuqencing (Figure 9.3). DHPLC yields highly purified amplicons, free of spurious
amplification products while simultaneously providing information on the
amplification yield quantity. Determination of mixed templates has traditionally
required dye-terminator labeling and subsequent sequencing, however, DHPLC
analysis yields immediate information on sample complexity without the need
for further sample manipulation. DHPLC also adds mixture fractionation
capabilities, which in conjunction with LPA allows for mtDNA mixture separation
and contributor identification. Mitochondrial DNA analyses by DHPLC require
only minor modifications to standard operating procedures currently employed
in forensic caseworking laboratories. All DHPLC instrument components and
applications have been validated in accordance with SWGDAM developmental
validation guidelines (SWGDAM, 2004). These factors are essential in
implementing DHPLC analysis in a forensic casework environment and for the
admissibility of DHPLC and LPA in court.
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Figure 9.3: Sample process flow for mtDNA sequence analysis using DHPLC, dyeterminator sequencing and LPA. DHPLC analyses are used for sample purification
and quantification in a single step. DHPLC analyses are also used for mixture
identification/fractionation and to screen negative controls and reagent blanks.
LPA is used to determine the linkage phase (i.e., the haplotypes) of the individual
contributors to mtDNA mixtures and to calculate the statistical confidence of
mixture resolution for each base position.
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Appendices

Appendix A
Sequence polymorphisms in HV1 for the 99 samples collected and used in this
study as compared to the revised Cambridge Reference Sequence (rCRS).
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Sequence polymorphisms in HV2 for the 99 samples collected and used in this
study as compared to the revised Cambridge Reference Sequence (rCRS).
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Appendix B

Reproducibility of electrophoretic peak heights for the mtDNA HV1A amplicon
sequenced with the A1 primer (Table 2.1) . The data represent the mean peak
heights ± standard deviations from five independent labeling reactions for each
of five DNA input quantities.

Reproducibility of electrophoretic peak heights for the mtDNA HV1A amplicon
sequenced with the B2 primer (Table 2.1) . The data represent the mean peak
heights ± standard deviations from five independent labeling reactions for each
of five DNA input quantities.
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Reproducibility of electrophoretic peak heights for the mtDNA HV1B amplicon
sequenced with the B1 primer (Table 2.1) . The data represent the mean peak
heights ± standard deviations from five independent labeling reactions for each
of five DNA input quantities.

Reproducibility of electrophoretic peak heights for the mtDNA HV1B amplicon
sequenced with the A2 primer (Table 2.1) . The data represent the mean peak
heights ± standard deviations from five independent labeling reactions for each
of five DNA input quantities.
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Reproducibility of electrophoretic peak heights for the mtDNA HV2A amplicon
sequenced with the C1 primer (Table 2.1) . The data represent the mean peak
heights ± standard deviations from five independent labeling reactions for each
of five DNA input quantities.

Reproducibility of electrophoretic peak heights for the mtDNA HV2A amplicon
sequenced with the D2 primer (Table 2.1) . The data represent the mean peak
heights ± standard deviations from five independent labeling reactions for each
of five DNA input quantities.
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Reproducibility of electrophoretic peak heights for the mtDNA HV2B amplicon
sequenced with the D1 primer (Table 2.1) . The data represent the mean peak
heights ± standard deviations from five independent labeling reactions for each
of five DNA input quantities.

Reproducibility of electrophoretic peak heights for the mtDNA HV2B amplicon
sequenced with the C2 primer (Table 2.1) . The data represent the mean peak
heights ± standard deviations from five independent labeling reactions for each
of five DNA input quantities.
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